Nyannie的个人主页 - 老虎社区

Nyannie

Nyannie

暂无个人介绍

IP属地：未知

311关注

24粉丝

0主题

0勋章

2021-12-14

Good

3M to combine food safety business with Neogen

2021-12-13

Good

Amazon Stock vs. the Omicron Variant – What You Need to Know

2021-12-11

Good

Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting

2021-12-10

Vgg

Tesla shares dropped 1% in premarket trading

2021-12-07

Good

Apple Gets Another Street-High Target on Virtual Reality Boost

2021-12-05

Good

DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'

2021-12-03

Good

Grab SPAC Merger Alert: 8 Things to Know as GRAB Stock Falls 20% on Its Nasdaq Debut

2021-11-30

Nice

Wall Street Dip Buyers Defy Omicron Inflation Risk at Their Own Peril

2021-11-29

Good

Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week

2021-11-28

Good

U.S. issues 'Do Not Travel' advisory for eight African countries

2021-11-27

Good

These 3 Stocks Punished the Dow Friday

2021-11-26

Good

China to remain 'super market' into next year - Daimler China chief

2021-11-25

Good

抱歉，原内容已删除

2021-11-23

Nice

Samsung to Choose Taylor, Texas, for $17 Billion Chipmaking Factory

2021-11-22

Good

抱歉，原内容已删除

2021-11-21

Good

Does Sono Group Have a Breakthrough Innovation That Could Put “Range Anxiety” to Bed?

2021-11-19

Nice

CVS to close 900 drugstores in three years to beef up health services

2021-11-17

Good

抱歉，原内容已删除

2021-11-16

Good

抱歉，原内容已删除

2021-11-15

Good

Pfizer’s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582719067968878","uuid":"3582719067968878","gmtCreate":1619626233994,"gmtModify":1634435628264,"name":"Nyannie","pinyin":"nyannie","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":24,"headSize":311,"tweetSize":116,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":607391289,"gmtCreate":1639485590344,"gmtModify":1639485590615,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607391289","repostId":"1110120887","repostType":4,"repost":{"id":"1110120887","kind":"news","pubTimestamp":1639482502,"share":"https://www.laohu8.com/m/news/1110120887?lang=&edition=full","pubTime":"2021-12-14 19:48","market":"us","language":"en","title":"3M to combine food safety business with Neogen","url":"https://stock-news.laohu8.com/highlight/detail?id=1110120887","media":"Reuters","summary":"Industrial giant 3M Co(MMM.N)will separate its food safety business and merge it with Neogen Corp(NE","content":"<p>Industrial giant 3M Co(MMM.N)will separate its food safety business and merge it with Neogen Corp(NEOG.O)in a $5.3 billion deal, including new debt, the food testing and animal healthcare specialist said on Tuesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3M to combine food safety business with Neogen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3M to combine food safety business with Neogen\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/markets/deals/3m-combine-food-safety-business-with-neogen-2021-12-14/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Industrial giant 3M Co(MMM.N)will separate its food safety business and merge it with Neogen Corp(NEOG.O)in a $5.3 billion deal, including new debt, the food testing and animal healthcare specialist ...</p>\n\n<a href=\"https://www.reuters.com/markets/deals/3m-combine-food-safety-business-with-neogen-2021-12-14/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MMM":"3M"},"source_url":"https://www.reuters.com/markets/deals/3m-combine-food-safety-business-with-neogen-2021-12-14/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110120887","content_text":"Industrial giant 3M Co(MMM.N)will separate its food safety business and merge it with Neogen Corp(NEOG.O)in a $5.3 billion deal, including new debt, the food testing and animal healthcare specialist said on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604830655,"gmtCreate":1639366638899,"gmtModify":1639366639203,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604830655","repostId":"1137818413","repostType":4,"repost":{"id":"1137818413","kind":"news","pubTimestamp":1639364203,"share":"https://www.laohu8.com/m/news/1137818413?lang=&edition=full","pubTime":"2021-12-13 10:56","market":"us","language":"en","title":"Amazon Stock vs. the Omicron Variant – What You Need to Know","url":"https://stock-news.laohu8.com/highlight/detail?id=1137818413","media":"TheStreet","summary":"Amazon didn’t just survive the first round of Covid lockdowns – it thrived because of them. With the","content":"<p>Amazon didn’t just survive the first round of Covid lockdowns – it thrived because of them. With the Omicron variant rattling the stock market, investors are wondering if Amazon can pull it off again.</p>\n<p>Although 2020 was a curse for brick-and-mortar businesses, it was a blessing for e-commerce. And among the most blessed of all was&nbsp;<b>Amazon</b>(<b>AMZN</b>).</p>\n<p>With billions of people around the globe stuck at home due to government-mandated lockdowns, it’s no surprise that Amazon’s sales skyrocketed last year.</p>\n<p>And it should also come as no surprise that, once lockdown restrictions eased in 2021, the Seattle-based behemoth saw its revenue growth start to slow.</p>\n<p>That was especially the case in the third quarter, when Amazon’s revenue missed both top- and bottom-line expectations.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b26230534e7279e5f9c21077e59cf721\" tg-width=\"1240\" tg-height=\"930\" width=\"100%\" height=\"auto\"><span>Figure 1: Amazon Go store in New York, NY.</span></p>\n<p>But now the Omicron variant has the world worried again. Currently, we don’t know just how dangerous this fast-spreading strain of COVID is. But the growing number of cases has people wondering if more lockdown mandates are in the works.</p>\n<p>If the world were to shut down again, would Amazon’s revenue repeat last year’s performance? Let’s take a look at what might be in store for AMZN stock.</p>\n<p><b>Would another lockdown hurt Amazon?</b></p>\n<p>Analysts agree: If the Omicron variant causes another lockdown, it’s likely we’ll see another increase in e-commerce sales.</p>\n<p>But this time, traditionally brick-and-mortar retailers have “wised up” and improved their own e-commerce efforts. Will this increase in competition sink Amazon’s profits?</p>\n<p>At this point, Amazon is so huge that even an iceberg of rivals would hardly make a dent.</p>\n<p>Other retailers have been suffering from supply-chain constraints and labor-related pressures. But Amazon has the advantages of scale. The company has also been investing in improvements to its supply-chain infrastructure to keep products on warehouse shelves.</p>\n<p>As for labor, the company has always had a high turnover rate around 150%. Amazon has had plenty of practice of finding new workers.</p>\n<p>In fact, given the company’s many advantages, it’s possible that investors could use Amazon’s stock as a hedge against another lockdown.</p>\n<p><b>Amazon is Cramer’s No. 1 pick</b></p>\n<p><i>Mad Money</i>&nbsp;host Jim Cramer&nbsp;recently announced&nbsp;that Amazon is his No. 1 stock pick if the Omicron variant causes either another round of lockdowns or a slowdown in the economy.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4c69a86e9a1e2e2f2ec78ad5128d0907\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 2: Mad Money's host Jim Cramer.</span></p>\n<p>He argued that – in addition to Amazon’s e-commerce business – its Amazon Web Services (AWS) segment sets it apart from the rest.</p>\n<p>According to Cramer, no matter what happens with the Omicron variant or the economy, businesses will still migrate to cloud computing. And so far, AWS is the market leader by a wide margin.</p>\n<blockquote>\n “[Amazon] is a company that does well when people are scared to go to the mall. And it does well as more companies embrace the cloud, because Amazon Web Services is indeed the dominant player in cloud infrastructure,” he noted.\n</blockquote>\n<p>In addition, he noted that, when the going gets tough, Amazon can always get away with raising its prices.</p>\n<p><b>Our take</b></p>\n<p>Although we don’t know for certain what effects the Omicron strain will ultimately have on the global economy, it has already caused some extra volatility in the markets.</p>\n<p>For investors, Amazon’s stock might work well as a hedge against another lockdown. After all, its business segments – including e-commerce and cloud computing – have already benefited from such a scenario. Why not do it again?</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon Stock vs. the Omicron Variant – What You Need to Know</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon Stock vs. the Omicron Variant – What You Need to Know\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 10:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/amazon/news/amazon-stock-vs-the-omicron-variant-what-you-need-to-know><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon didn’t just survive the first round of Covid lockdowns – it thrived because of them. With the Omicron variant rattling the stock market, investors are wondering if Amazon can pull it off again....</p>\n\n<a href=\"https://www.thestreet.com/amazon/news/amazon-stock-vs-the-omicron-variant-what-you-need-to-know\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.thestreet.com/amazon/news/amazon-stock-vs-the-omicron-variant-what-you-need-to-know","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137818413","content_text":"Amazon didn’t just survive the first round of Covid lockdowns – it thrived because of them. With the Omicron variant rattling the stock market, investors are wondering if Amazon can pull it off again.\nAlthough 2020 was a curse for brick-and-mortar businesses, it was a blessing for e-commerce. And among the most blessed of all was Amazon(AMZN).\nWith billions of people around the globe stuck at home due to government-mandated lockdowns, it’s no surprise that Amazon’s sales skyrocketed last year.\nAnd it should also come as no surprise that, once lockdown restrictions eased in 2021, the Seattle-based behemoth saw its revenue growth start to slow.\nThat was especially the case in the third quarter, when Amazon’s revenue missed both top- and bottom-line expectations.\nFigure 1: Amazon Go store in New York, NY.\nBut now the Omicron variant has the world worried again. Currently, we don’t know just how dangerous this fast-spreading strain of COVID is. But the growing number of cases has people wondering if more lockdown mandates are in the works.\nIf the world were to shut down again, would Amazon’s revenue repeat last year’s performance? Let’s take a look at what might be in store for AMZN stock.\nWould another lockdown hurt Amazon?\nAnalysts agree: If the Omicron variant causes another lockdown, it’s likely we’ll see another increase in e-commerce sales.\nBut this time, traditionally brick-and-mortar retailers have “wised up” and improved their own e-commerce efforts. Will this increase in competition sink Amazon’s profits?\nAt this point, Amazon is so huge that even an iceberg of rivals would hardly make a dent.\nOther retailers have been suffering from supply-chain constraints and labor-related pressures. But Amazon has the advantages of scale. The company has also been investing in improvements to its supply-chain infrastructure to keep products on warehouse shelves.\nAs for labor, the company has always had a high turnover rate around 150%. Amazon has had plenty of practice of finding new workers.\nIn fact, given the company’s many advantages, it’s possible that investors could use Amazon’s stock as a hedge against another lockdown.\nAmazon is Cramer’s No. 1 pick\nMad Money host Jim Cramer recently announced that Amazon is his No. 1 stock pick if the Omicron variant causes either another round of lockdowns or a slowdown in the economy.\nFigure 2: Mad Money's host Jim Cramer.\nHe argued that – in addition to Amazon’s e-commerce business – its Amazon Web Services (AWS) segment sets it apart from the rest.\nAccording to Cramer, no matter what happens with the Omicron variant or the economy, businesses will still migrate to cloud computing. And so far, AWS is the market leader by a wide margin.\n\n “[Amazon] is a company that does well when people are scared to go to the mall. And it does well as more companies embrace the cloud, because Amazon Web Services is indeed the dominant player in cloud infrastructure,” he noted.\n\nIn addition, he noted that, when the going gets tough, Amazon can always get away with raising its prices.\nOur take\nAlthough we don’t know for certain what effects the Omicron strain will ultimately have on the global economy, it has already caused some extra volatility in the markets.\nFor investors, Amazon’s stock might work well as a hedge against another lockdown. After all, its business segments – including e-commerce and cloud computing – have already benefited from such a scenario. Why not do it again?","news_type":1},"isVote":1,"tweetType":1,"viewCount":675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605596343,"gmtCreate":1639187445275,"gmtModify":1639187445530,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605596343","repostId":"2190673267","repostType":4,"repost":{"id":"2190673267","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639176815,"share":"https://www.laohu8.com/m/news/2190673267?lang=&edition=full","pubTime":"2021-12-11 06:53","market":"hk","language":"en","title":"Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2190673267","media":"Reuters","summary":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year,","content":"<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St Week Ahead-Investors await faster taper, inflation view at Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 06:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190673267","content_text":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.\nStocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.\nThere is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.\nMarkets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.\n“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.\nHigher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.\nThe S&P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.\nThe yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.\nSome stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.\nThe broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.\nThe Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.\nBets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.\nInvestors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.\nOne possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.\nMona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.\n“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":837,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605134376,"gmtCreate":1639127509897,"gmtModify":1639127823038,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Vgg","listText":"Vgg","text":"Vgg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605134376","repostId":"1116553400","repostType":4,"repost":{"id":"1116553400","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639126992,"share":"https://www.laohu8.com/m/news/1116553400?lang=&edition=full","pubTime":"2021-12-10 17:03","market":"us","language":"en","title":"Tesla shares dropped 1% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1116553400","media":"Tiger Newspress","summary":"Tesla shares dropped 1% in premarket trading after Musk sold Tesla shares worth $963.2 million and M","content":"<p>Tesla shares dropped 1% in premarket trading&nbsp;after&nbsp;Musk sold Tesla shares worth $963.2 million&nbsp;and&nbsp;Musk said he was 'thinking of' quitting his jobs.</p>\n<p><img src=\"https://static.tigerbbs.com/c002d1f5382a827395e32925514d05f4\" tg-width=\"843\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Tesla Inc&nbsp;Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.</p>\n<p>He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.</p>\n<p>Tesla Inc&nbsp;Chief Executive Officer Elon Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.</p>\n<p>\"thinking of quitting my jobs &amp; becoming an influencer full-time wdyt,\" Musk&nbsp;said&nbsp;in the tweet, without elaborating.</p>\n<p>It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.</p>\n<p>Musk, who is also the founder and CEO of rocket company SpaceX, and leads brain-chip startup Neuralink and infrastructure firm The Boring Company, said during a conference call in January that he expects to be the CEO of Tesla for \"several years\".</p>\n<p>\"It would be nice to have a bit more free time on my hands as opposed to just working day and night, from when I wake up to when I go to sleep 7 days a week. Pretty intense.\"</p>\n<p>Last month, he asked his followers on Twitter whether he should sell 10% of his stake in the electric-car maker, to which the majority agreed. He has sold shares worth nearly $12 billion since.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla shares dropped 1% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla shares dropped 1% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tesla shares dropped 1% in premarket trading&nbsp;after&nbsp;Musk sold Tesla shares worth $963.2 million&nbsp;and&nbsp;Musk said he was 'thinking of' quitting his jobs.</p>\n<p><img src=\"https://static.tigerbbs.com/c002d1f5382a827395e32925514d05f4\" tg-width=\"843\" tg-height=\"620\" referrerpolicy=\"no-referrer\"></p>\n<p>Tesla Inc&nbsp;Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.</p>\n<p>He also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.</p>\n<p>Tesla Inc&nbsp;Chief Executive Officer Elon Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.</p>\n<p>\"thinking of quitting my jobs &amp; becoming an influencer full-time wdyt,\" Musk&nbsp;said&nbsp;in the tweet, without elaborating.</p>\n<p>It was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.</p>\n<p>Musk, who is also the founder and CEO of rocket company SpaceX, and leads brain-chip startup Neuralink and infrastructure firm The Boring Company, said during a conference call in January that he expects to be the CEO of Tesla for \"several years\".</p>\n<p>\"It would be nice to have a bit more free time on my hands as opposed to just working day and night, from when I wake up to when I go to sleep 7 days a week. Pretty intense.\"</p>\n<p>Last month, he asked his followers on Twitter whether he should sell 10% of his stake in the electric-car maker, to which the majority agreed. He has sold shares worth nearly $12 billion since.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116553400","content_text":"Tesla shares dropped 1% in premarket trading after Musk sold Tesla shares worth $963.2 million and Musk said he was 'thinking of' quitting his jobs.\n\nTesla Inc Chief Executive Officer Elon Musk has sold another 934,091 shares of the electric vehicle maker worth $963.2 million, U.S. securities filings showed on Thursday.\nHe also exercised stock options to buy 2.17 million shares of Tesla, according to the filings.\nTesla Inc Chief Executive Officer Elon Musk is \"thinking of\" leaving his jobs and becoming an influencer, the world's richest man tweeted on Thursday.\n\"thinking of quitting my jobs & becoming an influencer full-time wdyt,\" Musk said in the tweet, without elaborating.\nIt was not immediately clear if Musk, a prolific user of the social media platform, was being serious about quitting his roles.\nMusk, who is also the founder and CEO of rocket company SpaceX, and leads brain-chip startup Neuralink and infrastructure firm The Boring Company, said during a conference call in January that he expects to be the CEO of Tesla for \"several years\".\n\"It would be nice to have a bit more free time on my hands as opposed to just working day and night, from when I wake up to when I go to sleep 7 days a week. Pretty intense.\"\nLast month, he asked his followers on Twitter whether he should sell 10% of his stake in the electric-car maker, to which the majority agreed. He has sold shares worth nearly $12 billion since.","news_type":1},"isVote":1,"tweetType":1,"viewCount":832,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606673970,"gmtCreate":1638878391460,"gmtModify":1638878391674,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606673970","repostId":"1102192068","repostType":4,"repost":{"id":"1102192068","kind":"news","pubTimestamp":1638875652,"share":"https://www.laohu8.com/m/news/1102192068?lang=&edition=full","pubTime":"2021-12-07 19:14","market":"us","language":"en","title":"Apple Gets Another Street-High Target on Virtual Reality Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=1102192068","media":"Bloomberg","summary":"Apple to benefit from VR products, vehicles: Morgan Stanley\nIPhone maker’s shares closed at record h","content":"<ul>\n <li>Apple to benefit from VR products, vehicles: Morgan Stanley</li>\n <li>IPhone maker’s shares closed at record high on Monday</li>\n</ul>\n<p>Apple Inc.&nbsp;got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.</p>\n<p>Analyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. The shares rose as much as 2% to $168.63 in U.S. premarket trading.</p>\n<p>While investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.</p>\n<p>“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”</p>\n<p><img src=\"https://static.tigerbbs.com/7d1d69bd985c3b74963515674f2da918\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>Apple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.</p>\n<p>Huberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Gets Another Street-High Target on Virtual Reality Boost</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Gets Another Street-High Target on Virtual Reality Boost\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 19:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-07/apple-gets-another-street-high-target-on-virtual-reality-boost?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple to benefit from VR products, vehicles: Morgan Stanley\nIPhone maker’s shares closed at record high on Monday\n\nApple Inc. got its second Street-high price target as Morgan Stanley sees it ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-07/apple-gets-another-street-high-target-on-virtual-reality-boost?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-07/apple-gets-another-street-high-target-on-virtual-reality-boost?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102192068","content_text":"Apple to benefit from VR products, vehicles: Morgan Stanley\nIPhone maker’s shares closed at record high on Monday\n\nApple Inc. got its second Street-high price target as Morgan Stanley sees it benefiting from new product categories in virtual reality and autonomous vehicles.\nAnalyst Katy Huberty, who rates Apple overweight, raised her price target to $200 from $164, matching Wedbush as the highest among targets tracked by Bloomberg. The shares rose as much as 2% to $168.63 in U.S. premarket trading.\nWhile investors have struggled to value the iPhone maker’s new products given the company’s secrecy, Huberty expects augmented and virtual reality, as well as autonomous vehicles, to eventually be priced in, and says Apple should also benefit from a “flight to quality” in technology stocks.\n“Despite a consistent and material revenue contribution from new products and services over time, Apple shares don’t seem to bake in the impact from upcoming new product launches,” Huberty wrote in a note. “We believe this will change as Apple approaches the launch of an AR/VR product over the next year.”\n\nApple’s shares have surged 25% this year and ended Monday’s session at a fresh record. Investors consider the tech giant a safe bet in an increasingly volatile market, as the highest-valued names in the sector get hit by hawkish signals from the Federal Reserve.\nHuberty also increased her estimates for Apple’s December quarter, citing improving iPhone supply as manufacturing disruptions ease.","news_type":1},"isVote":1,"tweetType":1,"viewCount":776,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608861237,"gmtCreate":1638683088038,"gmtModify":1638683088195,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608861237","repostId":"2188578706","repostType":4,"repost":{"id":"2188578706","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638577500,"share":"https://www.laohu8.com/m/news/2188578706?lang=&edition=full","pubTime":"2021-12-04 08:25","market":"us","language":"en","title":"DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'","url":"https://stock-news.laohu8.com/highlight/detail?id=2188578706","media":"Dow Jones","summary":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pande","content":"<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 08:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4528":"SaaS概念","DOCU":"Docusign"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188578706","content_text":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down\nDocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.\nShares of DocuSign $(DOCU)$ fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"\nThe stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&P 500 index has rallied 21% this year after climbing 16% last year.\nThe company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"\nCiti Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.\n\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.\nRadke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.\nEvercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"\nBut the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"\nWhile he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"\nHe cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.\nDocuSign shares are off roughly 52% from their September closing high of $310.05.","news_type":1},"isVote":1,"tweetType":1,"viewCount":939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601170693,"gmtCreate":1638502178933,"gmtModify":1638502179055,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601170693","repostId":"1108760971","repostType":4,"repost":{"id":"1108760971","kind":"news","pubTimestamp":1638499412,"share":"https://www.laohu8.com/m/news/1108760971?lang=&edition=full","pubTime":"2021-12-03 10:43","market":"us","language":"en","title":"Grab SPAC Merger Alert: 8 Things to Know as GRAB Stock Falls 20% on Its Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1108760971","media":"InvestorPlace","summary":"Southeast Asia ride-hailing and food-delivery company Grab(NASDAQ:GRAB) went public today to a fairl","content":"<p>Southeast Asia ride-hailing and food-delivery company&nbsp;<b>Grab</b>(NASDAQ:<b><u>GRAB</u></b>) went public today to a fairly muted reaction from investors. The Singapore-based company first piqued investors’ attention with its array of super apps across financial, delivery and transportation services. Despite opening at $12.40 this morning, GRAB stock has steadily declined, currently sitting at $8.75 at market close, more than 20% down on the day.</p>\n<p>Grab is one of many highly anticipated companies that have gone public via special purpose acquisition company (SPAC) mergers. Indeed, it’s been a&nbsp;packed field&nbsp;for SPAC mergers this season. More and more companies opt to go public via SPAC nowadays, as it has the potential to save tremendous amounts of time and money in their initial public offerings (IPOs). Not every company thrives off of it, however, as is evident this afternoon.</p>\n<p>Grab Chief Executive Anthony Tan&nbsp;commented onGRAB’s downtrend today. “The price makes no difference to me. I’m going to celebrate tonight and get back to work tomorrow,” Tan said.</p>\n<p>So, what else should investors know about GRAB stock today?</p>\n<p>8 Things to Know as GRAB Stock Slides Today</p>\n<ol>\n <li>GRAB’s backdoor listing comes after an agreement with U.S. tech SPAC,&nbsp;<b>Altimeter Growth Corp</b>.</li>\n <li>The deal saw GRAB raise $4.5 billion in funding, including $750 million from Altimeter.</li>\n <li>Grab is a high-growth contender. Some expect the Southeast Asia digital economy to double by 2025.</li>\n <li>The company began as a Malaysia-based taxi app in 2012. Since then, it’s expanded into various other industries and mobile services.</li>\n <li>Additionally, GRAB has support from some big players. Indeed,&nbsp;<b>Toyota</b>(NYSE:<b><u>TM</u></b>),&nbsp;<b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) and&nbsp;<b>Uber</b>(NYSE:<b><u>UBER</u></b>) each have a stake in the company.</li>\n <li>Unfortunately, Grab had less-than stellar revenue numbers to report this past quarter. Revenue was down 9% year-over-year, mostly attributed to Covid-19-related lockdowns across Southeast Asia, especially Vietnam.</li>\n <li>However, Grab is aiming for profitability by 2023. At that point, the burgeoning Southeast Asian internet economy is expected to have grown substantially.</li>\n <li>The super apps are operational in more than 465 cities across eight countries and offer everything from food-delivery to investment services.</li>\n</ol>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab SPAC Merger Alert: 8 Things to Know as GRAB Stock Falls 20% on Its Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab SPAC Merger Alert: 8 Things to Know as GRAB Stock Falls 20% on Its Nasdaq Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 10:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/grab-spac-merger-alert-8-things-to-know-as-grab-stock-falls-20-on-its-nasdaq-debut/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Southeast Asia ride-hailing and food-delivery company Grab(NASDAQ:GRAB) went public today to a fairly muted reaction from investors. The Singapore-based company first piqued investors’ attention with ...</p>\n\n<a href=\"https://investorplace.com/2021/12/grab-spac-merger-alert-8-things-to-know-as-grab-stock-falls-20-on-its-nasdaq-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"source_url":"https://investorplace.com/2021/12/grab-spac-merger-alert-8-things-to-know-as-grab-stock-falls-20-on-its-nasdaq-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108760971","content_text":"Southeast Asia ride-hailing and food-delivery company Grab(NASDAQ:GRAB) went public today to a fairly muted reaction from investors. The Singapore-based company first piqued investors’ attention with its array of super apps across financial, delivery and transportation services. Despite opening at $12.40 this morning, GRAB stock has steadily declined, currently sitting at $8.75 at market close, more than 20% down on the day.\nGrab is one of many highly anticipated companies that have gone public via special purpose acquisition company (SPAC) mergers. Indeed, it’s been a packed field for SPAC mergers this season. More and more companies opt to go public via SPAC nowadays, as it has the potential to save tremendous amounts of time and money in their initial public offerings (IPOs). Not every company thrives off of it, however, as is evident this afternoon.\nGrab Chief Executive Anthony Tan commented onGRAB’s downtrend today. “The price makes no difference to me. I’m going to celebrate tonight and get back to work tomorrow,” Tan said.\nSo, what else should investors know about GRAB stock today?\n8 Things to Know as GRAB Stock Slides Today\n\nGRAB’s backdoor listing comes after an agreement with U.S. tech SPAC, Altimeter Growth Corp.\nThe deal saw GRAB raise $4.5 billion in funding, including $750 million from Altimeter.\nGrab is a high-growth contender. Some expect the Southeast Asia digital economy to double by 2025.\nThe company began as a Malaysia-based taxi app in 2012. Since then, it’s expanded into various other industries and mobile services.\nAdditionally, GRAB has support from some big players. Indeed, Toyota(NYSE:TM), Microsoft(NASDAQ:MSFT) and Uber(NYSE:UBER) each have a stake in the company.\nUnfortunately, Grab had less-than stellar revenue numbers to report this past quarter. Revenue was down 9% year-over-year, mostly attributed to Covid-19-related lockdowns across Southeast Asia, especially Vietnam.\nHowever, Grab is aiming for profitability by 2023. At that point, the burgeoning Southeast Asian internet economy is expected to have grown substantially.\nThe super apps are operational in more than 465 cities across eight countries and offer everything from food-delivery to investment services.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1055,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609392913,"gmtCreate":1638236931520,"gmtModify":1638237337163,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609392913","repostId":"1105270576","repostType":4,"repost":{"id":"1105270576","kind":"news","pubTimestamp":1638236121,"share":"https://www.laohu8.com/m/news/1105270576?lang=&edition=full","pubTime":"2021-11-30 09:35","market":"us","language":"en","title":"Wall Street Dip Buyers Defy Omicron Inflation Risk at Their Own Peril","url":"https://stock-news.laohu8.com/highlight/detail?id=1105270576","media":"Bloomberg","summary":"(Bloomberg) -- If there’s any lesson for Wall Street in the pandemic era, it’s this: Every selloff h","content":"<p>(Bloomberg) -- If there’s any lesson for Wall Street in the pandemic era, it’s this: Every selloff has proved a big opportunity to buy the dip in a world of activist central banks and limitless risk appetite.</p>\n<p>Yet the Monday rally as the omicron variant spreads will test the resolve of investors who thought they’d seen it all in the Covid roller coaster.</p>\n<p>With fresh travel bans looming and transmission fears rife, the S&amp;P 500 rallied more than 1% at the open after the index’s worst drop in nine months Friday. Treasuries slumped, sending yields higher, while oil jumped.</p>\n<p>To the likes of Goldman Sachs Group Inc. and UBS Wealth Management, it all makes sense -- they reckon bad virus news has some good news for markets as the variant assuages fears of monetary tightening. But strategists at Capital Economics and Mizuho International are among those urging caution as rising cases may worsen inflation, keeping policy makers on track to cut stimulus.</p>\n<p>“I know, I know, ‘U.S. equities only go up’ etc,” wrote Peter Chatwell, head of multi-asset strategy at Mizuho. “Monetary tightening is a structural downside risk to equities, and it may coincide with weaker growth in Q1.”</p>\n<p>While mild omicron symptoms and news of rapid vaccine reformulations are offering some relief Monday, European policy makers were already tightening rules to fight another wave of infections even before the mutation was discovered in southern Africa late last week.</p>\n<p>The sharp risk-off session Friday, exacerbated by thin liquidity after the Thanksgiving holiday, was a sign of investors’ sensitivity to any bad headlines, with their pockets already thickly lined from the S&amp;P 500’s 24% gain this year.</p>\n<p>While corporations have managed to deliver a sharp profit recovery in 2021, stock valuations are elevated historically: The U.S. benchmark is trading at 21 times the next year’s earnings, compared with 18 at the end of 2019 and a decade average of close to 17.</p>\n<p>Whether that multiple counts as stretched will largely depend on the monetary trajectory. And since omicron hit the headlines, money-market traders have pushed back expectations for global rate hikes, market-derived inflation expectations have fallen and oil has plunged.</p>\n<p>All that is a sign markets are pricing in a drop in demand from the new variant, which may prompt central banks to slow their tightening.</p>\n<p>“Ironically, it may be the omicron scare itself that now creates the best possibility of some relief over the period, either because incoming news about the variant is better than feared or because monetary policy makers take a somewhat more cautious stance in response to the news,” wrote Dominic Wilson at Goldman.</p>\n<p>At UBS’s wealth-management unit, a team led by chief investment officer Mark Haefele is telling clients to stay invested with the base case of robust economic growth intact and any concerns only likely to reduce monetary-tightening fears. At Nordea Investment Funds, senior macro strategist Sebastien Galy calls it a buying opportunity.</p>\n<p>After a spike in volatility like the VIX’s 10-point jump Friday, stocks usually stage “robust reversals,” writes Jonathan Golub, chief U.S. equity strategist at Credit Suisse, in a Monday note.</p>\n<p>Yet the policy response function may be less clear-cut than it was in the first all-hands-on-deck phase of the pandemic. Last year’s experience underscored the risk that if consumers shift their spending toward goods amid supply-chain bottlenecks, renewed virus anxieties can actually be inflationary.</p>\n<p>New infections may also temporarily shrink the labor force, suggests Neil Shearing, chief economist at Capital Economics.</p>\n<p>“Compared to previous waves of the virus, which were on balance disinflationary, a major new wave could now be inflationary,” he wrote in a note. “All of this further complicates an already-complex policy challenge.”</p>\n<p>It’s a big shift from a week ago, when investors were largely preoccupied with the rate outlook based on the pace of the U.S. recovery. An index for economic surprises only this month returned to positive territory, as payrolls and retail sales expanded faster than expected.</p>\n<p>But for investors giddy after the 66 record highs notched by the S&amp;P 500 this year, an intensifying Covid risk is hard to ignore.</p>\n<p>“I am not too positive on the situation as the cause of the selloff was the new variant, but it is also worth considering that the number of infections levels in Europe were unfortunately increasing anyway,” said Alberto Tocchio, a portfolio manager at Kairos Partners. “We will need more data before we will be able to judge.”</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Dip Buyers Defy Omicron Inflation Risk at Their Own Peril</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Dip Buyers Defy Omicron Inflation Risk at Their Own Peril\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 09:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/wall-street-dip-buyers-defy-135337950.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- If there’s any lesson for Wall Street in the pandemic era, it’s this: Every selloff has proved a big opportunity to buy the dip in a world of activist central banks and limitless risk ...</p>\n\n<a href=\"https://finance.yahoo.com/news/wall-street-dip-buyers-defy-135337950.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/wall-street-dip-buyers-defy-135337950.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105270576","content_text":"(Bloomberg) -- If there’s any lesson for Wall Street in the pandemic era, it’s this: Every selloff has proved a big opportunity to buy the dip in a world of activist central banks and limitless risk appetite.\nYet the Monday rally as the omicron variant spreads will test the resolve of investors who thought they’d seen it all in the Covid roller coaster.\nWith fresh travel bans looming and transmission fears rife, the S&P 500 rallied more than 1% at the open after the index’s worst drop in nine months Friday. Treasuries slumped, sending yields higher, while oil jumped.\nTo the likes of Goldman Sachs Group Inc. and UBS Wealth Management, it all makes sense -- they reckon bad virus news has some good news for markets as the variant assuages fears of monetary tightening. But strategists at Capital Economics and Mizuho International are among those urging caution as rising cases may worsen inflation, keeping policy makers on track to cut stimulus.\n“I know, I know, ‘U.S. equities only go up’ etc,” wrote Peter Chatwell, head of multi-asset strategy at Mizuho. “Monetary tightening is a structural downside risk to equities, and it may coincide with weaker growth in Q1.”\nWhile mild omicron symptoms and news of rapid vaccine reformulations are offering some relief Monday, European policy makers were already tightening rules to fight another wave of infections even before the mutation was discovered in southern Africa late last week.\nThe sharp risk-off session Friday, exacerbated by thin liquidity after the Thanksgiving holiday, was a sign of investors’ sensitivity to any bad headlines, with their pockets already thickly lined from the S&P 500’s 24% gain this year.\nWhile corporations have managed to deliver a sharp profit recovery in 2021, stock valuations are elevated historically: The U.S. benchmark is trading at 21 times the next year’s earnings, compared with 18 at the end of 2019 and a decade average of close to 17.\nWhether that multiple counts as stretched will largely depend on the monetary trajectory. And since omicron hit the headlines, money-market traders have pushed back expectations for global rate hikes, market-derived inflation expectations have fallen and oil has plunged.\nAll that is a sign markets are pricing in a drop in demand from the new variant, which may prompt central banks to slow their tightening.\n“Ironically, it may be the omicron scare itself that now creates the best possibility of some relief over the period, either because incoming news about the variant is better than feared or because monetary policy makers take a somewhat more cautious stance in response to the news,” wrote Dominic Wilson at Goldman.\nAt UBS’s wealth-management unit, a team led by chief investment officer Mark Haefele is telling clients to stay invested with the base case of robust economic growth intact and any concerns only likely to reduce monetary-tightening fears. At Nordea Investment Funds, senior macro strategist Sebastien Galy calls it a buying opportunity.\nAfter a spike in volatility like the VIX’s 10-point jump Friday, stocks usually stage “robust reversals,” writes Jonathan Golub, chief U.S. equity strategist at Credit Suisse, in a Monday note.\nYet the policy response function may be less clear-cut than it was in the first all-hands-on-deck phase of the pandemic. Last year’s experience underscored the risk that if consumers shift their spending toward goods amid supply-chain bottlenecks, renewed virus anxieties can actually be inflationary.\nNew infections may also temporarily shrink the labor force, suggests Neil Shearing, chief economist at Capital Economics.\n“Compared to previous waves of the virus, which were on balance disinflationary, a major new wave could now be inflationary,” he wrote in a note. “All of this further complicates an already-complex policy challenge.”\nIt’s a big shift from a week ago, when investors were largely preoccupied with the rate outlook based on the pace of the U.S. recovery. An index for economic surprises only this month returned to positive territory, as payrolls and retail sales expanded faster than expected.\nBut for investors giddy after the 66 record highs notched by the S&P 500 this year, an intensifying Covid risk is hard to ignore.\n“I am not too positive on the situation as the cause of the selloff was the new variant, but it is also worth considering that the number of infections levels in Europe were unfortunately increasing anyway,” said Alberto Tocchio, a portfolio manager at Kairos Partners. “We will need more data before we will be able to judge.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":762,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600234330,"gmtCreate":1638155494839,"gmtModify":1638155494989,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600234330","repostId":"1119853738","repostType":4,"repost":{"id":"1119853738","kind":"news","pubTimestamp":1638153494,"share":"https://www.laohu8.com/m/news/1119853738?lang=&edition=full","pubTime":"2021-11-29 10:38","market":"us","language":"en","title":"Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1119853738","media":"Motley Fool","summary":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday","content":"<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.</p>\n<p>While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.</p>\n<p>How should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers&nbsp;<b>Moderna</b>(NASDAQ:MRNA),<b>Pfizer</b>(NYSE:PFE), and&nbsp;<b>Novavax</b>(NASDAQ:NVAX)&nbsp;all&nbsp;vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.</p>\n<p>The pandemic's latest twist makes these three stocks screaming buys</p>\n<p>Moderna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.</p>\n<p>Pfizer, for its part, said that its&nbsp;<b>BioNTech</b>-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.</p>\n<p>Why are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.</p>\n<p>While Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.</p>\n<p>On the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have&nbsp;dipped in the back half of 2021&nbsp;in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.</p>\n<p>What's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.</p>\n<p>In short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer, and Novavax Are Must-Own Stocks This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119853738","content_text":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.\nWhile there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.\nHow should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers Moderna(NASDAQ:MRNA),Pfizer(NYSE:PFE), and Novavax(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.\nThe pandemic's latest twist makes these three stocks screaming buys\nModerna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.\nPfizer, for its part, said that its BioNTech-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.\nWhy are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.\nWhile Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.\nOn the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.\nWhat's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.\nIn short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":937,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600311170,"gmtCreate":1638066328792,"gmtModify":1638066328908,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/600311170","repostId":"2186282013","repostType":4,"repost":{"id":"2186282013","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638058448,"share":"https://www.laohu8.com/m/news/2186282013?lang=&edition=full","pubTime":"2021-11-28 08:14","market":"us","language":"en","title":"U.S. issues 'Do Not Travel' advisory for eight African countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2186282013","media":"Reuters","summary":"(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturd","content":"<p> (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturday advised against travel to eight southern African countries after the White House announced new travel restrictions in response to a new COVID-19 variant.</p>\n<p>The CDC raised its travel recommendation to \"Level Four: Very High\" for South Africa, Zimbabwe, Namibia, Mozambique, Malawi, Lesotho, Eswatini and Botswana while the State Department issued parallel \"Do Not Travel\" advisories Saturday. On Monday, the CDC had lowered its COVID-19 travel advisory for South Africa to \"Level 1: Low\" from \"Level 3: High\"</p>\n<p>Of the eight countries, only Botswana was previously listed as \"Level 4.\"</p>\n<p>Omicron, dubbed a \"variant of concern\" by the World Health Organization, is potentially more contagious than previous variants of the disease, although experts do not know yet if it will cause more or less severe COVID-19 compared to other strains. It could take weeks for scientists to fully understand the variant's mutations and whether existing vaccines and treatments are effective against it.</p>\n<p>The discovery of the variant has sparked global concern, a wave of travel bans or curbs and a sell-off on financial markets on Friday as investors worried that Omicron could stall a global recovery from the nearly two-year pandemic.</p>\n<p>The new variant prompted the White House to announce Friday it would bar nearly all foreign nationals who have been in any of eight countries within the last 14 days from flying to the United States effective Monday at 12:01 a.m. ET (0500 GMT). Travelers on flights that depart before that time will be allowed to land in the United States. But foreign nationals must be vaccinated and have tested negative within three days.</p>\n<p>Britain detected two cases of the new Omicron coronavirus variant on Saturday, even as Australia and other countries joined nations imposing restrictions on travel from southern Africa in an effort to stop its spread.</p>\n<p>The variant was first discovered in South Africa and had also since been detected in Belgium, Botswana, Israel and Hong Kong.</p>\n<p>A U.S. official told Reuters Friday the Biden administration could also add other countries to the travel curb list if the variant spreads. The United States only lifted travel restrictions on South Africa and 32 other countries on Nov. 8.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. issues 'Do Not Travel' advisory for eight African countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. issues 'Do Not Travel' advisory for eight African countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-28 08:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p> (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturday advised against travel to eight southern African countries after the White House announced new travel restrictions in response to a new COVID-19 variant.</p>\n<p>The CDC raised its travel recommendation to \"Level Four: Very High\" for South Africa, Zimbabwe, Namibia, Mozambique, Malawi, Lesotho, Eswatini and Botswana while the State Department issued parallel \"Do Not Travel\" advisories Saturday. On Monday, the CDC had lowered its COVID-19 travel advisory for South Africa to \"Level 1: Low\" from \"Level 3: High\"</p>\n<p>Of the eight countries, only Botswana was previously listed as \"Level 4.\"</p>\n<p>Omicron, dubbed a \"variant of concern\" by the World Health Organization, is potentially more contagious than previous variants of the disease, although experts do not know yet if it will cause more or less severe COVID-19 compared to other strains. It could take weeks for scientists to fully understand the variant's mutations and whether existing vaccines and treatments are effective against it.</p>\n<p>The discovery of the variant has sparked global concern, a wave of travel bans or curbs and a sell-off on financial markets on Friday as investors worried that Omicron could stall a global recovery from the nearly two-year pandemic.</p>\n<p>The new variant prompted the White House to announce Friday it would bar nearly all foreign nationals who have been in any of eight countries within the last 14 days from flying to the United States effective Monday at 12:01 a.m. ET (0500 GMT). Travelers on flights that depart before that time will be allowed to land in the United States. But foreign nationals must be vaccinated and have tested negative within three days.</p>\n<p>Britain detected two cases of the new Omicron coronavirus variant on Saturday, even as Australia and other countries joined nations imposing restrictions on travel from southern Africa in an effort to stop its spread.</p>\n<p>The variant was first discovered in South Africa and had also since been detected in Belgium, Botswana, Israel and Hong Kong.</p>\n<p>A U.S. official told Reuters Friday the Biden administration could also add other countries to the travel curb list if the variant spreads. The United States only lifted travel restrictions on South Africa and 32 other countries on Nov. 8.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186282013","content_text":"(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturday advised against travel to eight southern African countries after the White House announced new travel restrictions in response to a new COVID-19 variant.\nThe CDC raised its travel recommendation to \"Level Four: Very High\" for South Africa, Zimbabwe, Namibia, Mozambique, Malawi, Lesotho, Eswatini and Botswana while the State Department issued parallel \"Do Not Travel\" advisories Saturday. On Monday, the CDC had lowered its COVID-19 travel advisory for South Africa to \"Level 1: Low\" from \"Level 3: High\"\nOf the eight countries, only Botswana was previously listed as \"Level 4.\"\nOmicron, dubbed a \"variant of concern\" by the World Health Organization, is potentially more contagious than previous variants of the disease, although experts do not know yet if it will cause more or less severe COVID-19 compared to other strains. It could take weeks for scientists to fully understand the variant's mutations and whether existing vaccines and treatments are effective against it.\nThe discovery of the variant has sparked global concern, a wave of travel bans or curbs and a sell-off on financial markets on Friday as investors worried that Omicron could stall a global recovery from the nearly two-year pandemic.\nThe new variant prompted the White House to announce Friday it would bar nearly all foreign nationals who have been in any of eight countries within the last 14 days from flying to the United States effective Monday at 12:01 a.m. ET (0500 GMT). Travelers on flights that depart before that time will be allowed to land in the United States. But foreign nationals must be vaccinated and have tested negative within three days.\nBritain detected two cases of the new Omicron coronavirus variant on Saturday, even as Australia and other countries joined nations imposing restrictions on travel from southern Africa in an effort to stop its spread.\nThe variant was first discovered in South Africa and had also since been detected in Belgium, Botswana, Israel and Hong Kong.\nA U.S. official told Reuters Friday the Biden administration could also add other countries to the travel curb list if the variant spreads. The United States only lifted travel restrictions on South Africa and 32 other countries on Nov. 8.","news_type":1},"isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877795262,"gmtCreate":1637980592492,"gmtModify":1637980592681,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877795262","repostId":"1128119268","repostType":4,"repost":{"id":"1128119268","kind":"news","pubTimestamp":1637972590,"share":"https://www.laohu8.com/m/news/1128119268?lang=&edition=full","pubTime":"2021-11-27 08:23","market":"us","language":"en","title":"These 3 Stocks Punished the Dow Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1128119268","media":"Motley Fool","summary":"The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the ","content":"<p>The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the new Omicron variant of COVID-19 led to widespread concerns about a possible return to lockdown conditions. By the end of the day, the&nbsp;<b>Dow Jones Industrial Average</b>(DJINDICES:^DJI),<b>S&amp;P 500</b>(SNPINDEX:^GSPC), and&nbsp;<b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC)were all down between 2% and 3%.</p>\n<p>Today's news hurt stocks in many different sectors of the market, with a wide variety of factors playing into losses. Because of theDow's price-weighted nature, a few stocks had a disproportionate influence on the average's moves. Below, we'll look at how&nbsp;<b>American Express</b>(NYSE:AXP),<b>Boeing</b>(NYSE:BA), and&nbsp;<b>Goldman Sachs</b>(NYSE:GS)combined to lop about 250 points off the Dow by themselves.</p>\n<p>A double hit for American Express</p>\n<p>American Express was the worst performer in the Dow, falling almost 9%. The financial company saw its stock fall for two different reasons related to the news about the pandemic.</p>\n<p>First and foremost, American Express has historically relied on global travel to drive a substantial part of its business. Its traveler's checks are known around the world as a means of doing business, and its charge cards have prestige in key market destinations. The prospects for further restrictions on travel, therefore, would have a detrimental impact on its business.</p>\n<p>Moreover, as a financial institution,American Express benefits from a steeper yield curve. The recent trend in that direction met an abrupt reversal on Friday, as bond yields plunged on prospects for a possible economic slowdown. Investors anticipate that the company could have problems meeting its own expectations if the pandemic worsens, and that's why the stock cost the Dow about 100 points on Friday.</p>\n<p>Flying lower</p>\n<p>Another company that one would've expected to fare poorly given the news was&nbsp;<b>Boeing</b>(NYSE:BA). The aerospace company fell more than 5%, and its higher-priced shares gave it a big impact on the Dow.</p>\n<p>You won't find&nbsp;airline stocks&nbsp;in the Dow Industrials, but they took even larger hits as a result of the COVID news. Already, the U.S. and other nations have put travel restrictions on South Africa and neighboring countries to try to stem the spread of the Omicron variant. That bodes poorly for airlines serving those markets, and it indirectly affects Boeing by raising the possibility that airlines will have to cancel or postpone orders if they come under additional economic pressure.</p>\n<p>Boeing has suffered substantial losses, but investors were starting to hope that it would turn profitable again in 2022. The latest news threatens that assessment, and investors don't like the prospects for more red ink from the aircraft manufacturer.</p>\n<p>Banking on rate rises</p>\n<p>Goldman Sachs was down 2.5% on Friday. Its nearly $10 decline cost the Dow roughly 70 points on the day.</p>\n<p>Goldman faced some of the same challenges that American Express does. Increasingly,Goldman has tried to boost its retail banking presence&nbsp;through its Marcus unit, and that has exposed the Wall Street financial giant to greater interest rate sensitivity. The flattening yield curve Friday didn't do any favors to the company's consumer banking segment.</p>\n<p>Wall Street has also benefited from huge levels of investment banking activity, where Goldman excels. If a market pullback leads to reduced activity for initial public offerings, acquisitions, and other corporate events, then it could hurt that part of Goldman's business as well.</p>\n<p>Don't panic</p>\n<p>A 900-point plunge for the Dow makes for a scary headline, but it's just part of the natural volatility of the stock market. Don't lose perspective, and if you stick with your long-term investment strategy, things will likely go better for you than if you panic.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Stocks Punished the Dow Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Stocks Punished the Dow Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-27 08:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/26/these-3-stocks-punished-the-dow-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the new Omicron variant of COVID-19 led to widespread concerns about a possible return to lockdown ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/26/these-3-stocks-punished-the-dow-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXP":"美国运通","GS":"高盛","BA":"波音"},"source_url":"https://www.fool.com/investing/2021/11/26/these-3-stocks-punished-the-dow-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128119268","content_text":"The stock market was definitely not in a holiday mood on the day after Thanksgiving, as news of the new Omicron variant of COVID-19 led to widespread concerns about a possible return to lockdown conditions. By the end of the day, the Dow Jones Industrial Average(DJINDICES:^DJI),S&P 500(SNPINDEX:^GSPC), and Nasdaq Composite(NASDAQINDEX:^IXIC)were all down between 2% and 3%.\nToday's news hurt stocks in many different sectors of the market, with a wide variety of factors playing into losses. Because of theDow's price-weighted nature, a few stocks had a disproportionate influence on the average's moves. Below, we'll look at how American Express(NYSE:AXP),Boeing(NYSE:BA), and Goldman Sachs(NYSE:GS)combined to lop about 250 points off the Dow by themselves.\nA double hit for American Express\nAmerican Express was the worst performer in the Dow, falling almost 9%. The financial company saw its stock fall for two different reasons related to the news about the pandemic.\nFirst and foremost, American Express has historically relied on global travel to drive a substantial part of its business. Its traveler's checks are known around the world as a means of doing business, and its charge cards have prestige in key market destinations. The prospects for further restrictions on travel, therefore, would have a detrimental impact on its business.\nMoreover, as a financial institution,American Express benefits from a steeper yield curve. The recent trend in that direction met an abrupt reversal on Friday, as bond yields plunged on prospects for a possible economic slowdown. Investors anticipate that the company could have problems meeting its own expectations if the pandemic worsens, and that's why the stock cost the Dow about 100 points on Friday.\nFlying lower\nAnother company that one would've expected to fare poorly given the news was Boeing(NYSE:BA). The aerospace company fell more than 5%, and its higher-priced shares gave it a big impact on the Dow.\nYou won't find airline stocks in the Dow Industrials, but they took even larger hits as a result of the COVID news. Already, the U.S. and other nations have put travel restrictions on South Africa and neighboring countries to try to stem the spread of the Omicron variant. That bodes poorly for airlines serving those markets, and it indirectly affects Boeing by raising the possibility that airlines will have to cancel or postpone orders if they come under additional economic pressure.\nBoeing has suffered substantial losses, but investors were starting to hope that it would turn profitable again in 2022. The latest news threatens that assessment, and investors don't like the prospects for more red ink from the aircraft manufacturer.\nBanking on rate rises\nGoldman Sachs was down 2.5% on Friday. Its nearly $10 decline cost the Dow roughly 70 points on the day.\nGoldman faced some of the same challenges that American Express does. Increasingly,Goldman has tried to boost its retail banking presence through its Marcus unit, and that has exposed the Wall Street financial giant to greater interest rate sensitivity. The flattening yield curve Friday didn't do any favors to the company's consumer banking segment.\nWall Street has also benefited from huge levels of investment banking activity, where Goldman excels. If a market pullback leads to reduced activity for initial public offerings, acquisitions, and other corporate events, then it could hurt that part of Goldman's business as well.\nDon't panic\nA 900-point plunge for the Dow makes for a scary headline, but it's just part of the natural volatility of the stock market. Don't lose perspective, and if you stick with your long-term investment strategy, things will likely go better for you than if you panic.","news_type":1},"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877316779,"gmtCreate":1637887845784,"gmtModify":1637887845898,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877316779","repostId":"2186395841","repostType":4,"repost":{"id":"2186395841","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637884517,"share":"https://www.laohu8.com/m/news/2186395841?lang=&edition=full","pubTime":"2021-11-26 07:55","market":"uk","language":"en","title":"China to remain 'super market' into next year - Daimler China chief","url":"https://stock-news.laohu8.com/highlight/detail?id=2186395841","media":"Reuters","summary":"BERLIN, Nov 25 (Reuters) - Daimler's China sales will stay strong next year, the carmaker's China ch","content":"<p>BERLIN, Nov 25 (Reuters) - Daimler's China sales will stay strong next year, the carmaker's China chief said on Thursday, adding he was confident that Mercedes-Benz could grow its share of the country's electric vehicle market given little competition in the premium car segment.</p>\n<p>Its car sales in China jumped 12% last year to a record 774,000 despite the pandemic, and over 8% growth has been registered this year so far, Hubertus Troska told journalists.</p>\n<p>\"Everything speaks for the fact that China will be a super market next year as well,\" Troska said.</p>\n<p>Daimler's market share of electric vehicle sales is still small in China, Troska said, where it competes with numerous Chinese electric vehicle makers from Xpeng to Li Auto and Nio&nbsp;as well as U.S. EV giant Tesla.</p>\n<p>However, most Chinese companies sell in the price range of 35,000 euros ($39,270) or less, Troska said, below Daimler's range.</p>\n<p>With the number of Daimler EV models for sale in the country set to grow from one to five next year, Daimler will be able to better establish itself in the higher-priced premium car segment, he said.</p>\n<p>Still, demand for fossil-fuel burning cars is likely to last for some time in China, Troska said, pointing to the large swathes of the country outside urban centres where charging infrastructure could be harder to come by.</p>\n<p>\"It's a huge country, so in my view there will still be internal combustion engine cars in China for some time,\" Troska said.</p>\n<p>Daimler has said that all new vehicle platforms from 2025 will be electric, with a view to producing all-electric only by 2030 where market conditions allow.</p>\n<p>China, which is the world's largest car market and is responsible for a third of Daimler's revenues, has so far refrained from following Europe in setting dates for bans on production of fossil-fuel emitting cars.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China to remain 'super market' into next year - Daimler China chief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina to remain 'super market' into next year - Daimler China chief\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-26 07:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BERLIN, Nov 25 (Reuters) - Daimler's China sales will stay strong next year, the carmaker's China chief said on Thursday, adding he was confident that Mercedes-Benz could grow its share of the country's electric vehicle market given little competition in the premium car segment.</p>\n<p>Its car sales in China jumped 12% last year to a record 774,000 despite the pandemic, and over 8% growth has been registered this year so far, Hubertus Troska told journalists.</p>\n<p>\"Everything speaks for the fact that China will be a super market next year as well,\" Troska said.</p>\n<p>Daimler's market share of electric vehicle sales is still small in China, Troska said, where it competes with numerous Chinese electric vehicle makers from Xpeng to Li Auto and Nio&nbsp;as well as U.S. EV giant Tesla.</p>\n<p>However, most Chinese companies sell in the price range of 35,000 euros ($39,270) or less, Troska said, below Daimler's range.</p>\n<p>With the number of Daimler EV models for sale in the country set to grow from one to five next year, Daimler will be able to better establish itself in the higher-priced premium car segment, he said.</p>\n<p>Still, demand for fossil-fuel burning cars is likely to last for some time in China, Troska said, pointing to the large swathes of the country outside urban centres where charging infrastructure could be harder to come by.</p>\n<p>\"It's a huge country, so in my view there will still be internal combustion engine cars in China for some time,\" Troska said.</p>\n<p>Daimler has said that all new vehicle platforms from 2025 will be electric, with a view to producing all-electric only by 2030 where market conditions allow.</p>\n<p>China, which is the world's largest car market and is responsible for a third of Daimler's revenues, has so far refrained from following Europe in setting dates for bans on production of fossil-fuel emitting cars.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DDAIF":"戴姆勒汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186395841","content_text":"BERLIN, Nov 25 (Reuters) - Daimler's China sales will stay strong next year, the carmaker's China chief said on Thursday, adding he was confident that Mercedes-Benz could grow its share of the country's electric vehicle market given little competition in the premium car segment.\nIts car sales in China jumped 12% last year to a record 774,000 despite the pandemic, and over 8% growth has been registered this year so far, Hubertus Troska told journalists.\n\"Everything speaks for the fact that China will be a super market next year as well,\" Troska said.\nDaimler's market share of electric vehicle sales is still small in China, Troska said, where it competes with numerous Chinese electric vehicle makers from Xpeng to Li Auto and Nio as well as U.S. EV giant Tesla.\nHowever, most Chinese companies sell in the price range of 35,000 euros ($39,270) or less, Troska said, below Daimler's range.\nWith the number of Daimler EV models for sale in the country set to grow from one to five next year, Daimler will be able to better establish itself in the higher-priced premium car segment, he said.\nStill, demand for fossil-fuel burning cars is likely to last for some time in China, Troska said, pointing to the large swathes of the country outside urban centres where charging infrastructure could be harder to come by.\n\"It's a huge country, so in my view there will still be internal combustion engine cars in China for some time,\" Troska said.\nDaimler has said that all new vehicle platforms from 2025 will be electric, with a view to producing all-electric only by 2030 where market conditions allow.\nChina, which is the world's largest car market and is responsible for a third of Daimler's revenues, has so far refrained from following Europe in setting dates for bans on production of fossil-fuel emitting cars.","news_type":1},"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874528240,"gmtCreate":1637803334110,"gmtModify":1637803334227,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/874528240","repostId":"1176842797","repostType":4,"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875820421,"gmtCreate":1637633429828,"gmtModify":1637633430018,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875820421","repostId":"1192554686","repostType":4,"repost":{"id":"1192554686","kind":"news","pubTimestamp":1637629334,"share":"https://www.laohu8.com/m/news/1192554686?lang=&edition=full","pubTime":"2021-11-23 09:02","market":"us","language":"en","title":"Samsung to Choose Taylor, Texas, for $17 Billion Chipmaking Factory","url":"https://stock-news.laohu8.com/highlight/detail?id=1192554686","media":"The Wall Street Journal","summary":"The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say\n","content":"<p>The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say</p>\n<p>Samsung&nbsp;Electronics Co. plans to&nbsp;build a roughly $17 billion chip-making plant&nbsp;in Taylor, Texas, according to people familiar with the matter, a mega investment by the South Korean tech giant, as the Biden administration pushes for an expansion of U.S. semiconductor production.</p>\n<p>An announcement could come as early as Tuesday, people familiar with the matter said. Gov. Greg Abbott is scheduled to make an “economic announcement” Tuesday at 5 p.m. local time.</p>\n<p>The Taylor facility, located in central Texas, plans to create around 1,800 jobs, though chip production is not expected to start until the end of 2024, according to documents Samsung had previously filed with Texas authorities. To woo Samsung, Taylor had offered incentives that include the equivalent of property-tax breaks of up to 92.5% for the first 10 years, with the write-offs gradually declining over the next several decades.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Samsung to Choose Taylor, Texas, for $17 Billion Chipmaking Factory</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSamsung to Choose Taylor, Texas, for $17 Billion Chipmaking Factory\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 09:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/samsung-to-choose-taylor-texas-for-17-billion-chipmaking-factory-11637627613?mod=hp_lista_pos2><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say\nSamsung Electronics Co. plans to build a roughly $17 billion chip-making plant in Taylor, Texas, ...</p>\n\n<a href=\"https://www.wsj.com/articles/samsung-to-choose-taylor-texas-for-17-billion-chipmaking-factory-11637627613?mod=hp_lista_pos2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SSNLF":"三星电子"},"source_url":"https://www.wsj.com/articles/samsung-to-choose-taylor-texas-for-17-billion-chipmaking-factory-11637627613?mod=hp_lista_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192554686","content_text":"The announcement is expected at Tuesday event to be attended by Texas Gov. Greg Abbott, sources say\nSamsung Electronics Co. plans to build a roughly $17 billion chip-making plant in Taylor, Texas, according to people familiar with the matter, a mega investment by the South Korean tech giant, as the Biden administration pushes for an expansion of U.S. semiconductor production.\nAn announcement could come as early as Tuesday, people familiar with the matter said. Gov. Greg Abbott is scheduled to make an “economic announcement” Tuesday at 5 p.m. local time.\nThe Taylor facility, located in central Texas, plans to create around 1,800 jobs, though chip production is not expected to start until the end of 2024, according to documents Samsung had previously filed with Texas authorities. To woo Samsung, Taylor had offered incentives that include the equivalent of property-tax breaks of up to 92.5% for the first 10 years, with the write-offs gradually declining over the next several decades.","news_type":1},"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872565417,"gmtCreate":1637549083380,"gmtModify":1637549127663,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/872565417","repostId":"2185826127","repostType":4,"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872800284,"gmtCreate":1637465891041,"gmtModify":1637465891154,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872800284","repostId":"1193739210","repostType":4,"repost":{"id":"1193739210","kind":"news","pubTimestamp":1637457862,"share":"https://www.laohu8.com/m/news/1193739210?lang=&edition=full","pubTime":"2021-11-21 09:24","market":"us","language":"en","title":"Does Sono Group Have a Breakthrough Innovation That Could Put “Range Anxiety” to Bed?","url":"https://stock-news.laohu8.com/highlight/detail?id=1193739210","media":"Investorplace","summary":"In a blink-and-you-miss-it moment this week, one of the most interestingelectric vehicle (EV) startu","content":"<p>In a blink-and-you-miss-it moment this week, one of the most interesting<b><i>electric vehicle (EV) startups</i></b>in the worldwent publicthrough a super successful initial public offering (IPO).</p>\n<p>That company is the Germany-based&nbsp;<b>Sono Group</b>(NASDAQ:<b><u>SEV</u></b>) – a small EV company that’s unlike any other electric vehicle firm on the planet. This isn’t the next&nbsp;<b>Tesla</b>(NASDAQ:<b><u>TSLA</u></b>)<b>,</b>nor is it the next&nbsp;<b>Lucid</b>&nbsp;<b>Group</b>(NASDAQ:<b><u>LCID</u></b>) or&nbsp;<b>Rivian</b>(NASDAQ:<b><u>RIVN</u></b>)… and that’s by design.</p>\n<p>Because, while all those EV makers are making plug-in electric vehicles, Sono is making the world’s first<b>solar electric vehicle</b>, or “<b>SEV</b>.”</p>\n<p>Soaring 150%-plus from its $15 IPO price Wednesday, investors have sat up to take notice of this company that is helmed by a CEO barely out of university.</p>\n<p>Indeed, at age 26, Sono founder Laurin Hahn cuts a very different image than your typical CEO. Hahn’s an environmentalist and idealist at heart, which is why Sono’s goal isn’t just to sell cars, but to “implement an innovative CO2-neutral mobility concept.” Out of that vision comes the&nbsp;<b>Sion</b>– an understated, no-frills attempt at designing an effective solar EV for the masses.</p>\n<p>And unlike the glossy, leather-clad premium electric vehicles dominating most conversations around EVs, the Sion actually feels like a vehicle designed to put the world on the right path toward net-zero carbon emissions.</p>\n<p>To ensure its vision aligned with the needs of everyday drivers, the company’s signature vehicle – the Sion – had its users in mind from the very beginning. Everything from the color and upholstery of the car to the voltage and resulting range of the battery was voted on by a community of 15,000.</p>\n<p>As for its look, the Sion essentially replaces the exterior aluminum and paint on an electric car with 248 flexible solar modules that are perfectly adapted to the shape of the vehicle.</p>\n<p>The car looks, drives, and acts just like any other mass-market EV. But as it drives, it charges itself through these solar cells. There’s a still a battery at the core of the vehicle, but it doesn’t rely on being plugged in – the battery can be recharged by simply leaving it out in the sun.</p>\n<p>The huge value-add here, of course, is solving so-called EV “<b><i>range anxiety</i></b><i>,</i>” or the fear that EVs won’t be able to drive you as far as you need to go.</p>\n<p>To-date, such fears have proven very legitimate. After all, your typical EV today fetches around 250 miles of driving range. Your average gas car can travel up to 400 miles per tank. So, yes, EVs have historically been limiting in terms of how far they can travel.</p>\n<p>Sono Motors believes that its solar EV tech will fix this issue. And while it is a very innovative solution that we find super interesting, there’s just one small issue:<b>It doesn’t actually solve the “range anxiety” problem.</b></p>\n<p>Sono’s claim is that its solar cells collectively add about 70 miles of driving range to its Sion EV, which has a built-in driving range of 190 miles. Add it up, and even with these solar panels, the Sion still gets less than 300 miles of real-time driving range – much less than the 400 miles a gas-powered car fetches per tank.</p>\n<p>But solar technology is not static –it’s very dynamic. And right now, scientists across the globe are working on multiple solar technology breakthroughs to dramatically improve the performance of solar cells. One such promising breakthrough is the inclusion of perovskites in solar cells. Perovskites are a very flexible material, and therefore, could be included in Sono’s solar mobility tech to significantly improve the performance of these SEVs.</p>\n<p>In other words, while solar electric vehicles are cool, the underlying solar cell technology here is still many years away from being robust enough to actually solve EV range anxiety fears.</p>\n<p>That’s the bad news.</p>\n<p>The good news, though, is that we don’t even<i>need</i>solar electric vehicles to solve range anxiety…</p>\n<p>Because there is&nbsp;<b><i>another breakthrough battery technology being pioneered today</i></b>, which is ready to add not just 70 or 80 miles of driving range to an EV – but potentially thousands of miles of driving range to an EV, thereby allowing electric cars to travel as much as 10X as far as gas-powered cars on a single charge.</p>\n<p>These batteries are the future and will forever solve the EV “range anxiety” problem.</p>\n<p>It’s simple, really… With them, EVs will last forever.</p>\n<p>The technology behind these forever batteries is exceptionally complex – so complex, in fact, that no one has been able to make one big enough to power an electric car yet.</p>\n<p><b><i>But that’s changing right now</i></b>, as some companies in this space have – for the first time ever – built small-scale “forever batteries” that are working. Now, all these companies have to do is scale these batteries and make them bigger.</p>\n<p>Make no mistake. They’re going to do just that. And the companies behind this forever battery technology will turn into titans of the EV industry.</p>\n<p>Not to mention,<b>their stocks will score shareholders enormous returns.</b></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Does Sono Group Have a Breakthrough Innovation That Could Put “Range Anxiety” to Bed?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoes Sono Group Have a Breakthrough Innovation That Could Put “Range Anxiety” to Bed?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-21 09:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/><strong>Investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In a blink-and-you-miss-it moment this week, one of the most interestingelectric vehicle (EV) startupsin the worldwent publicthrough a super successful initial public offering (IPO).\nThat company is ...</p>\n\n<a href=\"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/hypergrowthinvesting/2021/11/does-sono-group-have-a-breakthrough-innovation-that-could-put-range-anxiety-to-bed/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1193739210","content_text":"In a blink-and-you-miss-it moment this week, one of the most interestingelectric vehicle (EV) startupsin the worldwent publicthrough a super successful initial public offering (IPO).\nThat company is the Germany-based Sono Group(NASDAQ:SEV) – a small EV company that’s unlike any other electric vehicle firm on the planet. This isn’t the next Tesla(NASDAQ:TSLA),nor is it the next Lucid Group(NASDAQ:LCID) or Rivian(NASDAQ:RIVN)… and that’s by design.\nBecause, while all those EV makers are making plug-in electric vehicles, Sono is making the world’s firstsolar electric vehicle, or “SEV.”\nSoaring 150%-plus from its $15 IPO price Wednesday, investors have sat up to take notice of this company that is helmed by a CEO barely out of university.\nIndeed, at age 26, Sono founder Laurin Hahn cuts a very different image than your typical CEO. Hahn’s an environmentalist and idealist at heart, which is why Sono’s goal isn’t just to sell cars, but to “implement an innovative CO2-neutral mobility concept.” Out of that vision comes the Sion– an understated, no-frills attempt at designing an effective solar EV for the masses.\nAnd unlike the glossy, leather-clad premium electric vehicles dominating most conversations around EVs, the Sion actually feels like a vehicle designed to put the world on the right path toward net-zero carbon emissions.\nTo ensure its vision aligned with the needs of everyday drivers, the company’s signature vehicle – the Sion – had its users in mind from the very beginning. Everything from the color and upholstery of the car to the voltage and resulting range of the battery was voted on by a community of 15,000.\nAs for its look, the Sion essentially replaces the exterior aluminum and paint on an electric car with 248 flexible solar modules that are perfectly adapted to the shape of the vehicle.\nThe car looks, drives, and acts just like any other mass-market EV. But as it drives, it charges itself through these solar cells. There’s a still a battery at the core of the vehicle, but it doesn’t rely on being plugged in – the battery can be recharged by simply leaving it out in the sun.\nThe huge value-add here, of course, is solving so-called EV “range anxiety,” or the fear that EVs won’t be able to drive you as far as you need to go.\nTo-date, such fears have proven very legitimate. After all, your typical EV today fetches around 250 miles of driving range. Your average gas car can travel up to 400 miles per tank. So, yes, EVs have historically been limiting in terms of how far they can travel.\nSono Motors believes that its solar EV tech will fix this issue. And while it is a very innovative solution that we find super interesting, there’s just one small issue:It doesn’t actually solve the “range anxiety” problem.\nSono’s claim is that its solar cells collectively add about 70 miles of driving range to its Sion EV, which has a built-in driving range of 190 miles. Add it up, and even with these solar panels, the Sion still gets less than 300 miles of real-time driving range – much less than the 400 miles a gas-powered car fetches per tank.\nBut solar technology is not static –it’s very dynamic. And right now, scientists across the globe are working on multiple solar technology breakthroughs to dramatically improve the performance of solar cells. One such promising breakthrough is the inclusion of perovskites in solar cells. Perovskites are a very flexible material, and therefore, could be included in Sono’s solar mobility tech to significantly improve the performance of these SEVs.\nIn other words, while solar electric vehicles are cool, the underlying solar cell technology here is still many years away from being robust enough to actually solve EV range anxiety fears.\nThat’s the bad news.\nThe good news, though, is that we don’t evenneedsolar electric vehicles to solve range anxiety…\nBecause there is another breakthrough battery technology being pioneered today, which is ready to add not just 70 or 80 miles of driving range to an EV – but potentially thousands of miles of driving range to an EV, thereby allowing electric cars to travel as much as 10X as far as gas-powered cars on a single charge.\nThese batteries are the future and will forever solve the EV “range anxiety” problem.\nIt’s simple, really… With them, EVs will last forever.\nThe technology behind these forever batteries is exceptionally complex – so complex, in fact, that no one has been able to make one big enough to power an electric car yet.\nBut that’s changing right now, as some companies in this space have – for the first time ever – built small-scale “forever batteries” that are working. Now, all these companies have to do is scale these batteries and make them bigger.\nMake no mistake. They’re going to do just that. And the companies behind this forever battery technology will turn into titans of the EV industry.\nNot to mention,their stocks will score shareholders enormous returns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":309,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876699481,"gmtCreate":1637299071469,"gmtModify":1637299071582,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876699481","repostId":"1148769228","repostType":4,"repost":{"id":"1148769228","kind":"news","pubTimestamp":1637290317,"share":"https://www.laohu8.com/m/news/1148769228?lang=&edition=full","pubTime":"2021-11-19 10:51","market":"us","language":"en","title":"CVS to close 900 drugstores in three years to beef up health services","url":"https://stock-news.laohu8.com/highlight/detail?id=1148769228","media":"Reuters","summary":"(Reuters) - CVS Health Corp(CVS.N)will shut about 900 stores over the next three years, it said on T","content":"<p>(Reuters) - CVS Health Corp(CVS.N)will shut about 900 stores over the next three years, it said on Thursday as the company tries to adapt to changing consumer preferences by pivoting to new store formats that offer more health services.</p>\n<p>Best known for its chain of drugstores in more than 9,900 locations, the company has been working to expand its services since it acquired health insurer Aetna in 2018.</p>\n<p>CVS said that as part of its strategic review it would create an enhanced version of its health hubs that offer treatment for common ailments as well as chronic care to add more customers.</p>\n<p>The reduction in stores will result in CVS taking an impairment charge of between $1 billion and $1.2 billion in the fourth quarter.</p>\n<p>People walk by a CVS pharmacy store in Manhattan, New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly</p>\n<p>As part of the new strategy, the company also created a new position of chief pharmacy officer and appointed executive vice president of specialty pharmacy and product innovation Prem Shah to the role.</p>\n<p>\"We see this as consistent with our expected LT (long-term) strategy for CVS, moving to grow managed care and care delivery, while shrinking legacy bricks-and-mortar retail business,\" said Bernstein analyst Lance Wilkes in a note.</p>\n<p>Rival Walgreens Boots Alliance(WBA.O)also recently shifted focus beyond its drugstores, investing $5.2 billion in VillageMD and $330 million in post-acute and home care provider CareCentrix.read more</p>\n<p>CVS cut its annual 2021 profit per share forecast to between $5.46 and $5.67 from $6.13 to $6.23, but stuck to its adjusted profit view saying there will be no impact from the store closures this year and the next.</p>\n<p>It also said Neela Montgomery, president of CVS Pharmacy, would leave company at the end of 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CVS to close 900 drugstores in three years to beef up health services</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCVS to close 900 drugstores in three years to beef up health services\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 10:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/healthcare-pharmaceuticals/cvs-health-close-stores-record-impairment-charge-2021-11-18/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - CVS Health Corp(CVS.N)will shut about 900 stores over the next three years, it said on Thursday as the company tries to adapt to changing consumer preferences by pivoting to new store ...</p>\n\n<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/cvs-health-close-stores-record-impairment-charge-2021-11-18/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVS":"西维斯健康"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/cvs-health-close-stores-record-impairment-charge-2021-11-18/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148769228","content_text":"(Reuters) - CVS Health Corp(CVS.N)will shut about 900 stores over the next three years, it said on Thursday as the company tries to adapt to changing consumer preferences by pivoting to new store formats that offer more health services.\nBest known for its chain of drugstores in more than 9,900 locations, the company has been working to expand its services since it acquired health insurer Aetna in 2018.\nCVS said that as part of its strategic review it would create an enhanced version of its health hubs that offer treatment for common ailments as well as chronic care to add more customers.\nThe reduction in stores will result in CVS taking an impairment charge of between $1 billion and $1.2 billion in the fourth quarter.\nPeople walk by a CVS pharmacy store in Manhattan, New York City, New York, U.S., November 17, 2021. REUTERS/Andrew Kelly\nAs part of the new strategy, the company also created a new position of chief pharmacy officer and appointed executive vice president of specialty pharmacy and product innovation Prem Shah to the role.\n\"We see this as consistent with our expected LT (long-term) strategy for CVS, moving to grow managed care and care delivery, while shrinking legacy bricks-and-mortar retail business,\" said Bernstein analyst Lance Wilkes in a note.\nRival Walgreens Boots Alliance(WBA.O)also recently shifted focus beyond its drugstores, investing $5.2 billion in VillageMD and $330 million in post-acute and home care provider CareCentrix.read more\nCVS cut its annual 2021 profit per share forecast to between $5.46 and $5.67 from $6.13 to $6.23, but stuck to its adjusted profit view saying there will be no impact from the store closures this year and the next.\nIt also said Neela Montgomery, president of CVS Pharmacy, would leave company at the end of 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":190,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871712954,"gmtCreate":1637112106105,"gmtModify":1637112106415,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871712954","repostId":"2184873748","repostType":4,"isVote":1,"tweetType":1,"viewCount":217,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871334657,"gmtCreate":1637025375997,"gmtModify":1637025376102,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"&nbsp;Good","listText":"&nbsp;Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871334657","repostId":"1140879609","repostType":4,"isVote":1,"tweetType":1,"viewCount":476,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873591395,"gmtCreate":1636956756661,"gmtModify":1636956756779,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873591395","repostId":"1136859135","repostType":4,"repost":{"id":"1136859135","kind":"news","pubTimestamp":1636947003,"share":"https://www.laohu8.com/m/news/1136859135?lang=&edition=full","pubTime":"2021-11-15 11:30","market":"us","language":"en","title":"Pfizer’s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.","url":"https://stock-news.laohu8.com/highlight/detail?id=1136859135","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson &amp; Johnson (JNJ) and Eli Lilly (LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.<img src=\"https://static.tigerbbs.com/7b64a90a2587bba33128c2a9cf35a596\" tg-width=\"961\" tg-height=\"647\" width=\"100%\" height=\"auto\">The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer’s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer’s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-15 11:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=newsviewer_click><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.marketwatch.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1136859135","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":865832907,"gmtCreate":1632966196232,"gmtModify":1632966196420,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/865832907","repostId":"1104172212","repostType":4,"repost":{"id":"1104172212","kind":"news","pubTimestamp":1632965278,"share":"https://www.laohu8.com/m/news/1104172212?lang=&edition=full","pubTime":"2021-09-30 09:27","market":"us","language":"en","title":"2021 Global Market Outlook - Q4 Update: Growing Pains","url":"https://stock-news.laohu8.com/highlight/detail?id=1104172212","media":"seekingalpha","summary":"Summary\n\nThe post-lockdown recovery has been powerful, and most developed economies have seen double","content":"<p><b>Summary</b></p>\n<ul>\n <li>The post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows.</li>\n <li>The reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor.</li>\n <li>The key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter.</li>\n</ul>\n<p>The COVID-19 delta variant, inflation and central bank tapering are unnerving investors. <b>We expect the pandemic-recovery trade to resume as inflation subsides, infection rates decline and tapering turns out to not equal tightening. Amid this backdrop, our outlook favors equities over bonds, the value factor over the growth factor and non-U.S. stocks over U.S. stocks.</b></p>\n<p><b>Introduction</b></p>\n<p>The post-lockdown recovery has transitioned from energetic youthfulness to awkward adolescence. It’s still growing, although at a slower pace, and there are worries about what happens next, particularly about monetary policy and the outlook for inflation. Theinflation spikehas been larger than expected, but we still think it istransitory, caused by base effects from when the U.S. consumer price index (CPI) fell during the lockdown last year and by temporary supply bottlenecks. Inflation may remain high over the remainder of 2021 but should decline in early 2022. This means that even though the U.S. Federal Reserve (Fed) is likely to begin tapering back on asset purchases before the end of the year, rate hikes are unlikely before the second half of 2023.</p>\n<p>Another worry is thehighly contagious COVID-19 delta variant. The evidence so far is that vaccines are effective in preventing serious COVID-19 infections. Vaccination rates are accelerating globally, and emerging economies are catching up with developed markets. Infection rates appear to have peaked globally in early September. This means the reopening of economies should continue over the remainder of 2021. The onset of winter in the northern hemisphere will be a test, but the rollout of booster vaccination shots should help prevent widescale renewed lockdowns.</p>\n<p>The conclusions from our cycle, value and sentiment (CVS) investment decision-making process are broadly unchanged from our previous quarterly report. Global equities remain expensive, with the very expensive U.S. market offsetting better value elsewhere. Sentiment is slightly overbought, but not close to dangerous levels of euphoria. The strong cycle delivers a preference for equities over bonds for at least the next 12 months, despite expensive valuations. It also reinforces our preference for thevalue equity factor over the growth factorand for non-U.S. equities to outperform the U.S. market.</p>\n<p><b>Cycle still in recovery phase</b></p>\n<p>The post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows. Even so, we think the cycle is still in the recovery phase, although it is maturing. Despite strong growth, there is plenty of spare capacity. This can be seen in the employment-to-population ratio for prime-age workers in the United States. The chart below shows the ratio has recovered from the pandemic lows, but only to levels reached during the relatively mild recessions in the early 1990s and 2000s. We expect theU.S. labor-market recoveryshould still resemble a typical post-recession recovery over the next few quarters.</p>\n<p><b>U.S. EMPLOYMENT-POPULATION RATIO FOR PRIME-AGE WORKERS</b></p>\n<p><img src=\"https://static.tigerbbs.com/28a91fe2991463e2285879c32cb1b8c7\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. recovery, however, is more advanced than that of other developed economies. The following chart shows how far GDP has recovered, relative to the pre-COVID-19 peak in 2019. GDP is 0.8% higher in the U.S., although this level is still short relative to the pre-COVID-19 trend. GDP is 2.5% below 2019 levels in the euro area and 4.5% below in the United Kingdom. We expect more cyclical upside for economic growth outside the U.S., and this should allow market leadership to rotate toward the rest of the world.</p>\n<p><b>GDP IN Q2 2021 RELATIVE TO PRE-COVID-19 PEAK IN 2019</b></p>\n<p><img src=\"https://static.tigerbbs.com/577d1b96aef08b71c9bdb6665a21b2ac\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Two key indicators</b></p>\n<p>Last quarter, we listed two indicators that should offer a guide to the Fed’s expected reaction to the inflation spike.</p>\n<p>The first is five-year/five-year breakeven inflation expectations, based on the pricing of Treasury Inflation Protected Securities (TIPS). This is the market’s forecast for average inflation over five years in five years’ time. It tells us that investors expect inflation will average 2.17% in the five years from late 2026 to late 2031. The TIPS yields are based on the CPI, while the Fed targets inflation as measured by the personal consumption expenditure (PCE) deflator. The two move together over time, but CPI inflation is generally around 0.25% higher than PCE inflation. A breakeven rate of 2.75% would suggest the market sees PCE inflation above 2.5% in five years’ time. Market inflation expectations are currently comfortably below the Fed’s worry point.</p>\n<p><b>WATCHPOINT INDICATOR #1: U.S. 5-YEAR/5-YEAR BREAKEVEN INFLATION RATE</b></p>\n<p><img src=\"https://static.tigerbbs.com/13f3cf57b58f600fe6681e9015779e85\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p>The second indicator is the Atlanta Fed’s Wage Growth Tracker, and this has a less-comforting message about inflation risks. It reached 3.9% in August, which isclose to the 4% thresholdwhere we judge that the Fed will become concerned about the inflationary impact on the growth of wages. A breakdown shows that the spike has been mostly driven by wages for low-skilled, young people in the leisure and hospitality industry. This suggests the surge has been caused by temporary labor supply shortages and that wage pressures should subside as economic activity normalizes. This indicator, however, will be an important watchpoint over the next few months.</p>\n<p><b>WATCHPOINT INDICATOR #2: ATLANTA FED WAGE GROWTH TRACKER</b></p>\n<p><img src=\"https://static.tigerbbs.com/a1d3ff1ca26f6d29a28f919c65531c9a\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Reopening trade still makes sense</b></p>\n<p>The reopening trade, which lifts long-term interest rates and favors cyclical and value stocks over technology and growth stocks, worked well for several months following the vaccine announcement last November. Value outperformed growth and yield curves steepened. The trade has reversed in recent months, however, amid fears that the delta variant might derail the economic recovery. The impact has been magnified by short covering in bond markets as investors, who have been short or underweight, have been forced by the rally to buy back into the market, pushing bond yields even lower.</p>\n<p>The reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor. Financial stocks comprise the largest sector in the MSCI World Value Index, and they should benefit from further yield-curve steepening, which boosts the profitability of banks. Long-term interest rates should rise as global growth remains above trend, delta-variant fears fade, the short squeeze unwinds and central banks begin tapering back on bond purchases.</p>\n<p>The rotation in economic growth leadership away from the United States should also help the reopening trade. The rest of the world is overweight cyclical value stocks relative to the U.S., which has a higher weight to technology stocks.</p>\n<p>Emerging market (EM) equities have been poor performers since the vaccine announcement, but there are some encouraging signs. Initially, they were held back by the exposure to technology stocks in the MSCI Emerging Markets Index and the slow rollout of COVID-19 vaccines. More recently, they have come under pressure from the slowdown in the Chinese economy and theregulatory crackdown on Chinese tech companies. The vaccine rollout across emerging markets has accelerated and policy easing in China should soon improve the growth outlook. The path of Chinese regulation is harder to predict, but it is now largely priced in, with Chinese technology companies underperforming their global peers by nearly 50% from February 2021 through mid-September.</p>\n<p>The resumption of the reopening trade should also result in U.S. dollar weakness. The U.S. Dollar Index (DXY) has traded sideways since the vaccine announcement. It should weaken once investors have confidence that delta-variant risks are subsiding and realize that the Fed is likely to remain dovish as inflation risks decline. The dollar typically gains during global downturns and declines in the recovery phase. Dollar weakness should support the performance of non-U.S. markets, particularly emerging markets.</p>\n<p><b>Risks: variants, inflation, China weakness</b></p>\n<p>The key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter. The evidence so far is that vaccinations are highly effective in preventing serious illness. In Israel, booster shots appear to have slowed the rate of new cases.</p>\n<p>Another watchpoint is inflation and the response of central banks. Our expectation is that this year’s inflation spike is mostly transitory and that the major central banks, led by the Fed, are still two years from raising interest rates.</p>\n<p>Finally, there is the risk of a sharper-than-expected slowdown in China.Credit growth has slowed this yearand the purchasing managers’ indexes (PMI) have trended lower. Monetary and fiscal policy have been eased, however, and senior officials have signaled that more stimulus is on the way. China policy direction and credit trends will be an important watchpoint over coming months.</p>\n<p><b>Regional snapshotsUnited States</b></p>\n<p>The U.S. economy is likely to sustain above-trend growth into 2022. However, the easiest gains appear in the rear-view mirror at the end of the third quarter as the recovery phase of the business cycle matures. This is most visible for corporate earnings, where S&amp;P 500® Index earnings-per-share already sit 20% above their previous cyclical high.</p>\n<p>Strong fundamentals have helped power the stock market to new highs. Early evidence that the delta-variant wave may be fading and the potential for greater vaccine access for children are positives for a more complete recovery in the quarters ahead. The Fedlooks poised to start tapering its asset purchasesaround the end of 2021. The timing of the first rate hike will then hinge on what happens to inflation next year. Our models suggest that inflation is likely to drop back below the Fed’s 2% target in 2022. If that is correct, the Fed is likely to remain on hold into the second half of 2023.</p>\n<p>Wage inflation is a key risk to this view. It is running unusually strong for this stage of the cycle, and record hiring intentions from businesses could exhaust spare capacity in the year ahead. We expect the 10-year U.S. Treasury yield to rise moderately from 1.37% in mid-September to 1.75% in coming months.</p>\n<p>Fiscal stimulus negotiations continue to grab headlines in Washington, D.C. Thetax provisions in these billsare likely to be the most impactful for financial markets. We estimate thathigher corporate taxescould subtract about four percentage points from S&amp;P 500 earnings growth in 2022. This could create volatility and opportunity in markets. Given our strong cyclical outlook, our bias continues to be a<i>risk-on</i>preference for equities over bonds for the medium-term.</p>\n<p><b>Eurozone</b></p>\n<p>Euro area growthslowed through the third quarter but looks on track for a return to above-trend growth over the fourth quarter and into 2022. Vaccination rates are high, and the euro area has more catch-up potential than other major economies, particularly the United States. The euro area is also set to receive more fiscal support than other regions, with the European Union’s pandemic recovery fund only just starting to disburse stimulus, which will provide significant support in southern Europe. Polls in advance of Germany’s federal election on Sept. 26 suggested the electorate was moving toward the political left, which means the new government is likely to support expansionary fiscal policy and a continued dovish stance by the European Central Bank (ECB).</p>\n<p>The MSCI EMU Index, which reflects the European Economic and Monetary Union, has performed broadly in line with the S&amp;P 500 so far in 2021. We think it has potential to outperform in coming quarters. Europe’s exposure to financials and cyclically sensitive sectors such as industrials, materials and energy, and its relatively small exposure to technology, gives it the potential to outperform as delta-variant fears subside, economic activity picks up and yield curves in Europe steepen.</p>\n<p><b>United Kingdom</b></p>\n<p>As of mid-year, UK GDP was still nearly 4.5% below its pre-pandemic peak. We see plenty of scope for strong catch-up growth as borders are fully reopened and activity normalizes. Supply bottlenecks and labor shortages have triggered a sharp rise in underlying inflation and created concerns that the Bank of England (BoE) may start rate hikes in the first half of 2022. We think the BoE is unlikely to be that aggressive. We expect inflation to decline in early 2022 as supply constraints ease, which should convince the BoE to delay rate hikes.</p>\n<p>The FTSE 100 Index is the cheapest of the major developed equity markets in late 2021, and this should help it reflect higher returns than other markets over the next decade. Around 70% of UK corporate earnings come from offshore, so one near-term risk is that further strengthening of British sterling dampens earnings growth. The other risks are mostly around policy missteps, for example, early tightening by the Bank of England.</p>\n<p><b>Japan</b></p>\n<p>The Japanese economy is expected to get a shot in the arm as rising vaccination rates improve mobility and reduce the risk of further lockdowns, and as political leadership changes result in more fiscal stimulus: the Japanese election is due to be held before Nov. 28. Japanese equities look slightly more expensive than other regions such as the UK and Europe. We maintain our view that the Bank of Japan will significantly lag other central banks in normalizing policy.</p>\n<p><b>China</b></p>\n<p>We expect Chinese economic growth to berobust over the next 12 months, supported by a post-lockdown jump in consumer spending and incremental fiscal and monetary easing. Despite a big improvement in vaccination rates,COVID-19 outbreaks remain a riskgiven the Chinese government’s zero-tolerance approach. The major consumer technology companies have seen significant drops in stock prices recently due to more aggressive regulation. Some uncertainty remains around thepath of future regulation, especially as it relates to technology companies, and as a result we expect investors will remain cautious on Chinese equities in the coming months. The property market, particularly property developers as recently highlighted by Evergrande’s debt crisis, remains a risk that we are monitoring closely.</p>\n<p><b>Canada</b></p>\n<p>Canada leads the G71countries in terms of the vaccination rollout, which should minimize the risk of large-scale lockdowns over winter. The delta variant has taken an economic toll, however, with industry consensus projections now predicting 5% GDP growth in 2021 versus estimates of more than 6% just three months ago. Even so, growth remains above-trend and the odds of additional fiscal expenditures to support the economy have increased. This means that weaker growth due to COVID-19 is unlikely to change the Bank of Canada's (BoC) tightening bias.</p>\n<p>Tapering of asset purchasesshould be complete by the end of the first quarter of 2022. BoC Governor Tiff Macklem has indicated that the reinvestment phase of the bonds held by the central bank will commence once quantitative easing has ended. This should generate an estimated C$1 billion in weekly bond purchases, down from the current pace of C$2 billion. The BoC will likely only consider shrinking its balance sheet after it has started lifting interest rates. The BoC projects that the output gap will close sometime over the second half of 2022, and that rate hikes will be considered after economic slack has disappeared. We believe that the timeline may be a tad aggressive, and a delay to 2023 for liftoff is more likely. This would better align the Canadian central bank with its American counterpart.</p>\n<p><b>Australia/New Zealand</b></p>\n<p>The Australian economy is set to return to life, with lockdowns likely to be eased in October and November. Consumer and business balance sheets continue to look healthy, which should facilitate a strong recovery. The reopening of the international border in 2022 will provide a further boost. Fiscal policy has supported the economy through the downturn, and there is potential for further stimulus in the lead-up to the federal election, which is due before the end of 2022. The Reserve Bank of Australia has begun the process of tapering its bond-purchase program, but we expect that a rise in the cash rate is unlikely until at least the second half of 2023.</p>\n<p>New Zealand’s most recent lockdown will drag on Q3 GDP, but similar to Australia, we expect a solid rebound as the economy reopens. The government aims to provide a vaccine to all adults by the end of 2021, after which borders will gradually reopen. This will provide a boost, particularly to tourism-exposed sectors. Despite having recently put off hiking interest rates due to the recent lockdown, we expect the Reserve Bank of New Zealand will start raising rates this year. Even though they have significantly underperformed global equities this year, New Zealand equities still screen as relatively expensive compared to other regions.</p>\n<p><b>Asset-class preferences</b></p>\n<p>Our cycle, value and sentiment investment decision-making process in late September 2021 has a moderately positive medium-term view on global equities. Value is expensive across most markets except for UK equities, which are near fair value. The cycle is risk-asset supportive for the medium-term. The major economies still have spare capacity and inflation pressures appear transitory, caused by COVID-19-related supply shortages. Rate hikes by the U.S. Fed seem unlikely before the second half of 2023. Sentiment, after reaching overbought levels earlier in the year, has returned to more neutral levels.</p>\n<p><b>COMPOSITE CONTRARIAN INDICATOR: SENTIMENT SHIFTS TOWARD NEUTRAL</b></p>\n<p><img src=\"https://static.tigerbbs.com/5c527955abbc9e770d200c1d709f80d8\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>We prefer<b>non-U.S. equities</b>to U.S. equities. Stronger economic growth and steeper yield curves after the third-quarter slowdown should favor undervalued cyclical value stocks over expensive technology and growth stocks. Relative to the U.S., the rest of the world is overweight cyclical value stocks.</li>\n <li><b>Emerging markets equities</b>have been relatively poor performers this year, but there are some encouraging signs. The vaccine rollout across EM has accelerated and policy easing in China should soon boost the economic growth outlook.China’s regulatory crackdownhas caused significant underperformance by Chinese technology companies, but this should be less of a headwind going forward now that it is priced in.</li>\n <li><b>High yield</b>and<b>investment grade credit</b>are expensive on a spread basis but have support from a positive cycle view that accommodates corporate profit growth and keeps default rates low. U.S. dollar-denominated<b>emerging markets debt</b>is close to fair value in spread terms and will gain support on U.S. dollar weakness.</li>\n <li><b>Government bonds</b>are expensive, and yields should come under upward pressure as output gaps close and central banks look to taper back asset purchases. We expect the 10-year U.S. Treasury yield to rise toward 1.75% in coming months.</li>\n <li><b>Real assets</b>: Real Estate Investment Trusts (REITs) have significantly outperformed Global Listed Infrastructure (GLI) so far this year, to the extent that REITS are now expensive relative to GLI. Both should benefit from the pandemic recovery, but GLI has some catch-up potential. GLI should benefit from the global re-opening boosting domestic and international travel.<b>Commodities</b>have been the best-performing asset class this year amid strong demand and supply bottlenecks. The gains have been led by industrial metals and energy. The pace of increase should ease as supply issues are resolved, butcommodities should retain supportfrom above-trend global demand.</li>\n <li>The<b>U.S. dollar</b>has been supported this year by expectations for early Fed tightening and U.S. economic growth leadership. It should weaken as global growth leadership rotates away from the U.S. and toward Europe and other developed economies. The dollar typically gains during global downturns and declines in the recovery phase. The main beneficiary is likely to be the<b>euro</b>, which is still undervalued. We also believe<b>British sterling</b>and the economically sensitive<i>commodity currencies</i>—the<b>Australian dollar</b>, the<b>New Zealand dollar</b>and the<b>Canadian dollar</b>—can make further gains, although these currencies are not undervalued from a longer-term perspective.</li>\n</ul>\n<p><b>ASSET PERFORMANCE SINCE THE BEGINNING OF 2021</b></p>\n<p><img src=\"https://static.tigerbbs.com/50e253becd38bd122d9fc211e7b0f583\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p>1The Group of Seven is an inter-governmental political forum consisting of Canada, France, Germany, Italy, Japan, the United Kingdom and the United States.</p>\n<p><b>Important Information</b></p>\n<p>The views in this Global Market Outlook report are subject to change at any time based upon market or other conditions and are current as of September 27, 2021. While all material is deemed to be reliable, accuracy and completeness cannot be guaranteed.</p>\n<p>Please remember that all investments carry some level of risk, including the potential loss of principal invested. They do not typically grow at an even rate of return and may experience negative growth. As with any type of portfolio structuring, attempting to reduce risk and increase return could, at certain times, unintentionally reduce returns.</p>\n<p>Keep in mind that, like all investing, multi-asset investing does not assure a profit or protect against loss.</p>\n<p>No model or group of models can offer a precise estimate of future returns available from capital markets. We remain cautious that rational analytical techniques cannot predict extremes in financial behavior, such as periods of financial euphoria or investor panic. Our models rest on the assumptions of normal and rational financial behavior. Forecasting models are inherently uncertain, subject to change at any time based on a variety of factors and can be inaccurate. Russell believes that the utility of this information is highest in evaluating the relative relationships of various components of a globally diversified portfolio. As such, the models may offer insights into the prudence of over or under weighting those components from time to time or under periods of extreme dislocation. The models are explicitly not intended as market timing signals.</p>\n<p>Forecasting represents predictions of market prices and/or volume patterns utilizing varying analytical data. It is not representative of a projection of the stock market, or of any specific investment.</p>\n<p>Investment in global, international or emerging markets may be significantly affected by political or economic conditions and regulatory requirements in a particular country. Investments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation. Such securities may be less liquid and more volatile. Investments in emerging or developing markets involve exposure to economic structures that are generally less diverse and mature, and political systems with less stability than in more developed countries.</p>\n<p>Currency investing involves risks including fluctuations in currency values, whether the home currency or the foreign currency. They can either enhance or reduce the returns associated with foreign investments.</p>\n<p>Investments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation.</p>\n<p>Bond investors should carefully consider risks such as interest rate, credit, default and duration risks. Greater risk, such as increased volatility, limited liquidity, prepayment, non-payment and increased default risk, is inherent in portfolios that invest in high yield (“junk”) bonds or mortgage-backed securities, especially mortgage-backed securities with exposure to sub-prime mortgages. Generally, when interest rates rise, prices of fixed income securities fall. Interest rates in the United States are at, or near, historic lows, which may increase a Fund’s exposure to risks associated with rising rates. Investment in non-U.S. and emerging market securities is subject to the risk of currency fluctuations and to economic and political risks associated with such foreign countries.</p>\n<p>Performance quoted represents past performance and should not be viewed as a guarantee of future results.</p>\n<p>The FTSE 100 Index is a market-capitalization weighted index of UK-listed blue chip companies.</p>\n<p>The S&amp;P 500® Index, or the Standard &amp; Poor’s 500, is a stock market index based on the market capitalizations of 500 large companies having common stock listed on the NYSE or NASDAQ.</p>\n<p>The MSCI EMU Index (European Economic and Monetary Union) captures large and mid cap representation across the 10 developed markets countries in the EMU. With 246 constituents, the index covers approximately 85% of the free float-adjusted market capitalization of the EMU.</p>\n<p>Indexes are unmanaged and cannot be invested in directly.</p>\n<p>Copyright © Russell Investments 2021. All rights reserved. This material is proprietary and may not be reproduced, transferred, or distributed in any form without prior written permission from Russell Investments. It is delivered on an “as is” basis without warranty.</p>\n<p>Frank Russell Company is the owner of the Russell trademarks contained in this material and all trademark rights related to the Russell trademarks, which the members of the Russell Investments group of companies are permitted to use under license from Frank Russell Company. The members of the Russell Investments group of companies are not affiliated in any manner with Frank Russell Company or any entity operating under the “FTSE RUSSELL” brand.</p>\n<p>Products and services described on this website are intended for<b>United States residents only</b>. Nothing contained in this material is intended to constitute legal, tax, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. The general information contained on this website should not be acted upon without obtaining specific legal, tax, and investment advice from a licensed professional. Persons outside the United States may find more information about products and services available within their jurisdictions by going to Russell Investments' Worldwide site.</p>\n<p>Russell Investments is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards.</p>\n<p>Russell Investments' ownership is composed of a majority stake held by funds managed by TA Associates, with a significant minority stake held by funds managed by Reverence Capital Partners. Russell Investments' employees and Hamilton Lane Advisors, LLC also hold minority, non-controlling, ownership stakes.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2021 Global Market Outlook - Q4 Update: Growing Pains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2021 Global Market Outlook - Q4 Update: Growing Pains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 09:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4457651-2021-global-market-outlook-q4-update-growing-pains><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows.\nThe reopening trade should resume in ...</p>\n\n<a href=\"https://seekingalpha.com/article/4457651-2021-global-market-outlook-q4-update-growing-pains\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://seekingalpha.com/article/4457651-2021-global-market-outlook-q4-update-growing-pains","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1104172212","content_text":"Summary\n\nThe post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows.\nThe reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor.\nThe key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter.\n\nThe COVID-19 delta variant, inflation and central bank tapering are unnerving investors. We expect the pandemic-recovery trade to resume as inflation subsides, infection rates decline and tapering turns out to not equal tightening. Amid this backdrop, our outlook favors equities over bonds, the value factor over the growth factor and non-U.S. stocks over U.S. stocks.\nIntroduction\nThe post-lockdown recovery has transitioned from energetic youthfulness to awkward adolescence. It’s still growing, although at a slower pace, and there are worries about what happens next, particularly about monetary policy and the outlook for inflation. Theinflation spikehas been larger than expected, but we still think it istransitory, caused by base effects from when the U.S. consumer price index (CPI) fell during the lockdown last year and by temporary supply bottlenecks. Inflation may remain high over the remainder of 2021 but should decline in early 2022. This means that even though the U.S. Federal Reserve (Fed) is likely to begin tapering back on asset purchases before the end of the year, rate hikes are unlikely before the second half of 2023.\nAnother worry is thehighly contagious COVID-19 delta variant. The evidence so far is that vaccines are effective in preventing serious COVID-19 infections. Vaccination rates are accelerating globally, and emerging economies are catching up with developed markets. Infection rates appear to have peaked globally in early September. This means the reopening of economies should continue over the remainder of 2021. The onset of winter in the northern hemisphere will be a test, but the rollout of booster vaccination shots should help prevent widescale renewed lockdowns.\nThe conclusions from our cycle, value and sentiment (CVS) investment decision-making process are broadly unchanged from our previous quarterly report. Global equities remain expensive, with the very expensive U.S. market offsetting better value elsewhere. Sentiment is slightly overbought, but not close to dangerous levels of euphoria. The strong cycle delivers a preference for equities over bonds for at least the next 12 months, despite expensive valuations. It also reinforces our preference for thevalue equity factor over the growth factorand for non-U.S. equities to outperform the U.S. market.\nCycle still in recovery phase\nThe post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows. Even so, we think the cycle is still in the recovery phase, although it is maturing. Despite strong growth, there is plenty of spare capacity. This can be seen in the employment-to-population ratio for prime-age workers in the United States. The chart below shows the ratio has recovered from the pandemic lows, but only to levels reached during the relatively mild recessions in the early 1990s and 2000s. We expect theU.S. labor-market recoveryshould still resemble a typical post-recession recovery over the next few quarters.\nU.S. EMPLOYMENT-POPULATION RATIO FOR PRIME-AGE WORKERS\n\nThe U.S. recovery, however, is more advanced than that of other developed economies. The following chart shows how far GDP has recovered, relative to the pre-COVID-19 peak in 2019. GDP is 0.8% higher in the U.S., although this level is still short relative to the pre-COVID-19 trend. GDP is 2.5% below 2019 levels in the euro area and 4.5% below in the United Kingdom. We expect more cyclical upside for economic growth outside the U.S., and this should allow market leadership to rotate toward the rest of the world.\nGDP IN Q2 2021 RELATIVE TO PRE-COVID-19 PEAK IN 2019\n\nTwo key indicators\nLast quarter, we listed two indicators that should offer a guide to the Fed’s expected reaction to the inflation spike.\nThe first is five-year/five-year breakeven inflation expectations, based on the pricing of Treasury Inflation Protected Securities (TIPS). This is the market’s forecast for average inflation over five years in five years’ time. It tells us that investors expect inflation will average 2.17% in the five years from late 2026 to late 2031. The TIPS yields are based on the CPI, while the Fed targets inflation as measured by the personal consumption expenditure (PCE) deflator. The two move together over time, but CPI inflation is generally around 0.25% higher than PCE inflation. A breakeven rate of 2.75% would suggest the market sees PCE inflation above 2.5% in five years’ time. Market inflation expectations are currently comfortably below the Fed’s worry point.\nWATCHPOINT INDICATOR #1: U.S. 5-YEAR/5-YEAR BREAKEVEN INFLATION RATE\n\nThe second indicator is the Atlanta Fed’s Wage Growth Tracker, and this has a less-comforting message about inflation risks. It reached 3.9% in August, which isclose to the 4% thresholdwhere we judge that the Fed will become concerned about the inflationary impact on the growth of wages. A breakdown shows that the spike has been mostly driven by wages for low-skilled, young people in the leisure and hospitality industry. This suggests the surge has been caused by temporary labor supply shortages and that wage pressures should subside as economic activity normalizes. This indicator, however, will be an important watchpoint over the next few months.\nWATCHPOINT INDICATOR #2: ATLANTA FED WAGE GROWTH TRACKER\n\nReopening trade still makes sense\nThe reopening trade, which lifts long-term interest rates and favors cyclical and value stocks over technology and growth stocks, worked well for several months following the vaccine announcement last November. Value outperformed growth and yield curves steepened. The trade has reversed in recent months, however, amid fears that the delta variant might derail the economic recovery. The impact has been magnified by short covering in bond markets as investors, who have been short or underweight, have been forced by the rally to buy back into the market, pushing bond yields even lower.\nThe reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor. Financial stocks comprise the largest sector in the MSCI World Value Index, and they should benefit from further yield-curve steepening, which boosts the profitability of banks. Long-term interest rates should rise as global growth remains above trend, delta-variant fears fade, the short squeeze unwinds and central banks begin tapering back on bond purchases.\nThe rotation in economic growth leadership away from the United States should also help the reopening trade. The rest of the world is overweight cyclical value stocks relative to the U.S., which has a higher weight to technology stocks.\nEmerging market (EM) equities have been poor performers since the vaccine announcement, but there are some encouraging signs. Initially, they were held back by the exposure to technology stocks in the MSCI Emerging Markets Index and the slow rollout of COVID-19 vaccines. More recently, they have come under pressure from the slowdown in the Chinese economy and theregulatory crackdown on Chinese tech companies. The vaccine rollout across emerging markets has accelerated and policy easing in China should soon improve the growth outlook. The path of Chinese regulation is harder to predict, but it is now largely priced in, with Chinese technology companies underperforming their global peers by nearly 50% from February 2021 through mid-September.\nThe resumption of the reopening trade should also result in U.S. dollar weakness. The U.S. Dollar Index (DXY) has traded sideways since the vaccine announcement. It should weaken once investors have confidence that delta-variant risks are subsiding and realize that the Fed is likely to remain dovish as inflation risks decline. The dollar typically gains during global downturns and declines in the recovery phase. Dollar weakness should support the performance of non-U.S. markets, particularly emerging markets.\nRisks: variants, inflation, China weakness\nThe key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter. The evidence so far is that vaccinations are highly effective in preventing serious illness. In Israel, booster shots appear to have slowed the rate of new cases.\nAnother watchpoint is inflation and the response of central banks. Our expectation is that this year’s inflation spike is mostly transitory and that the major central banks, led by the Fed, are still two years from raising interest rates.\nFinally, there is the risk of a sharper-than-expected slowdown in China.Credit growth has slowed this yearand the purchasing managers’ indexes (PMI) have trended lower. Monetary and fiscal policy have been eased, however, and senior officials have signaled that more stimulus is on the way. China policy direction and credit trends will be an important watchpoint over coming months.\nRegional snapshotsUnited States\nThe U.S. economy is likely to sustain above-trend growth into 2022. However, the easiest gains appear in the rear-view mirror at the end of the third quarter as the recovery phase of the business cycle matures. This is most visible for corporate earnings, where S&P 500® Index earnings-per-share already sit 20% above their previous cyclical high.\nStrong fundamentals have helped power the stock market to new highs. Early evidence that the delta-variant wave may be fading and the potential for greater vaccine access for children are positives for a more complete recovery in the quarters ahead. The Fedlooks poised to start tapering its asset purchasesaround the end of 2021. The timing of the first rate hike will then hinge on what happens to inflation next year. Our models suggest that inflation is likely to drop back below the Fed’s 2% target in 2022. If that is correct, the Fed is likely to remain on hold into the second half of 2023.\nWage inflation is a key risk to this view. It is running unusually strong for this stage of the cycle, and record hiring intentions from businesses could exhaust spare capacity in the year ahead. We expect the 10-year U.S. Treasury yield to rise moderately from 1.37% in mid-September to 1.75% in coming months.\nFiscal stimulus negotiations continue to grab headlines in Washington, D.C. Thetax provisions in these billsare likely to be the most impactful for financial markets. We estimate thathigher corporate taxescould subtract about four percentage points from S&P 500 earnings growth in 2022. This could create volatility and opportunity in markets. Given our strong cyclical outlook, our bias continues to be arisk-onpreference for equities over bonds for the medium-term.\nEurozone\nEuro area growthslowed through the third quarter but looks on track for a return to above-trend growth over the fourth quarter and into 2022. Vaccination rates are high, and the euro area has more catch-up potential than other major economies, particularly the United States. The euro area is also set to receive more fiscal support than other regions, with the European Union’s pandemic recovery fund only just starting to disburse stimulus, which will provide significant support in southern Europe. Polls in advance of Germany’s federal election on Sept. 26 suggested the electorate was moving toward the political left, which means the new government is likely to support expansionary fiscal policy and a continued dovish stance by the European Central Bank (ECB).\nThe MSCI EMU Index, which reflects the European Economic and Monetary Union, has performed broadly in line with the S&P 500 so far in 2021. We think it has potential to outperform in coming quarters. Europe’s exposure to financials and cyclically sensitive sectors such as industrials, materials and energy, and its relatively small exposure to technology, gives it the potential to outperform as delta-variant fears subside, economic activity picks up and yield curves in Europe steepen.\nUnited Kingdom\nAs of mid-year, UK GDP was still nearly 4.5% below its pre-pandemic peak. We see plenty of scope for strong catch-up growth as borders are fully reopened and activity normalizes. Supply bottlenecks and labor shortages have triggered a sharp rise in underlying inflation and created concerns that the Bank of England (BoE) may start rate hikes in the first half of 2022. We think the BoE is unlikely to be that aggressive. We expect inflation to decline in early 2022 as supply constraints ease, which should convince the BoE to delay rate hikes.\nThe FTSE 100 Index is the cheapest of the major developed equity markets in late 2021, and this should help it reflect higher returns than other markets over the next decade. Around 70% of UK corporate earnings come from offshore, so one near-term risk is that further strengthening of British sterling dampens earnings growth. The other risks are mostly around policy missteps, for example, early tightening by the Bank of England.\nJapan\nThe Japanese economy is expected to get a shot in the arm as rising vaccination rates improve mobility and reduce the risk of further lockdowns, and as political leadership changes result in more fiscal stimulus: the Japanese election is due to be held before Nov. 28. Japanese equities look slightly more expensive than other regions such as the UK and Europe. We maintain our view that the Bank of Japan will significantly lag other central banks in normalizing policy.\nChina\nWe expect Chinese economic growth to berobust over the next 12 months, supported by a post-lockdown jump in consumer spending and incremental fiscal and monetary easing. Despite a big improvement in vaccination rates,COVID-19 outbreaks remain a riskgiven the Chinese government’s zero-tolerance approach. The major consumer technology companies have seen significant drops in stock prices recently due to more aggressive regulation. Some uncertainty remains around thepath of future regulation, especially as it relates to technology companies, and as a result we expect investors will remain cautious on Chinese equities in the coming months. The property market, particularly property developers as recently highlighted by Evergrande’s debt crisis, remains a risk that we are monitoring closely.\nCanada\nCanada leads the G71countries in terms of the vaccination rollout, which should minimize the risk of large-scale lockdowns over winter. The delta variant has taken an economic toll, however, with industry consensus projections now predicting 5% GDP growth in 2021 versus estimates of more than 6% just three months ago. Even so, growth remains above-trend and the odds of additional fiscal expenditures to support the economy have increased. This means that weaker growth due to COVID-19 is unlikely to change the Bank of Canada's (BoC) tightening bias.\nTapering of asset purchasesshould be complete by the end of the first quarter of 2022. BoC Governor Tiff Macklem has indicated that the reinvestment phase of the bonds held by the central bank will commence once quantitative easing has ended. This should generate an estimated C$1 billion in weekly bond purchases, down from the current pace of C$2 billion. The BoC will likely only consider shrinking its balance sheet after it has started lifting interest rates. The BoC projects that the output gap will close sometime over the second half of 2022, and that rate hikes will be considered after economic slack has disappeared. We believe that the timeline may be a tad aggressive, and a delay to 2023 for liftoff is more likely. This would better align the Canadian central bank with its American counterpart.\nAustralia/New Zealand\nThe Australian economy is set to return to life, with lockdowns likely to be eased in October and November. Consumer and business balance sheets continue to look healthy, which should facilitate a strong recovery. The reopening of the international border in 2022 will provide a further boost. Fiscal policy has supported the economy through the downturn, and there is potential for further stimulus in the lead-up to the federal election, which is due before the end of 2022. The Reserve Bank of Australia has begun the process of tapering its bond-purchase program, but we expect that a rise in the cash rate is unlikely until at least the second half of 2023.\nNew Zealand’s most recent lockdown will drag on Q3 GDP, but similar to Australia, we expect a solid rebound as the economy reopens. The government aims to provide a vaccine to all adults by the end of 2021, after which borders will gradually reopen. This will provide a boost, particularly to tourism-exposed sectors. Despite having recently put off hiking interest rates due to the recent lockdown, we expect the Reserve Bank of New Zealand will start raising rates this year. Even though they have significantly underperformed global equities this year, New Zealand equities still screen as relatively expensive compared to other regions.\nAsset-class preferences\nOur cycle, value and sentiment investment decision-making process in late September 2021 has a moderately positive medium-term view on global equities. Value is expensive across most markets except for UK equities, which are near fair value. The cycle is risk-asset supportive for the medium-term. The major economies still have spare capacity and inflation pressures appear transitory, caused by COVID-19-related supply shortages. Rate hikes by the U.S. Fed seem unlikely before the second half of 2023. Sentiment, after reaching overbought levels earlier in the year, has returned to more neutral levels.\nCOMPOSITE CONTRARIAN INDICATOR: SENTIMENT SHIFTS TOWARD NEUTRAL\n\n\nWe prefernon-U.S. equitiesto U.S. equities. Stronger economic growth and steeper yield curves after the third-quarter slowdown should favor undervalued cyclical value stocks over expensive technology and growth stocks. Relative to the U.S., the rest of the world is overweight cyclical value stocks.\nEmerging markets equitieshave been relatively poor performers this year, but there are some encouraging signs. The vaccine rollout across EM has accelerated and policy easing in China should soon boost the economic growth outlook.China’s regulatory crackdownhas caused significant underperformance by Chinese technology companies, but this should be less of a headwind going forward now that it is priced in.\nHigh yieldandinvestment grade creditare expensive on a spread basis but have support from a positive cycle view that accommodates corporate profit growth and keeps default rates low. U.S. dollar-denominatedemerging markets debtis close to fair value in spread terms and will gain support on U.S. dollar weakness.\nGovernment bondsare expensive, and yields should come under upward pressure as output gaps close and central banks look to taper back asset purchases. We expect the 10-year U.S. Treasury yield to rise toward 1.75% in coming months.\nReal assets: Real Estate Investment Trusts (REITs) have significantly outperformed Global Listed Infrastructure (GLI) so far this year, to the extent that REITS are now expensive relative to GLI. Both should benefit from the pandemic recovery, but GLI has some catch-up potential. GLI should benefit from the global re-opening boosting domestic and international travel.Commoditieshave been the best-performing asset class this year amid strong demand and supply bottlenecks. The gains have been led by industrial metals and energy. The pace of increase should ease as supply issues are resolved, butcommodities should retain supportfrom above-trend global demand.\nTheU.S. dollarhas been supported this year by expectations for early Fed tightening and U.S. economic growth leadership. It should weaken as global growth leadership rotates away from the U.S. and toward Europe and other developed economies. The dollar typically gains during global downturns and declines in the recovery phase. The main beneficiary is likely to be theeuro, which is still undervalued. We also believeBritish sterlingand the economically sensitivecommodity currencies—theAustralian dollar, theNew Zealand dollarand theCanadian dollar—can make further gains, although these currencies are not undervalued from a longer-term perspective.\n\nASSET PERFORMANCE SINCE THE BEGINNING OF 2021\n\n1The Group of Seven is an inter-governmental political forum consisting of Canada, France, Germany, Italy, Japan, the United Kingdom and the United States.\nImportant Information\nThe views in this Global Market Outlook report are subject to change at any time based upon market or other conditions and are current as of September 27, 2021. While all material is deemed to be reliable, accuracy and completeness cannot be guaranteed.\nPlease remember that all investments carry some level of risk, including the potential loss of principal invested. They do not typically grow at an even rate of return and may experience negative growth. As with any type of portfolio structuring, attempting to reduce risk and increase return could, at certain times, unintentionally reduce returns.\nKeep in mind that, like all investing, multi-asset investing does not assure a profit or protect against loss.\nNo model or group of models can offer a precise estimate of future returns available from capital markets. We remain cautious that rational analytical techniques cannot predict extremes in financial behavior, such as periods of financial euphoria or investor panic. Our models rest on the assumptions of normal and rational financial behavior. Forecasting models are inherently uncertain, subject to change at any time based on a variety of factors and can be inaccurate. Russell believes that the utility of this information is highest in evaluating the relative relationships of various components of a globally diversified portfolio. As such, the models may offer insights into the prudence of over or under weighting those components from time to time or under periods of extreme dislocation. The models are explicitly not intended as market timing signals.\nForecasting represents predictions of market prices and/or volume patterns utilizing varying analytical data. It is not representative of a projection of the stock market, or of any specific investment.\nInvestment in global, international or emerging markets may be significantly affected by political or economic conditions and regulatory requirements in a particular country. Investments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation. Such securities may be less liquid and more volatile. Investments in emerging or developing markets involve exposure to economic structures that are generally less diverse and mature, and political systems with less stability than in more developed countries.\nCurrency investing involves risks including fluctuations in currency values, whether the home currency or the foreign currency. They can either enhance or reduce the returns associated with foreign investments.\nInvestments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation.\nBond investors should carefully consider risks such as interest rate, credit, default and duration risks. Greater risk, such as increased volatility, limited liquidity, prepayment, non-payment and increased default risk, is inherent in portfolios that invest in high yield (“junk”) bonds or mortgage-backed securities, especially mortgage-backed securities with exposure to sub-prime mortgages. Generally, when interest rates rise, prices of fixed income securities fall. Interest rates in the United States are at, or near, historic lows, which may increase a Fund’s exposure to risks associated with rising rates. Investment in non-U.S. and emerging market securities is subject to the risk of currency fluctuations and to economic and political risks associated with such foreign countries.\nPerformance quoted represents past performance and should not be viewed as a guarantee of future results.\nThe FTSE 100 Index is a market-capitalization weighted index of UK-listed blue chip companies.\nThe S&P 500® Index, or the Standard & Poor’s 500, is a stock market index based on the market capitalizations of 500 large companies having common stock listed on the NYSE or NASDAQ.\nThe MSCI EMU Index (European Economic and Monetary Union) captures large and mid cap representation across the 10 developed markets countries in the EMU. With 246 constituents, the index covers approximately 85% of the free float-adjusted market capitalization of the EMU.\nIndexes are unmanaged and cannot be invested in directly.\nCopyright © Russell Investments 2021. All rights reserved. This material is proprietary and may not be reproduced, transferred, or distributed in any form without prior written permission from Russell Investments. It is delivered on an “as is” basis without warranty.\nFrank Russell Company is the owner of the Russell trademarks contained in this material and all trademark rights related to the Russell trademarks, which the members of the Russell Investments group of companies are permitted to use under license from Frank Russell Company. The members of the Russell Investments group of companies are not affiliated in any manner with Frank Russell Company or any entity operating under the “FTSE RUSSELL” brand.\nProducts and services described on this website are intended forUnited States residents only. Nothing contained in this material is intended to constitute legal, tax, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. The general information contained on this website should not be acted upon without obtaining specific legal, tax, and investment advice from a licensed professional. Persons outside the United States may find more information about products and services available within their jurisdictions by going to Russell Investments' Worldwide site.\nRussell Investments is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards.\nRussell Investments' ownership is composed of a majority stake held by funds managed by TA Associates, with a significant minority stake held by funds managed by Reverence Capital Partners. Russell Investments' employees and Hamilton Lane Advisors, LLC also hold minority, non-controlling, ownership stakes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815864853,"gmtCreate":1630667298872,"gmtModify":1631892030480,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/815864853","repostId":"2164876904","repostType":4,"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":841156816,"gmtCreate":1635897806335,"gmtModify":1635897806453,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/841156816","repostId":"2180736486","repostType":4,"isVote":1,"tweetType":1,"viewCount":105,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":814461179,"gmtCreate":1630871614591,"gmtModify":1631892030473,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/814461179","repostId":"2164808914","repostType":4,"isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":816953230,"gmtCreate":1630462036820,"gmtModify":1631892030493,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/816953230","repostId":"1193943153","repostType":4,"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":831323954,"gmtCreate":1629290213878,"gmtModify":1631893805374,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Ok&nbsp;","listText":"Ok&nbsp;","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/831323954","repostId":"1131876419","repostType":4,"repost":{"id":"1131876419","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629288195,"share":"https://www.laohu8.com/m/news/1131876419?lang=&edition=full","pubTime":"2021-08-18 20:03","market":"us","language":"en","title":"Toplines Before US Market Opens Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1131876419","media":"Tiger Newspress","summary":"US equity futures and global markets were flat in listless trading as investors assessed the outlook","content":"<p>US equity futures and global markets were flat in listless trading as investors assessed the outlook for economic recovery and awaited the latest Federal Reserve minutes to gauge the direction of monetary policy while tracking the latest covid lockdown in New Zealand and on edge ahead of possible turbulence in Friday's OpEx. </p>\n<p>Overnight the MSCI Asia Pacific Index added 0.4% while Japan’s Topix index closed 0.4% higher. In Europe the Stoxx 600 Index was broadly unchanged. S&amp;P 500 futures pointed to a small move lower at the open, the 10-year Treasury yield was at 1.277%, oil rose and gold moved higher, while cryptos rebounded from a late Tuesday selloff.</p>\n<p>At 7:55 a.m. ET, Dow E-minis were down 64 points, or 0.18%, S&amp;P 500 E-minis were down&nbsp;4 points, or 0.09% and Nasdaq 100 E-minis were&nbsp;up&nbsp;8 points, or 0.05%.</p>\n<p><img src=\"https://static.tigerbbs.com/5b8765de5383459e16baef1249617b5b\" tg-width=\"1125\" tg-height=\"413\" width=\"100%\" height=\"auto\"></p>\n<h3><b>Stocks making the biggest moves in the premarket:</b></h3>\n<p>1.&nbsp;<b><a href=\"https://laohu8.com/S/LOW\">Lowe's</a></b> – The home improvement retailer reported an adjusted quarterly profit of $4.25 per share, beating the consensus estimate of $4.01. Revenue beat forecasts, and the same-store sales decline of 1.6% was less than the 2.2% decline predicted by analysts. Lowe’s also raised its full-year financial outlook, as spending by builders and professionals rose. Lowe’s rallied 4.60% in the premarket.</p>\n<p>2.&nbsp;<b><a href=\"https://laohu8.com/S/TGT\">Target</a> </b>– The retailer beat estimates by 15 cents with adjusted quarterly earnings of $3.64 per share, and revenue slightly above analyst forecasts. Comparable store sales rose 8.9%, slightly above the 8.8% consensus estimate. Target shares added 2.42% in premarket trading.</p>\n<p>3.&nbsp;<b><a href=\"https://laohu8.com/S/DNUT\">Krispy Kreme, Inc.</a></b> – The doughnut chain fell a penny shy of Street forecasts with an adjusted quarterly profit of 13 cents per share, though revenue did beat estimates. Krispy Kreme also gave a better-than-expected revenue forecast, based on projected strength from online ordering and new menu items. The stock added 2.9% in premarket action.</p>\n<p>4.&nbsp;<b><a href=\"https://laohu8.com/S/ALC\">Alcon Inc.</a></b> – The maker of eyecare and surgical products surged 9.89% in the premarket, after reporting better-than-expected quarterly results and raising its full-year guidance. The quarter marked the debut of Alcon’s Vivity intraocular contact lens, which analysts say will help drive sales growth.</p>\n<p>5.&nbsp;<b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b>,&nbsp;<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– Moderna rose 1.74% in premarket trading while BioNTech gained 1.38%, ahead of an expected announcement by the White House calling for a booster shot for Americans already fully vaccinated against Covid-19.</p>\n<p>6.&nbsp;<b><a href=\"https://laohu8.com/S/TMUS\">T-Mobile US</a></b> – Following an investigation, the wireless carrier now says the personal information of about 7.8 million customers was compromised in a recent data breach. That included dates of birth, social security numbers and driver’s license information, although no financial information was stolen.</p>\n<p>7.&nbsp;<b><a href=\"https://laohu8.com/S/VIAC\">Viacom CBS</a> </b>– Shares of the media giant gained 2.77% in premarket action after Wells Fargo Securities upgraded the stock to “overweight” from “equal weight”. Wells Fargo said ViacomCBS is one of the players poised to benefit from industry consolidation and it is also impressed by the upcoming programming slate for the company’s Paramount+ streaming service.</p>\n<p>8. <b><a href=\"https://laohu8.com/S/BB\">BlackBerry</a></b> – The communications software maker said it released software patches to fix an issue with older versions of its QNX operating system and has notified all customers. U.S. officials had said earlier yesterday that the software flaw could put cars and medical equipment at risk. BlackBerry shares gained 1.34% in the premarket.</p>\n<p>9.&nbsp;<b><a href=\"https://laohu8.com/S/TLRY\">Tilray Inc.</a></b> – The Canada-based cannabis producer’s shares surged 9.22% in premarket trading, after striking a deal to buy $166 million in convertible debt of U.S. producer MedMen Enterprises. Canadian producers cannot yet directly own a U.S.-based marijuana business, but Tilray could be poised to benefit from the deal if and when U.S. laws change.</p>\n<p>10.&nbsp;<b><a href=\"https://laohu8.com/S/A\">Agilent</a> Technologies</b>&nbsp;– Agilent gained 2.39% in the premarket after the life sciences company beat top and bottom-line estimates for its latest quarter and raised its full-year forecast. Agilent said its metrics were upbeat across all its units and added that its non-Covid diagnostics business has recovered beyond pre-pandemic levels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Opens Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Opens Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-18 20:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>US equity futures and global markets were flat in listless trading as investors assessed the outlook for economic recovery and awaited the latest Federal Reserve minutes to gauge the direction of monetary policy while tracking the latest covid lockdown in New Zealand and on edge ahead of possible turbulence in Friday's OpEx. </p>\n<p>Overnight the MSCI Asia Pacific Index added 0.4% while Japan’s Topix index closed 0.4% higher. In Europe the Stoxx 600 Index was broadly unchanged. S&amp;P 500 futures pointed to a small move lower at the open, the 10-year Treasury yield was at 1.277%, oil rose and gold moved higher, while cryptos rebounded from a late Tuesday selloff.</p>\n<p>At 7:55 a.m. ET, Dow E-minis were down 64 points, or 0.18%, S&amp;P 500 E-minis were down&nbsp;4 points, or 0.09% and Nasdaq 100 E-minis were&nbsp;up&nbsp;8 points, or 0.05%.</p>\n<p><img src=\"https://static.tigerbbs.com/5b8765de5383459e16baef1249617b5b\" tg-width=\"1125\" tg-height=\"413\" width=\"100%\" height=\"auto\"></p>\n<h3><b>Stocks making the biggest moves in the premarket:</b></h3>\n<p>1.&nbsp;<b><a href=\"https://laohu8.com/S/LOW\">Lowe's</a></b> – The home improvement retailer reported an adjusted quarterly profit of $4.25 per share, beating the consensus estimate of $4.01. Revenue beat forecasts, and the same-store sales decline of 1.6% was less than the 2.2% decline predicted by analysts. Lowe’s also raised its full-year financial outlook, as spending by builders and professionals rose. Lowe’s rallied 4.60% in the premarket.</p>\n<p>2.&nbsp;<b><a href=\"https://laohu8.com/S/TGT\">Target</a> </b>– The retailer beat estimates by 15 cents with adjusted quarterly earnings of $3.64 per share, and revenue slightly above analyst forecasts. Comparable store sales rose 8.9%, slightly above the 8.8% consensus estimate. Target shares added 2.42% in premarket trading.</p>\n<p>3.&nbsp;<b><a href=\"https://laohu8.com/S/DNUT\">Krispy Kreme, Inc.</a></b> – The doughnut chain fell a penny shy of Street forecasts with an adjusted quarterly profit of 13 cents per share, though revenue did beat estimates. Krispy Kreme also gave a better-than-expected revenue forecast, based on projected strength from online ordering and new menu items. The stock added 2.9% in premarket action.</p>\n<p>4.&nbsp;<b><a href=\"https://laohu8.com/S/ALC\">Alcon Inc.</a></b> – The maker of eyecare and surgical products surged 9.89% in the premarket, after reporting better-than-expected quarterly results and raising its full-year guidance. The quarter marked the debut of Alcon’s Vivity intraocular contact lens, which analysts say will help drive sales growth.</p>\n<p>5.&nbsp;<b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a></b>,&nbsp;<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> </b>– Moderna rose 1.74% in premarket trading while BioNTech gained 1.38%, ahead of an expected announcement by the White House calling for a booster shot for Americans already fully vaccinated against Covid-19.</p>\n<p>6.&nbsp;<b><a href=\"https://laohu8.com/S/TMUS\">T-Mobile US</a></b> – Following an investigation, the wireless carrier now says the personal information of about 7.8 million customers was compromised in a recent data breach. That included dates of birth, social security numbers and driver’s license information, although no financial information was stolen.</p>\n<p>7.&nbsp;<b><a href=\"https://laohu8.com/S/VIAC\">Viacom CBS</a> </b>– Shares of the media giant gained 2.77% in premarket action after Wells Fargo Securities upgraded the stock to “overweight” from “equal weight”. Wells Fargo said ViacomCBS is one of the players poised to benefit from industry consolidation and it is also impressed by the upcoming programming slate for the company’s Paramount+ streaming service.</p>\n<p>8. <b><a href=\"https://laohu8.com/S/BB\">BlackBerry</a></b> – The communications software maker said it released software patches to fix an issue with older versions of its QNX operating system and has notified all customers. U.S. officials had said earlier yesterday that the software flaw could put cars and medical equipment at risk. BlackBerry shares gained 1.34% in the premarket.</p>\n<p>9.&nbsp;<b><a href=\"https://laohu8.com/S/TLRY\">Tilray Inc.</a></b> – The Canada-based cannabis producer’s shares surged 9.22% in premarket trading, after striking a deal to buy $166 million in convertible debt of U.S. producer MedMen Enterprises. Canadian producers cannot yet directly own a U.S.-based marijuana business, but Tilray could be poised to benefit from the deal if and when U.S. laws change.</p>\n<p>10.&nbsp;<b><a href=\"https://laohu8.com/S/A\">Agilent</a> Technologies</b>&nbsp;– Agilent gained 2.39% in the premarket after the life sciences company beat top and bottom-line estimates for its latest quarter and raised its full-year forecast. Agilent said its metrics were upbeat across all its units and added that its non-Covid diagnostics business has recovered beyond pre-pandemic levels.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","BB":"黑莓","TLRY":"Tilray Inc.","LOW":"劳氏","A":"安捷伦科技","TGT":"塔吉特","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131876419","content_text":"US equity futures and global markets were flat in listless trading as investors assessed the outlook for economic recovery and awaited the latest Federal Reserve minutes to gauge the direction of monetary policy while tracking the latest covid lockdown in New Zealand and on edge ahead of possible turbulence in Friday's OpEx. \nOvernight the MSCI Asia Pacific Index added 0.4% while Japan’s Topix index closed 0.4% higher. In Europe the Stoxx 600 Index was broadly unchanged. S&P 500 futures pointed to a small move lower at the open, the 10-year Treasury yield was at 1.277%, oil rose and gold moved higher, while cryptos rebounded from a late Tuesday selloff.\nAt 7:55 a.m. ET, Dow E-minis were down 64 points, or 0.18%, S&P 500 E-minis were down 4 points, or 0.09% and Nasdaq 100 E-minis were up 8 points, or 0.05%.\n\nStocks making the biggest moves in the premarket:\n1. Lowe's – The home improvement retailer reported an adjusted quarterly profit of $4.25 per share, beating the consensus estimate of $4.01. Revenue beat forecasts, and the same-store sales decline of 1.6% was less than the 2.2% decline predicted by analysts. Lowe’s also raised its full-year financial outlook, as spending by builders and professionals rose. Lowe’s rallied 4.60% in the premarket.\n2. Target – The retailer beat estimates by 15 cents with adjusted quarterly earnings of $3.64 per share, and revenue slightly above analyst forecasts. Comparable store sales rose 8.9%, slightly above the 8.8% consensus estimate. Target shares added 2.42% in premarket trading.\n3. Krispy Kreme, Inc. – The doughnut chain fell a penny shy of Street forecasts with an adjusted quarterly profit of 13 cents per share, though revenue did beat estimates. Krispy Kreme also gave a better-than-expected revenue forecast, based on projected strength from online ordering and new menu items. The stock added 2.9% in premarket action.\n4. Alcon Inc. – The maker of eyecare and surgical products surged 9.89% in the premarket, after reporting better-than-expected quarterly results and raising its full-year guidance. The quarter marked the debut of Alcon’s Vivity intraocular contact lens, which analysts say will help drive sales growth.\n5. Moderna, Inc., BioNTech SE – Moderna rose 1.74% in premarket trading while BioNTech gained 1.38%, ahead of an expected announcement by the White House calling for a booster shot for Americans already fully vaccinated against Covid-19.\n6. T-Mobile US – Following an investigation, the wireless carrier now says the personal information of about 7.8 million customers was compromised in a recent data breach. That included dates of birth, social security numbers and driver’s license information, although no financial information was stolen.\n7. Viacom CBS – Shares of the media giant gained 2.77% in premarket action after Wells Fargo Securities upgraded the stock to “overweight” from “equal weight”. Wells Fargo said ViacomCBS is one of the players poised to benefit from industry consolidation and it is also impressed by the upcoming programming slate for the company’s Paramount+ streaming service.\n8. BlackBerry – The communications software maker said it released software patches to fix an issue with older versions of its QNX operating system and has notified all customers. U.S. officials had said earlier yesterday that the software flaw could put cars and medical equipment at risk. BlackBerry shares gained 1.34% in the premarket.\n9. Tilray Inc. – The Canada-based cannabis producer’s shares surged 9.22% in premarket trading, after striking a deal to buy $166 million in convertible debt of U.S. producer MedMen Enterprises. Canadian producers cannot yet directly own a U.S.-based marijuana business, but Tilray could be poised to benefit from the deal if and when U.S. laws change.\n10. Agilent Technologies – Agilent gained 2.39% in the premarket after the life sciences company beat top and bottom-line estimates for its latest quarter and raised its full-year forecast. Agilent said its metrics were upbeat across all its units and added that its non-Covid diagnostics business has recovered beyond pre-pandemic levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":75,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":845047467,"gmtCreate":1636257556096,"gmtModify":1636257565036,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"&nbsp;Fokf","listText":"&nbsp;Fokf","text":"Fokf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/845047467","repostId":"2181974224","repostType":4,"repost":{"id":"2181974224","kind":"highlight","pubTimestamp":1636196400,"share":"https://www.laohu8.com/m/news/2181974224?lang=&edition=full","pubTime":"2021-11-06 19:00","market":"us","language":"en","title":"3 Discounted Growth Stocks to Buy If There's a Stock Market Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=2181974224","media":"Motley Fool","summary":"Short-term pain can lead to big long-term gains for opportunistic investors.","content":"<p>Things have been nearly perfect for Wall Street and the investment community of late -- perhaps a bit <i>too</i> perfect.</p>\n<p>Since the benchmark <b>S&amp;P 500</b> (SNPINDEX:^GSPC) bottomed out in March 2020, the index has more than doubled in value. It's the strongest bounce back from a bear-market bottom in the S&amp;P 500's long history. Yet history also shows that stock market crashes and corrections are a common occurrence and the price to be paid for taking part in <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest wealth creators on the planet.</p>\n<h2>Stock market crashes and corrections are a common occurrence</h2>\n<p>Data from market analytics company Yardeni Research shows that the S&amp;P 500 has undergone 38 double-digit percentage moves lower since the beginning of 1950. This works out to a notable decline, on average, every 1.87 years. Even though Wall Street doesn't adhere to averages, it does demonstrate just how frequent steep corrections and crashes have been throughout history.</p>\n<p>Speaking of history, Wall Street has consistently shown for decades that bouncing back from a bear-market bottom is a process. Following each of the previous eight bear market troughs, the S&amp;P 500 shed at least 10% of its value on one or two occasions within 36 months. We're currently more than 19 months removed from the pandemic bottom and have yet to endure a double-digit decline.</p>\n<p>History has also been quite clear what happens to equities when valuations get overly extended to the upside. On Nov. 1, the S&amp;P 500's Shiller price-to-earnings (P/E) ratio closed above 39. The Shiller P/E examines inflation-adjusted earnings over the past 10 years. In the four previous instances where the S&amp;P 500's Shiller P/E surpassed 30, dating back to 1870, the index has subsequently lost at least 20% of its value.</p>\n<p>The point being that the likelihood of a crash or correction is growing. We may not know precisely when it's going to happen, how steep the decline will be, or how long it'll last, but this data certainly offers credence to the idea that a double-digit percentage drop may be coming.</p>\n<h2>Market declines are a surefire opportunity for patient investors</h2>\n<p>The good news for long-term investors is that every single double-digit percentage decline in the stock market throughout history has proved to be a buying opportunity. These drops have been especially lucrative opportunities to buy discounted growth stocks, which tend to get hit hard during crashes and corrections.</p>\n<p>If a stock market crash or steep correction does rear its head, the following three discounted growth stocks would make for perfect buys.</p>\n<h2>Redfin</h2>\n<p>The first discounted growth stock investors can confidently scoop up during a crash or correction is technology-driven real estate company <b>Redfin</b> (NASDAQ:RDFN).</p>\n<p>The biggest prevailing critique of Redfin is that the company has benefited from historically low mortgage rates, which are bound to head higher over time. History has shown that higher mortgage rates tend to suppress homebuying activity, which would, in turn, slow Redfin's rapid growth rate. While this assessment has often been spot on for traditional real estate companies, Redfin is far from traditional.</p>\n<p>When a buyer or seller seeks a real estate professional, they're often going to pay a listing fee/commission ranging between 2.5% and 3%. However, with Redfin, the listing fee is either 1% or 1.5%, depending on how much prior business was done with the company. According to the National Association of Realtors, the median existing home sold in September 2021 had a sales price of $352,800.&nbsp; This means sellers choosing Redfin may be able to save a median of $7,000. That's not pocket change, and it demonstrates Redfin's willingness to save its clients money.</p>\n<p>Beyond just undercutting traditional real estate firms on price, Redfin is relying on its higher-margin personalized services to woo new clients. For instance, the company's Concierge service instructs sellers on staging and upgrades that'll help them maximize the sales price of their home. There's also the RedfinNow service, which has been expanded to a number of new cities. RedfinNow acquires homes from sellers with cash, thereby removing the hassle and haggling that typically accompanies selling a home.</p>\n<p>Since the end of 2015, Redfin's share of U.S. existing home sales has consistently expanded from 0.44% to 1.18%, and it has plenty of room to grow. If a big dip were to arise in the broader market, it'd be the perfect stock to scoop up.</p>\n<h2>Pinterest</h2>\n<p>Another discounted growth stock that'd be smart to buy if a market crash occurs is social media platform <b>Pinterest</b> (NYSE:PINS).</p>\n<p>Pinterest has taken a lot of heat from investors over the past three months. It disappointed with a sequential quarterly decline of 24 million monthly active users in the second quarter, and was the subject of short-lived rumors that it would be acquired by <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a></b>. PayPal has since denied any interest in buying Pinterest at this time. This confluence of factors has halved Pinterest from its all-time high.</p>\n<p>While there's no sugarcoating that things haven't been perfect for Pinterest, the pessimists are equally overlooking a number of important metrics. For instance, Pinterest's three-year monthly active user (MAU) growth trajectory is still well within its normal range, even with higher vaccination rates lowering net MAUs in Q2 and encouraging people to get out of their homes.</p>\n<p>What's even more important is that Pinterest's monetization efforts continue to be robust. Despite growing its total MAUs by \"only\" 9% in the June-ended quarter, average revenue per user (ARPU) increased by 89% globally and 163% internationally from the prior-year period.&nbsp; This demonstrates that merchants are more than willing to pay big bucks to reach Pinterest's potentially motivated shoppers.</p>\n<p>Furthermore, don't overlook how transparent Pinterest is, relative to other social media platforms. Its entire premise is built on users sharing the things, places, and services that interest them. This allows merchants to target their advertising dollars in a more effective way than virtually any other social media site. It also positions Pinterest to become an e-commerce force to be reckoned with by the end of the decade.</p>\n<p>Weakness in Pinterest's shares during a crash would make for an ideal buying opportunity.</p>\n<h2>Teladoc Health</h2>\n<p>A third discounted growth stock begging to be bought during a crash or steep correction is telemedicine kingpin <b>Teladoc Health</b> (NYSE:TDOC).</p>\n<p>The knock against Teladoc is similar to that of Redfin. In other words, it was in the right place at the right time when the pandemic struck and benefited immensely from a massive uptick in virtual visits. Pessimists believe virtual visit growth will slow considerably as vaccination rates pick up and life returns to some semblance of normal.</p>\n<p>The problem with this take is that it completely ignores how Teladoc is changing the healthcare treatment landscape. Providing virtual visit channels is more convenient for patients, and can be especially helpful for physicians when attempting to keep tabs on chronic-care patients. This ease-of-access should ultimately improve patient outcomes and reduce out-of-pocket costs for health insurers. In short, health insurers are going to be all-in on telemedicine applications for a long time to come.</p>\n<p>Teladoc also improved its long-term growth outlook by acquiring applied health signals company Livongo Health a year ago. Livongo utilizes artificial intelligence to send tips to chronic care members to help them lead healthier lives. As of the end of September, Livongo had 725,000 members enrolled.&nbsp; As Livongo expands its services beyond diabetes patients to those with hypertension and weight management control issues, its pool of potential members will skyrocket.</p>\n<p>Investors should note, as well, that Teladoc Health's operating results will vastly improve in 2022. Costs tied to the Livongo acquisition have substantially widened its losses in 2021. But these one-time expenses won't be around next year.</p>\n<p>If a crash occurs, Teladoc Health would make for a smart buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Discounted Growth Stocks to Buy If There's a Stock Market Crash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Discounted Growth Stocks to Buy If There's a Stock Market Crash\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 19:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/06/3-discounted-growth-stocks-to-buy-if-market-crash/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Things have been nearly perfect for Wall Street and the investment community of late -- perhaps a bit too perfect.\nSince the benchmark S&P 500 (SNPINDEX:^GSPC) bottomed out in March 2020, the index ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/06/3-discounted-growth-stocks-to-buy-if-market-crash/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SDS":"两倍做空标普500ETF",".SPX":"S&P 500 Index","OEX":"标普100","SPXU":"三倍做空标普500ETF","OEF":"标普100指数ETF-iShares","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF","UPRO":"三倍做多标普500ETF","SH":"标普500反向ETF"},"source_url":"https://www.fool.com/investing/2021/11/06/3-discounted-growth-stocks-to-buy-if-market-crash/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181974224","content_text":"Things have been nearly perfect for Wall Street and the investment community of late -- perhaps a bit too perfect.\nSince the benchmark S&P 500 (SNPINDEX:^GSPC) bottomed out in March 2020, the index has more than doubled in value. It's the strongest bounce back from a bear-market bottom in the S&P 500's long history. Yet history also shows that stock market crashes and corrections are a common occurrence and the price to be paid for taking part in one of the greatest wealth creators on the planet.\nStock market crashes and corrections are a common occurrence\nData from market analytics company Yardeni Research shows that the S&P 500 has undergone 38 double-digit percentage moves lower since the beginning of 1950. This works out to a notable decline, on average, every 1.87 years. Even though Wall Street doesn't adhere to averages, it does demonstrate just how frequent steep corrections and crashes have been throughout history.\nSpeaking of history, Wall Street has consistently shown for decades that bouncing back from a bear-market bottom is a process. Following each of the previous eight bear market troughs, the S&P 500 shed at least 10% of its value on one or two occasions within 36 months. We're currently more than 19 months removed from the pandemic bottom and have yet to endure a double-digit decline.\nHistory has also been quite clear what happens to equities when valuations get overly extended to the upside. On Nov. 1, the S&P 500's Shiller price-to-earnings (P/E) ratio closed above 39. The Shiller P/E examines inflation-adjusted earnings over the past 10 years. In the four previous instances where the S&P 500's Shiller P/E surpassed 30, dating back to 1870, the index has subsequently lost at least 20% of its value.\nThe point being that the likelihood of a crash or correction is growing. We may not know precisely when it's going to happen, how steep the decline will be, or how long it'll last, but this data certainly offers credence to the idea that a double-digit percentage drop may be coming.\nMarket declines are a surefire opportunity for patient investors\nThe good news for long-term investors is that every single double-digit percentage decline in the stock market throughout history has proved to be a buying opportunity. These drops have been especially lucrative opportunities to buy discounted growth stocks, which tend to get hit hard during crashes and corrections.\nIf a stock market crash or steep correction does rear its head, the following three discounted growth stocks would make for perfect buys.\nRedfin\nThe first discounted growth stock investors can confidently scoop up during a crash or correction is technology-driven real estate company Redfin (NASDAQ:RDFN).\nThe biggest prevailing critique of Redfin is that the company has benefited from historically low mortgage rates, which are bound to head higher over time. History has shown that higher mortgage rates tend to suppress homebuying activity, which would, in turn, slow Redfin's rapid growth rate. While this assessment has often been spot on for traditional real estate companies, Redfin is far from traditional.\nWhen a buyer or seller seeks a real estate professional, they're often going to pay a listing fee/commission ranging between 2.5% and 3%. However, with Redfin, the listing fee is either 1% or 1.5%, depending on how much prior business was done with the company. According to the National Association of Realtors, the median existing home sold in September 2021 had a sales price of $352,800.  This means sellers choosing Redfin may be able to save a median of $7,000. That's not pocket change, and it demonstrates Redfin's willingness to save its clients money.\nBeyond just undercutting traditional real estate firms on price, Redfin is relying on its higher-margin personalized services to woo new clients. For instance, the company's Concierge service instructs sellers on staging and upgrades that'll help them maximize the sales price of their home. There's also the RedfinNow service, which has been expanded to a number of new cities. RedfinNow acquires homes from sellers with cash, thereby removing the hassle and haggling that typically accompanies selling a home.\nSince the end of 2015, Redfin's share of U.S. existing home sales has consistently expanded from 0.44% to 1.18%, and it has plenty of room to grow. If a big dip were to arise in the broader market, it'd be the perfect stock to scoop up.\nPinterest\nAnother discounted growth stock that'd be smart to buy if a market crash occurs is social media platform Pinterest (NYSE:PINS).\nPinterest has taken a lot of heat from investors over the past three months. It disappointed with a sequential quarterly decline of 24 million monthly active users in the second quarter, and was the subject of short-lived rumors that it would be acquired by PayPal. PayPal has since denied any interest in buying Pinterest at this time. This confluence of factors has halved Pinterest from its all-time high.\nWhile there's no sugarcoating that things haven't been perfect for Pinterest, the pessimists are equally overlooking a number of important metrics. For instance, Pinterest's three-year monthly active user (MAU) growth trajectory is still well within its normal range, even with higher vaccination rates lowering net MAUs in Q2 and encouraging people to get out of their homes.\nWhat's even more important is that Pinterest's monetization efforts continue to be robust. Despite growing its total MAUs by \"only\" 9% in the June-ended quarter, average revenue per user (ARPU) increased by 89% globally and 163% internationally from the prior-year period.  This demonstrates that merchants are more than willing to pay big bucks to reach Pinterest's potentially motivated shoppers.\nFurthermore, don't overlook how transparent Pinterest is, relative to other social media platforms. Its entire premise is built on users sharing the things, places, and services that interest them. This allows merchants to target their advertising dollars in a more effective way than virtually any other social media site. It also positions Pinterest to become an e-commerce force to be reckoned with by the end of the decade.\nWeakness in Pinterest's shares during a crash would make for an ideal buying opportunity.\nTeladoc Health\nA third discounted growth stock begging to be bought during a crash or steep correction is telemedicine kingpin Teladoc Health (NYSE:TDOC).\nThe knock against Teladoc is similar to that of Redfin. In other words, it was in the right place at the right time when the pandemic struck and benefited immensely from a massive uptick in virtual visits. Pessimists believe virtual visit growth will slow considerably as vaccination rates pick up and life returns to some semblance of normal.\nThe problem with this take is that it completely ignores how Teladoc is changing the healthcare treatment landscape. Providing virtual visit channels is more convenient for patients, and can be especially helpful for physicians when attempting to keep tabs on chronic-care patients. This ease-of-access should ultimately improve patient outcomes and reduce out-of-pocket costs for health insurers. In short, health insurers are going to be all-in on telemedicine applications for a long time to come.\nTeladoc also improved its long-term growth outlook by acquiring applied health signals company Livongo Health a year ago. Livongo utilizes artificial intelligence to send tips to chronic care members to help them lead healthier lives. As of the end of September, Livongo had 725,000 members enrolled.  As Livongo expands its services beyond diabetes patients to those with hypertension and weight management control issues, its pool of potential members will skyrocket.\nInvestors should note, as well, that Teladoc Health's operating results will vastly improve in 2022. Costs tied to the Livongo acquisition have substantially widened its losses in 2021. But these one-time expenses won't be around next year.\nIf a crash occurs, Teladoc Health would make for a smart buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849181408,"gmtCreate":1635734912777,"gmtModify":1635734912902,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/849181408","repostId":"1150912013","repostType":4,"repost":{"id":"1150912013","kind":"news","pubTimestamp":1635724788,"share":"https://www.laohu8.com/m/news/1150912013?lang=&edition=full","pubTime":"2021-11-01 07:59","market":"us","language":"en","title":"What's the best month for stocks? Hint: the next four weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=1150912013","media":"finance.yahoo","summary":"The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.The start of the holiday season is typically a strong time of year on Wall Street, a pattern that analysts point to as a reason to remain optimistic that the stock market will remain at all-time highs following a turbulent September.Historically, November has been the best month of the year for the stock market—both since 1950 and over the past decade, according to LPL Financial.“November is t","content":"<p>The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.</p>\n<p>The start of the holiday season is typically a strong time of year on Wall Street, a pattern that analysts point to as a reason to remain optimistic that the stock market will remain at all-time highs following a turbulent September.</p>\n<p>Historically, November has been the best month of the year for the stock market—both since 1950 and over the past decade, according to LPL Financial.</p>\n<p>That’s not all. History shows the stock market’s strongest six-month period is November to April, according to the Stock Trader’s Almanac. November is also the first month of the market’s best three-month stretch, November to January.</p>\n<p>Why is November the best?</p>\n<p>This seasonal strength is created by a combination of factors. For one thing, the final three months of the year are typically the best for stocks, with stocks rising 3.8% on average, according to LPL Financial.</p>\n<p>Strong spending by shoppers during the holidays also tends to translate into strong quarters for consumer-focused businesses. Some analysts also attribute it to optimism during the holiday season, year-end portfolio adjustments and investors being on vacation.</p>\n<p>“November is the best month of the year, but it doesn’t seem to get nearly as much love as you’d think,” Ryan Detrick, chief market strategist at LPL Financial, said in a note to clients. “We all assume December is the best month, but November is actually better and gets very little fanfare. Maybe it should be a month for the bulls, not for turkeys.”</p>\n<p>Wall Street avoids spooky October</p>\n<p>While October is often considered a spooky month for investors, earning a bad reputation following the crashes of 1929, 1987 and during the global financial crisis in 2008, investors weren’t so fearful this year.</p>\n<p>After the S&amp;P 500 recorded its biggest monthly loss since the start of the coronavirus pandemic in September, the broad index rebounded more than 6% in October on further signs that corporate profits are growing once again following last year's recession.</p>\n<p>“It looks as though the market has resisted ‘Octoberphobia’ and averted the feared crashes or massacres that have given the month its bad reputation,” Jeff Hirsch, editor of the Stock Trader's Almanac, said in a note to clients.</p>\n<p>To be sure, November has taken hits during bear markets, when major averages drop more than 20% from a recent peak.</p>\n<p>For instance, November 2000 was the Nasdaq Composite’s second-worst month on record, with the technology-focused index plunging nearly 23%, according to the Stock Trader’s Almanac. Only October 1987 was worse, and that is when the \"Black Monday\" stock market crash occurred</p>\n<p>Why investors should be optimistic</p>\n<p>The U.S. economy&nbsp;slowed substantially from July through September&nbsp;following a series of obstacles, including a surge in COVID-19 cases, supply chain bottlenecks, rising consumer prices and the fading effects of federal stimulus measures.</p>\n<p>But with COVID-19 cases now falling and vaccinations rising, most economists are branding the weak showing a soft patch in a still-robust recovery from the pandemic-induced recession, with a healthy rebound projected in the final months of the year.</p>\n<p>There are signs that there could be more gains to come on Wall Street in the final months of the year on strong seasonality trends, better-than-expected corporate earnings and falling COVID-19 cases. Market breadth has also improved, meaning that more stocks are participating in the rally, a sign of a healthy and strong market.</p>\n<p>Jobless claims have also fallen steadily in recent weeks, with continuing claims sliding below 2.5 million recently for the first time since the coronavirus pandemic began.</p>\n<p>After suffering its first 5% pullback of 2021 in early October, the S&amp;P 500 has come roaring back and closed at a record high on October 21. The S&amp;P 500 Index has gained more than 20% so far this year, making more than 50 record highs along the way.</p>\n<p>That could be a positive sign for investors in the coming months. The past seven times the S&amp;P 500 had risen 15% for the year heading into the fourth quarter, that final quarter ended up higher each time, rising 5.8%, data from LPL Financial showed.</p>\n<p>“We firmly believe that new highs are something to be embraced, not feared, and history shows that new highs tend to come in bunches—something that has certainly been true so far this year,” according to Detrick.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's the best month for stocks? Hint: the next four weeks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's the best month for stocks? Hint: the next four weeks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/whats-best-month-stocks-hint-110106336.html><strong>finance.yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.\nThe start of the holiday season is typically a strong time of year on Wall Street, a pattern ...</p>\n\n<a href=\"https://finance.yahoo.com/news/whats-best-month-stocks-hint-110106336.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/whats-best-month-stocks-hint-110106336.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150912013","content_text":"The stock market’s record run is poised to gain steam in the weeks ahead — if history is any indication.\nThe start of the holiday season is typically a strong time of year on Wall Street, a pattern that analysts point to as a reason to remain optimistic that the stock market will remain at all-time highs following a turbulent September.\nHistorically, November has been the best month of the year for the stock market—both since 1950 and over the past decade, according to LPL Financial.\nThat’s not all. History shows the stock market’s strongest six-month period is November to April, according to the Stock Trader’s Almanac. November is also the first month of the market’s best three-month stretch, November to January.\nWhy is November the best?\nThis seasonal strength is created by a combination of factors. For one thing, the final three months of the year are typically the best for stocks, with stocks rising 3.8% on average, according to LPL Financial.\nStrong spending by shoppers during the holidays also tends to translate into strong quarters for consumer-focused businesses. Some analysts also attribute it to optimism during the holiday season, year-end portfolio adjustments and investors being on vacation.\n“November is the best month of the year, but it doesn’t seem to get nearly as much love as you’d think,” Ryan Detrick, chief market strategist at LPL Financial, said in a note to clients. “We all assume December is the best month, but November is actually better and gets very little fanfare. Maybe it should be a month for the bulls, not for turkeys.”\nWall Street avoids spooky October\nWhile October is often considered a spooky month for investors, earning a bad reputation following the crashes of 1929, 1987 and during the global financial crisis in 2008, investors weren’t so fearful this year.\nAfter the S&P 500 recorded its biggest monthly loss since the start of the coronavirus pandemic in September, the broad index rebounded more than 6% in October on further signs that corporate profits are growing once again following last year's recession.\n“It looks as though the market has resisted ‘Octoberphobia’ and averted the feared crashes or massacres that have given the month its bad reputation,” Jeff Hirsch, editor of the Stock Trader's Almanac, said in a note to clients.\nTo be sure, November has taken hits during bear markets, when major averages drop more than 20% from a recent peak.\nFor instance, November 2000 was the Nasdaq Composite’s second-worst month on record, with the technology-focused index plunging nearly 23%, according to the Stock Trader’s Almanac. Only October 1987 was worse, and that is when the \"Black Monday\" stock market crash occurred\nWhy investors should be optimistic\nThe U.S. economy slowed substantially from July through September following a series of obstacles, including a surge in COVID-19 cases, supply chain bottlenecks, rising consumer prices and the fading effects of federal stimulus measures.\nBut with COVID-19 cases now falling and vaccinations rising, most economists are branding the weak showing a soft patch in a still-robust recovery from the pandemic-induced recession, with a healthy rebound projected in the final months of the year.\nThere are signs that there could be more gains to come on Wall Street in the final months of the year on strong seasonality trends, better-than-expected corporate earnings and falling COVID-19 cases. Market breadth has also improved, meaning that more stocks are participating in the rally, a sign of a healthy and strong market.\nJobless claims have also fallen steadily in recent weeks, with continuing claims sliding below 2.5 million recently for the first time since the coronavirus pandemic began.\nAfter suffering its first 5% pullback of 2021 in early October, the S&P 500 has come roaring back and closed at a record high on October 21. The S&P 500 Index has gained more than 20% so far this year, making more than 50 record highs along the way.\nThat could be a positive sign for investors in the coming months. The past seven times the S&P 500 had risen 15% for the year heading into the fourth quarter, that final quarter ended up higher each time, rising 5.8%, data from LPL Financial showed.\n“We firmly believe that new highs are something to be embraced, not feared, and history shows that new highs tend to come in bunches—something that has certainly been true so far this year,” according to Detrick.","news_type":1},"isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820480770,"gmtCreate":1633415677663,"gmtModify":1633415677945,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/820480770","repostId":"2172968917","repostType":4,"repost":{"id":"2172968917","kind":"highlight","pubTimestamp":1633395971,"share":"https://www.laohu8.com/m/news/2172968917?lang=&edition=full","pubTime":"2021-10-05 09:06","market":"us","language":"en","title":"Why Adobe Stock Is a Buy for the Coming $10 Trillion \"Digital Transformation\" Boom","url":"https://stock-news.laohu8.com/highlight/detail?id=2172968917","media":"Motley Fool","summary":"Don't let a ho-hum September keep you away from this long-term winner.","content":"<p><b><a href=\"https://laohu8.com/S/ADBE\">Adobe</a> </b>(NASDAQ:ADBE) has hit the skids since its fiscal 2021 third quarter update in September. Shares are down some 12% on the month, putting the tech stock officially in \"correction\" territory. It's not that the report itself was bad, but fears that the software giant is \"overpriced\" and political angst caused by the U.S. debt limit debate have arisen.</p>\n<p>However, Adobe's cloud-based software is a key ingredient for getting work done these days and is still a fantastic long-term buy, especially with trillions of dollars expected to be spent on digital transformation tools like what Adobe offers.&nbsp;Here are three reasons to stay optimistic.</p>\n<h2>1. Adobe is a top partner for digital makeovers</h2>\n<p>Digital transformation (DX from here on out) is all the rage in the software community right now. Cloud computing was already promising to make business operations vastly more efficient and intuitive than in the past, but the pandemic proved beyond a doubt that the movement is the real deal. A frenzy of digital updates in the corporate world are now underway and could last for many years to come.</p>\n<p><img src=\"https://static.tigerbbs.com/b24d2cfc080b5567e11b770d940b9a41\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>To drive home the point, we can borrow a statistic from tech researcher IDC -- <a href=\"https://laohu8.com/S/AONE.U\">one</a> that Adobe peer and fellow DX champion <b>salesforce.com </b>(NYSE:CRM) shared recently during its investor day. IDC thinks no less than $10 trillion will be spent on DX initiatives from 2019 through 2024, and 57% of total global IT spend will be on DX by 2024 compared to just 42% in 2020.</p>\n<p>While Adobe can only address a fraction of this huge spending spree, its focus on cloud-based creativity, marketing, document management, and customer engagement software positions it as a potential primary partner for any firm looking to get with the times. Having hauled in $15 billion in sales over the last 12 months, Adobe is a massive firm already. But given the relentlessly rising demand for its software,&nbsp;Adobe has no shortage of room to get much larger.</p>\n<h2>2. A highly profitable growth business</h2>\n<p>Adobe is undeniably a fantastic -- and perhaps underrated -- long-term growth story. It's been growing revenue at a double-digit percentage clip for years, and the company thinks momentum will continue. For the final quarter of fiscal 2021, management is forecasting about a 19% year-over-year increase in sales to $4.07 billion.</p>\n<p>But this stock isn't just for investors with a growth mindset. Adobe is wildly profitable, too. It's been generating operating profit margins of well over 20% over the last decade, and operating margin was at 36% over the last 12-month stretch. With its sticky suite of subscription-based creativity and data management software poised to continue growing, those lucrative profit margins aren't going away anytime soon.</p>\n<p>Pairing those consistent profits with double-digit sales expansion and a valuation currently at 48 times trailing-12-month earnings, a case could be made that Adobe is a value stock hiding in growth stock clothing.</p>\n<h2>3. A superb balance sheet that's constantly being replenished</h2>\n<p>As of Sept. 3, 2021, Adobe had $6.16 billion in cash and equivalents on the books, offset by debt of just $4.12 billion. Its cash hoard is constantly being fed, too. Adobe generated $6.61 billion of free cash flow in the last 12 months, some of which it added to the balance sheet. But management also returns an ample amount to shareholders. Adobe doesn't pay a dividend, but it does repurchase stock. It spent $1 billion in share buybacks during Q3 of fiscal 2021 alone.</p>\n<p>That still leaves plenty of capital for Adobe to invest in new software, or make the occasional acquisition. Its latest purchase: The proposed $1.275 billion takeover of video collaboration platform Frame.io, which boasts over one million users and will integrate with Adobe's existing toolkit for content creators.</p>\n<p>Adobe is still growing fast, generating plenty of profits, and in prime position to help lead its customers into a new digital era. The digital transformation movement is just beginning, so this stock deserves to be a top-of-mind pick to build a portfolio around.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Adobe Stock Is a Buy for the Coming $10 Trillion \"Digital Transformation\" Boom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Adobe Stock Is a Buy for the Coming $10 Trillion \"Digital Transformation\" Boom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/01/3-reasons-adobe-stock-is-a-buy-for-the-coming-10-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Adobe (NASDAQ:ADBE) has hit the skids since its fiscal 2021 third quarter update in September. Shares are down some 12% on the month, putting the tech stock officially in \"correction\" territory. It's ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/01/3-reasons-adobe-stock-is-a-buy-for-the-coming-10-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADBE":"Adobe"},"source_url":"https://www.fool.com/investing/2021/10/01/3-reasons-adobe-stock-is-a-buy-for-the-coming-10-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172968917","content_text":"Adobe (NASDAQ:ADBE) has hit the skids since its fiscal 2021 third quarter update in September. Shares are down some 12% on the month, putting the tech stock officially in \"correction\" territory. It's not that the report itself was bad, but fears that the software giant is \"overpriced\" and political angst caused by the U.S. debt limit debate have arisen.\nHowever, Adobe's cloud-based software is a key ingredient for getting work done these days and is still a fantastic long-term buy, especially with trillions of dollars expected to be spent on digital transformation tools like what Adobe offers. Here are three reasons to stay optimistic.\n1. Adobe is a top partner for digital makeovers\nDigital transformation (DX from here on out) is all the rage in the software community right now. Cloud computing was already promising to make business operations vastly more efficient and intuitive than in the past, but the pandemic proved beyond a doubt that the movement is the real deal. A frenzy of digital updates in the corporate world are now underway and could last for many years to come.\n\nImage source: Getty Images.\nTo drive home the point, we can borrow a statistic from tech researcher IDC -- one that Adobe peer and fellow DX champion salesforce.com (NYSE:CRM) shared recently during its investor day. IDC thinks no less than $10 trillion will be spent on DX initiatives from 2019 through 2024, and 57% of total global IT spend will be on DX by 2024 compared to just 42% in 2020.\nWhile Adobe can only address a fraction of this huge spending spree, its focus on cloud-based creativity, marketing, document management, and customer engagement software positions it as a potential primary partner for any firm looking to get with the times. Having hauled in $15 billion in sales over the last 12 months, Adobe is a massive firm already. But given the relentlessly rising demand for its software, Adobe has no shortage of room to get much larger.\n2. A highly profitable growth business\nAdobe is undeniably a fantastic -- and perhaps underrated -- long-term growth story. It's been growing revenue at a double-digit percentage clip for years, and the company thinks momentum will continue. For the final quarter of fiscal 2021, management is forecasting about a 19% year-over-year increase in sales to $4.07 billion.\nBut this stock isn't just for investors with a growth mindset. Adobe is wildly profitable, too. It's been generating operating profit margins of well over 20% over the last decade, and operating margin was at 36% over the last 12-month stretch. With its sticky suite of subscription-based creativity and data management software poised to continue growing, those lucrative profit margins aren't going away anytime soon.\nPairing those consistent profits with double-digit sales expansion and a valuation currently at 48 times trailing-12-month earnings, a case could be made that Adobe is a value stock hiding in growth stock clothing.\n3. A superb balance sheet that's constantly being replenished\nAs of Sept. 3, 2021, Adobe had $6.16 billion in cash and equivalents on the books, offset by debt of just $4.12 billion. Its cash hoard is constantly being fed, too. Adobe generated $6.61 billion of free cash flow in the last 12 months, some of which it added to the balance sheet. But management also returns an ample amount to shareholders. Adobe doesn't pay a dividend, but it does repurchase stock. It spent $1 billion in share buybacks during Q3 of fiscal 2021 alone.\nThat still leaves plenty of capital for Adobe to invest in new software, or make the occasional acquisition. Its latest purchase: The proposed $1.275 billion takeover of video collaboration platform Frame.io, which boasts over one million users and will integrate with Adobe's existing toolkit for content creators.\nAdobe is still growing fast, generating plenty of profits, and in prime position to help lead its customers into a new digital era. The digital transformation movement is just beginning, so this stock deserves to be a top-of-mind pick to build a portfolio around.","news_type":1},"isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600311170,"gmtCreate":1638066328792,"gmtModify":1638066328908,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/600311170","repostId":"2186282013","repostType":4,"repost":{"id":"2186282013","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638058448,"share":"https://www.laohu8.com/m/news/2186282013?lang=&edition=full","pubTime":"2021-11-28 08:14","market":"us","language":"en","title":"U.S. issues 'Do Not Travel' advisory for eight African countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2186282013","media":"Reuters","summary":"(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturd","content":"<p> (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturday advised against travel to eight southern African countries after the White House announced new travel restrictions in response to a new COVID-19 variant.</p>\n<p>The CDC raised its travel recommendation to \"Level Four: Very High\" for South Africa, Zimbabwe, Namibia, Mozambique, Malawi, Lesotho, Eswatini and Botswana while the State Department issued parallel \"Do Not Travel\" advisories Saturday. On Monday, the CDC had lowered its COVID-19 travel advisory for South Africa to \"Level 1: Low\" from \"Level 3: High\"</p>\n<p>Of the eight countries, only Botswana was previously listed as \"Level 4.\"</p>\n<p>Omicron, dubbed a \"variant of concern\" by the World Health Organization, is potentially more contagious than previous variants of the disease, although experts do not know yet if it will cause more or less severe COVID-19 compared to other strains. It could take weeks for scientists to fully understand the variant's mutations and whether existing vaccines and treatments are effective against it.</p>\n<p>The discovery of the variant has sparked global concern, a wave of travel bans or curbs and a sell-off on financial markets on Friday as investors worried that Omicron could stall a global recovery from the nearly two-year pandemic.</p>\n<p>The new variant prompted the White House to announce Friday it would bar nearly all foreign nationals who have been in any of eight countries within the last 14 days from flying to the United States effective Monday at 12:01 a.m. ET (0500 GMT). Travelers on flights that depart before that time will be allowed to land in the United States. But foreign nationals must be vaccinated and have tested negative within three days.</p>\n<p>Britain detected two cases of the new Omicron coronavirus variant on Saturday, even as Australia and other countries joined nations imposing restrictions on travel from southern Africa in an effort to stop its spread.</p>\n<p>The variant was first discovered in South Africa and had also since been detected in Belgium, Botswana, Israel and Hong Kong.</p>\n<p>A U.S. official told Reuters Friday the Biden administration could also add other countries to the travel curb list if the variant spreads. The United States only lifted travel restrictions on South Africa and 32 other countries on Nov. 8.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. issues 'Do Not Travel' advisory for eight African countries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. issues 'Do Not Travel' advisory for eight African countries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-28 08:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p> (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturday advised against travel to eight southern African countries after the White House announced new travel restrictions in response to a new COVID-19 variant.</p>\n<p>The CDC raised its travel recommendation to \"Level Four: Very High\" for South Africa, Zimbabwe, Namibia, Mozambique, Malawi, Lesotho, Eswatini and Botswana while the State Department issued parallel \"Do Not Travel\" advisories Saturday. On Monday, the CDC had lowered its COVID-19 travel advisory for South Africa to \"Level 1: Low\" from \"Level 3: High\"</p>\n<p>Of the eight countries, only Botswana was previously listed as \"Level 4.\"</p>\n<p>Omicron, dubbed a \"variant of concern\" by the World Health Organization, is potentially more contagious than previous variants of the disease, although experts do not know yet if it will cause more or less severe COVID-19 compared to other strains. It could take weeks for scientists to fully understand the variant's mutations and whether existing vaccines and treatments are effective against it.</p>\n<p>The discovery of the variant has sparked global concern, a wave of travel bans or curbs and a sell-off on financial markets on Friday as investors worried that Omicron could stall a global recovery from the nearly two-year pandemic.</p>\n<p>The new variant prompted the White House to announce Friday it would bar nearly all foreign nationals who have been in any of eight countries within the last 14 days from flying to the United States effective Monday at 12:01 a.m. ET (0500 GMT). Travelers on flights that depart before that time will be allowed to land in the United States. But foreign nationals must be vaccinated and have tested negative within three days.</p>\n<p>Britain detected two cases of the new Omicron coronavirus variant on Saturday, even as Australia and other countries joined nations imposing restrictions on travel from southern Africa in an effort to stop its spread.</p>\n<p>The variant was first discovered in South Africa and had also since been detected in Belgium, Botswana, Israel and Hong Kong.</p>\n<p>A U.S. official told Reuters Friday the Biden administration could also add other countries to the travel curb list if the variant spreads. The United States only lifted travel restrictions on South Africa and 32 other countries on Nov. 8.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186282013","content_text":"(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Saturday advised against travel to eight southern African countries after the White House announced new travel restrictions in response to a new COVID-19 variant.\nThe CDC raised its travel recommendation to \"Level Four: Very High\" for South Africa, Zimbabwe, Namibia, Mozambique, Malawi, Lesotho, Eswatini and Botswana while the State Department issued parallel \"Do Not Travel\" advisories Saturday. On Monday, the CDC had lowered its COVID-19 travel advisory for South Africa to \"Level 1: Low\" from \"Level 3: High\"\nOf the eight countries, only Botswana was previously listed as \"Level 4.\"\nOmicron, dubbed a \"variant of concern\" by the World Health Organization, is potentially more contagious than previous variants of the disease, although experts do not know yet if it will cause more or less severe COVID-19 compared to other strains. It could take weeks for scientists to fully understand the variant's mutations and whether existing vaccines and treatments are effective against it.\nThe discovery of the variant has sparked global concern, a wave of travel bans or curbs and a sell-off on financial markets on Friday as investors worried that Omicron could stall a global recovery from the nearly two-year pandemic.\nThe new variant prompted the White House to announce Friday it would bar nearly all foreign nationals who have been in any of eight countries within the last 14 days from flying to the United States effective Monday at 12:01 a.m. ET (0500 GMT). Travelers on flights that depart before that time will be allowed to land in the United States. But foreign nationals must be vaccinated and have tested negative within three days.\nBritain detected two cases of the new Omicron coronavirus variant on Saturday, even as Australia and other countries joined nations imposing restrictions on travel from southern Africa in an effort to stop its spread.\nThe variant was first discovered in South Africa and had also since been detected in Belgium, Botswana, Israel and Hong Kong.\nA U.S. official told Reuters Friday the Biden administration could also add other countries to the travel curb list if the variant spreads. The United States only lifted travel restrictions on South Africa and 32 other countries on Nov. 8.","news_type":1},"isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":814016110,"gmtCreate":1630727054930,"gmtModify":1631892030478,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/814016110","repostId":"1186003479","repostType":4,"isVote":1,"tweetType":1,"viewCount":83,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811198035,"gmtCreate":1630294613627,"gmtModify":1704957977046,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Hood","listText":"Hood","text":"Hood","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/811198035","repostId":"2163776380","repostType":4,"isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":600234330,"gmtCreate":1638155494839,"gmtModify":1638155494989,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600234330","repostId":"1119853738","repostType":4,"repost":{"id":"1119853738","kind":"news","pubTimestamp":1638153494,"share":"https://www.laohu8.com/m/news/1119853738?lang=&edition=full","pubTime":"2021-11-29 10:38","market":"us","language":"en","title":"Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1119853738","media":"Motley Fool","summary":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday","content":"<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.</p>\n<p>While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.</p>\n<p>How should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers&nbsp;<b>Moderna</b>(NASDAQ:MRNA),<b>Pfizer</b>(NYSE:PFE), and&nbsp;<b>Novavax</b>(NASDAQ:NVAX)&nbsp;all&nbsp;vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.</p>\n<p>The pandemic's latest twist makes these three stocks screaming buys</p>\n<p>Moderna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.</p>\n<p>Pfizer, for its part, said that its&nbsp;<b>BioNTech</b>-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.</p>\n<p>Why are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.</p>\n<p>While Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.</p>\n<p>On the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have&nbsp;dipped in the back half of 2021&nbsp;in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.</p>\n<p>What's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.</p>\n<p>In short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer, and Novavax Are Must-Own Stocks This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 10:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119853738","content_text":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.\nWhile there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.\nHow should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers Moderna(NASDAQ:MRNA),Pfizer(NYSE:PFE), and Novavax(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.\nThe pandemic's latest twist makes these three stocks screaming buys\nModerna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.\nPfizer, for its part, said that its BioNTech-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.\nWhy are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.\nWhile Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.\nOn the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.\nWhat's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.\nIn short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":937,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872565417,"gmtCreate":1637549083380,"gmtModify":1637549127663,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/872565417","repostId":"2185826127","repostType":4,"repost":{"id":"2185826127","kind":"highlight","pubTimestamp":1637546864,"share":"https://www.laohu8.com/m/news/2185826127?lang=&edition=full","pubTime":"2021-11-22 10:07","market":"us","language":"en","title":"What Nvidia's CEO Just Said Could Mean Billions in More Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2185826127","media":"Motley Fool","summary":"Nvidia Omniverse could be the company's biggest growth opportunity.","content":"<p><a href=\"https://laohu8.com/S/NVDA\"><b>Nvidia</b>'s </a> stock price has stretched to a high valuation of 115 times earnings following another blockbuster earnings report.&nbsp;That is an expensive price tag, but Nvidia is keeping it interesting by continuing to launch new products that expand its long-term growth potential.</p>\n<p>During the earnings call, CEO Jensen Huang spoke about the massive opportunity with Nvidia Omniverse, a software platform that is designed as a collaboration tool for developers working on 3D simulation and virtual world-building.&nbsp;Huang said Omniverse is \"<a href=\"https://laohu8.com/S/AONE.U\">one</a> of the largest graphics opportunities that we've ever seen.\"</p>\n<p><img src=\"https://static.tigerbbs.com/621d8d1818fe4f66c2833fd0081ad62b\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<p>That statement has incredible significance for investors. Nvidia's professional visualization segment, which includes Omniverse, makes up only 8% of Nvidia's business right now.&nbsp;Moreover, Omniverse is a software platform, whereas Nvidia's main business is still about selling more graphics chips to data centers and gamers. If Huang is right, Nvidia might have just found another profitable growth driver that no one was talking about at the start of 2021.</p>\n<h2>Professional visualization revenue is accelerating</h2>\n<p>Omniverse is Nvidia's answer to the metaverse -- a virtual world that will allow people to communicate with one another and engage with 3D objects using augmented reality, virtual reality, and artificial intelligence. This is an idea that has been introduced in several movies and novels over the years, with notable ones like <i>The Matrix</i> (1999) and <i>Snow Crash</i> (1992), and Nvidia is working to bring it to reality.</p>\n<p>Nvidia just launched Omniverse Enterprise,&nbsp;which charges an annual license fee of $9,000,&nbsp;and it has been well received, with over 700 companies evaluating the platform.&nbsp;This launch comes just as Nvidia is starting to see a significant acceleration in the pro visualization segment.</p>\n<p>In the fiscal third-quarter earnings report, Nvidia reported that total revenue increased by an impressive 50% year over year to reach $7.1 billion,&nbsp;but revenue from pro visualization increased by 144% year over year, reaching $577 million.&nbsp;After years of inconsistent growth, this segment has just started to take off in the last two quarters.</p>\n<p><img src=\"https://static.tigerbbs.com/60cd86b023aab874cc92566fbeafa8f3\" tg-width=\"700\" tg-height=\"390\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Nvidia.</p>\n<p>This could be just the start of an upswing in revenue growth for the pro visualization business, and it has the potential to be as big as data center and most likely larger than the gaming segment over the long term.</p>\n<h2>Nvidia could enable the future of e-commerce</h2>\n<p>Omniverse is a replication engine for training robots, augmenting real-world data, and basically simulating how the real world functions.&nbsp;This is what is meant by the \"metaverse.\" It's not just playing games on <b>Roblox</b>&nbsp;or chatting with people using a virtual reality headset; it's envisioned as being a wholly separate, digital version of the real world.</p>\n<p>One of the features of the metaverse is using virtual avatars that replicate yourself for others to see. Nvidia is offering Omniverse Avatar for this special purpose. There could also be a wide use of robotic avatars that could change the way people shop online. For example, Huang mentioned on the earnings call that there are approximately 25 million retail stores.&nbsp;Each of those stores could have a robotic avatar powered by artificial intelligence to assist you with checkout or browsing merchandise.</p>\n<p>Nvidia Omniverse is essentially laying the infrastructure for the future of e-commerce. It also has practical applications for companies that can use Omniverse to create replications of buildings, factories, and cities to help optimize logistics and other business operations. It's a monster growth opportunity for Nvidia, but it may take a while to fully play out.</p>\n<h2>How big an opportunity is Omniverse?</h2>\n<p>During the earnings call, Huang referenced an annual license fee of $1,000 per user to use Omniverse.&nbsp;There are an estimated 40 million creators and designers around the world,&nbsp;which puts the addressable market at $40 billion.</p>\n<p>However, there is more to the opportunity here. The $40 billion figure excludes the extra sales of graphics processing units (GPUs) that users will buy for their PC or cloud servers in order to run Omniverse, which can run on any device using Nvidia's RTX graphics technology. This opens the door for the mass market since any consumer laptop equipped with an RTX graphics card can use Omniverse.</p>\n<p>Nvidia is really building a very lucrative flywheel around its hardware chip business with software platforms, which should continue to push Nvidia's gross margin and profits up over time.</p>\n<p>All of this explains why Huang calls Omniverse the company's largest graphics opportunity. For now, investors should consider investing in Nvidia on the merits of its data center and gaming business, but keep a close eye on growth in the pro visualization segment. It could be an overlooked growth catalyst.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Nvidia's CEO Just Said Could Mean Billions in More Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Nvidia's CEO Just Said Could Mean Billions in More Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/21/what-nvidia-ceo-said-mean-billions-revenue-growth/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nvidia's  stock price has stretched to a high valuation of 115 times earnings following another blockbuster earnings report. That is an expensive price tag, but Nvidia is keeping it interesting by ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/21/what-nvidia-ceo-said-mean-billions-revenue-growth/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2021/11/21/what-nvidia-ceo-said-mean-billions-revenue-growth/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185826127","content_text":"Nvidia's  stock price has stretched to a high valuation of 115 times earnings following another blockbuster earnings report. That is an expensive price tag, but Nvidia is keeping it interesting by continuing to launch new products that expand its long-term growth potential.\nDuring the earnings call, CEO Jensen Huang spoke about the massive opportunity with Nvidia Omniverse, a software platform that is designed as a collaboration tool for developers working on 3D simulation and virtual world-building. Huang said Omniverse is \"one of the largest graphics opportunities that we've ever seen.\"\n\nImage source: Getty Images.\nThat statement has incredible significance for investors. Nvidia's professional visualization segment, which includes Omniverse, makes up only 8% of Nvidia's business right now. Moreover, Omniverse is a software platform, whereas Nvidia's main business is still about selling more graphics chips to data centers and gamers. If Huang is right, Nvidia might have just found another profitable growth driver that no one was talking about at the start of 2021.\nProfessional visualization revenue is accelerating\nOmniverse is Nvidia's answer to the metaverse -- a virtual world that will allow people to communicate with one another and engage with 3D objects using augmented reality, virtual reality, and artificial intelligence. This is an idea that has been introduced in several movies and novels over the years, with notable ones like The Matrix (1999) and Snow Crash (1992), and Nvidia is working to bring it to reality.\nNvidia just launched Omniverse Enterprise, which charges an annual license fee of $9,000, and it has been well received, with over 700 companies evaluating the platform. This launch comes just as Nvidia is starting to see a significant acceleration in the pro visualization segment.\nIn the fiscal third-quarter earnings report, Nvidia reported that total revenue increased by an impressive 50% year over year to reach $7.1 billion, but revenue from pro visualization increased by 144% year over year, reaching $577 million. After years of inconsistent growth, this segment has just started to take off in the last two quarters.\n\nImage source: Nvidia.\nThis could be just the start of an upswing in revenue growth for the pro visualization business, and it has the potential to be as big as data center and most likely larger than the gaming segment over the long term.\nNvidia could enable the future of e-commerce\nOmniverse is a replication engine for training robots, augmenting real-world data, and basically simulating how the real world functions. This is what is meant by the \"metaverse.\" It's not just playing games on Roblox or chatting with people using a virtual reality headset; it's envisioned as being a wholly separate, digital version of the real world.\nOne of the features of the metaverse is using virtual avatars that replicate yourself for others to see. Nvidia is offering Omniverse Avatar for this special purpose. There could also be a wide use of robotic avatars that could change the way people shop online. For example, Huang mentioned on the earnings call that there are approximately 25 million retail stores. Each of those stores could have a robotic avatar powered by artificial intelligence to assist you with checkout or browsing merchandise.\nNvidia Omniverse is essentially laying the infrastructure for the future of e-commerce. It also has practical applications for companies that can use Omniverse to create replications of buildings, factories, and cities to help optimize logistics and other business operations. It's a monster growth opportunity for Nvidia, but it may take a while to fully play out.\nHow big an opportunity is Omniverse?\nDuring the earnings call, Huang referenced an annual license fee of $1,000 per user to use Omniverse. There are an estimated 40 million creators and designers around the world, which puts the addressable market at $40 billion.\nHowever, there is more to the opportunity here. The $40 billion figure excludes the extra sales of graphics processing units (GPUs) that users will buy for their PC or cloud servers in order to run Omniverse, which can run on any device using Nvidia's RTX graphics technology. This opens the door for the mass market since any consumer laptop equipped with an RTX graphics card can use Omniverse.\nNvidia is really building a very lucrative flywheel around its hardware chip business with software platforms, which should continue to push Nvidia's gross margin and profits up over time.\nAll of this explains why Huang calls Omniverse the company's largest graphics opportunity. For now, investors should consider investing in Nvidia on the merits of its data center and gaming business, but keep a close eye on growth in the pro visualization segment. It could be an overlooked growth catalyst.","news_type":1},"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848618867,"gmtCreate":1635994051024,"gmtModify":1635994181360,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/848618867","repostId":"2180636457","repostType":4,"repost":{"id":"2180636457","kind":"news","pubTimestamp":1635970899,"share":"https://www.laohu8.com/m/news/2180636457?lang=&edition=full","pubTime":"2021-11-04 04:21","market":"us","language":"en","title":"Wall St record run rolls on after Fed unveils anticipated bond-buying 'taper'","url":"https://stock-news.laohu8.com/highlight/detail?id=2180636457","media":"Reuters","summary":"Nov 3 (Reuters) - Major Wall Street indexes posted solid gains and marked closing record highs as th","content":"<p>Nov 3 (Reuters) - Major Wall Street indexes posted solid gains and marked closing record highs as the Federal Reserve said it will begin trimming its monthly bond purchases in November with plans to end them in 2022, an announcement that investors had been expecting.</p>\n<p>The S&amp;P 500 and Nasdaq notched record all-time closes for their fifth straight sessions, while the Dow Jones Industrial Average posted a record close for the fourth session in a row.</p>\n<p>The benchmark S&amp;P 500 advanced into positive territory and ended solidly higher after the U.S. central bank announced plans to begin tapering its bond purchases. Investors had widely anticipated the decision as the Fed pulls back on its monetary support with the economy recovering from the coronavirus pandemic.</p>\n<p>“The Fed did not rock the boat on this <a href=\"https://laohu8.com/S/AONE.U\">one</a>,\" said Ryan Detrick, chief market strategist at LPL Financial. \"It was fairly well-telegraphed what the Fed might do and they did what most people expected.\"</p>\n<p>The Dow Jones Industrial Average rose 104.95 points, or 0.29%, to 36,157.58, the S&amp;P 500 gained 29.92 points, or 0.65%, to 4,660.57 and the Nasdaq Composite added 161.98 points, or 1.04%, to 15,811.58.</p>\n<p>Of the 11 S&amp;P 500 sectors, consumer discretionary and materials were the top gainers, rising 1.8% and 1.1%, respectively. Energy lagged, falling 0.8%.</p>\n<p>The central bank's easy money policies have been a significant support for markets, with the S&amp;P 500 more than doubling since its March 2020 low at the onset of the pandemic.</p>\n<p>The Fed also held to its belief that high inflation would prove \"transitory\" and likely not require a fast rise in interest rates.</p>\n<p>“I don’t think that there’s anything unique in the statement other than the fact they’re trying to buy themselves time by saying both the inflation and supply chain disruptions are temporary, and that’s the bottom line,\" said Joseph LaVorgna, Americas chief economist at Natixis.</p>\n<p>In a press conference after the Fed's statement, Fed Chair Jerome Powell said it is possible the U.S. job market may have improved enough by the middle of next year to be considered at \"maximum employment,\" a key hurdle to clear for the central bank to consider increasing interest rates.</p>\n<p>Better-than-expected third-quarter earnings also have helped lift sentiment for equities. With about 360 companies having reported, S&amp;P 500 earnings are expected to have climbed 40.4% in the third quarter from a year earlier, according to Refinitiv IBES.</p>\n<p>In company news, CVS Health shares rose 5.7% after the company said its adjusted profit target for 2022 should largely meet Wall Street estimates, as it expects volatile medical costs in its health insurance unit to stabilize.</p>\n<p>Lyft shares rose 8.2% after the ride-hailing company reported an adjusted profit for the third quarter.</p>\n<p>Activision Blizzard Inc shares tumbled 14.1% after the videogame publisher delayed the launch of two much-awaited titles. The stock was the biggest individual drag on the S&amp;P 500.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.01-to-1 ratio; on Nasdaq, a 2.11-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 55 new 52-week highs and three new lows; the Nasdaq Composite recorded 230 new highs and 38 new lows.</p>\n<p>About 11 billion shares changed hands in U.S. exchanges, above the 10.3 billion daily average over the last 20 sessions. (Additional reporting by Stephen Culp and Herbert Lash in New York, Devik Jain and Shashank Nayar in Bengaluru; Editing by Marguerita Choy)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St record run rolls on after Fed unveils anticipated bond-buying 'taper'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St record run rolls on after Fed unveils anticipated bond-buying 'taper'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-04 04:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-st-record-202139031.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 3 (Reuters) - Major Wall Street indexes posted solid gains and marked closing record highs as the Federal Reserve said it will begin trimming its monthly bond purchases in November with plans to ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-record-202139031.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SPY":"标普500ETF","IVV":"标普500指数ETF","OEX":"标普100","SSO":"两倍做多标普500ETF","SH":"标普500反向ETF","ATVI":"动视暴雪","SPXU":"三倍做空标普500ETF","UPRO":"三倍做多标普500ETF","SDS":"两倍做空标普500ETF","COMP":"Compass, Inc.",".SPX":"S&P 500 Index","OEF":"标普100指数ETF-iShares"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-record-202139031.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2180636457","content_text":"Nov 3 (Reuters) - Major Wall Street indexes posted solid gains and marked closing record highs as the Federal Reserve said it will begin trimming its monthly bond purchases in November with plans to end them in 2022, an announcement that investors had been expecting.\nThe S&P 500 and Nasdaq notched record all-time closes for their fifth straight sessions, while the Dow Jones Industrial Average posted a record close for the fourth session in a row.\nThe benchmark S&P 500 advanced into positive territory and ended solidly higher after the U.S. central bank announced plans to begin tapering its bond purchases. Investors had widely anticipated the decision as the Fed pulls back on its monetary support with the economy recovering from the coronavirus pandemic.\n“The Fed did not rock the boat on this one,\" said Ryan Detrick, chief market strategist at LPL Financial. \"It was fairly well-telegraphed what the Fed might do and they did what most people expected.\"\nThe Dow Jones Industrial Average rose 104.95 points, or 0.29%, to 36,157.58, the S&P 500 gained 29.92 points, or 0.65%, to 4,660.57 and the Nasdaq Composite added 161.98 points, or 1.04%, to 15,811.58.\nOf the 11 S&P 500 sectors, consumer discretionary and materials were the top gainers, rising 1.8% and 1.1%, respectively. Energy lagged, falling 0.8%.\nThe central bank's easy money policies have been a significant support for markets, with the S&P 500 more than doubling since its March 2020 low at the onset of the pandemic.\nThe Fed also held to its belief that high inflation would prove \"transitory\" and likely not require a fast rise in interest rates.\n“I don’t think that there’s anything unique in the statement other than the fact they’re trying to buy themselves time by saying both the inflation and supply chain disruptions are temporary, and that’s the bottom line,\" said Joseph LaVorgna, Americas chief economist at Natixis.\nIn a press conference after the Fed's statement, Fed Chair Jerome Powell said it is possible the U.S. job market may have improved enough by the middle of next year to be considered at \"maximum employment,\" a key hurdle to clear for the central bank to consider increasing interest rates.\nBetter-than-expected third-quarter earnings also have helped lift sentiment for equities. With about 360 companies having reported, S&P 500 earnings are expected to have climbed 40.4% in the third quarter from a year earlier, according to Refinitiv IBES.\nIn company news, CVS Health shares rose 5.7% after the company said its adjusted profit target for 2022 should largely meet Wall Street estimates, as it expects volatile medical costs in its health insurance unit to stabilize.\nLyft shares rose 8.2% after the ride-hailing company reported an adjusted profit for the third quarter.\nActivision Blizzard Inc shares tumbled 14.1% after the videogame publisher delayed the launch of two much-awaited titles. The stock was the biggest individual drag on the S&P 500.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.01-to-1 ratio; on Nasdaq, a 2.11-to-1 ratio favored advancers.\nThe S&P 500 posted 55 new 52-week highs and three new lows; the Nasdaq Composite recorded 230 new highs and 38 new lows.\nAbout 11 billion shares changed hands in U.S. exchanges, above the 10.3 billion daily average over the last 20 sessions. (Additional reporting by Stephen Culp and Herbert Lash in New York, Devik Jain and Shashank Nayar in Bengaluru; Editing by Marguerita Choy)","news_type":1},"isVote":1,"tweetType":1,"viewCount":153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":858683109,"gmtCreate":1635044597255,"gmtModify":1635044597534,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/858683109","repostId":"1100055241","repostType":4,"repost":{"id":"1100055241","kind":"news","pubTimestamp":1635040192,"share":"https://www.laohu8.com/m/news/1100055241?lang=&edition=full","pubTime":"2021-10-24 09:49","market":"us","language":"en","title":"Intel: Good Value Or Value Trap?","url":"https://stock-news.laohu8.com/highlight/detail?id=1100055241","media":"Seeking Alpha","summary":"Intel had a mixed earnings report that sent some investors running for the hills.The company beat earnings and actually raised guidance for 2021, but they signaled that supply chain issues remain and profitability in 2022 will be lower.After the sell-off, is Intel a good value or a value trap?The waters have been pretty rough for Intel Corp.  investors over the past few years.It seems like every time the sun comes out...there is another storm right around the corner.As highlighted on the earning","content":"<p><b>Summary</b></p>\n<ul>\n <li>Intel had a mixed earnings report&nbsp;that sent some investors running for the hills.</li>\n <li>The company beat earnings and actually raised guidance for 2021, but they signaled that supply chain issues remain and profitability in 2022 will be lower.</li>\n <li>After the sell-off, is Intel a good value or a value trap?</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c02609041d90c055d66b217f06706d28\" tg-width=\"1536\" tg-height=\"1022\" referrerpolicy=\"no-referrer\"><span>4kodiak/iStock Unreleased via Getty Images</span></p>\n<p>The waters have been pretty rough for Intel Corp. (INTC) investors over the past few years.</p>\n<p>It seems like every time the sun comes out...there is another storm right around the corner.</p>\n<p>As highlighted on the earnings call last night, the next \"storm\" brewing for Intel is continued supply chain issues (component shortages in the PC business) and reduced near-term profitability from rising capital expenditure needs, which has sent the stock plummeting 11% this morning into the abyss.</p>\n<p><img src=\"https://static.tigerbbs.com/5bd612f6f25b6e86d7a72b38440d513f\" tg-width=\"640\" tg-height=\"449\" referrerpolicy=\"no-referrer\"></p>\n<p>However, buying the dips has actually been pretty lucrative in the recent past...if, of course, you were lucky enough to fade the rallies.</p>\n<p>To be fair, Intel has had its fair share of challenges this year, despite general tailwinds in the industry (i.e., chip demand far outpacing supply).</p>\n<p>Specifically, Intel has had some well-documented manufacturing blunders that have caused major delays and loss of some market share...mainly to Advanced Micro Devices (AMD).</p>\n<p>This has triggered concern amongst investors that the stock may be a potential \"value trap\" now.</p>\n<p>All that said, Intel is dedicated to spending $25 billion to $28 billion in 2022 and just broke ground on some new fabs.</p>\n<p>Personally, I don't think we are anywhere near peak demand for chips and I believe that Intel's fabrication capabilities are (and will continue to be) a huge advantage for the company for years to come.</p>\n<p>So how can we structure a trade to take advantage of the upside potential in the stock (after this pullback) while also protecting ourselves from more near-term downside (if any)?</p>\n<p><b>It's a perfect situation for a \"Triple Play\" trade!</b></p>\n<p>Intel Corp.</p>\n<p><b>Sector/Industry:</b>Technology/Semiconductors</p>\n<blockquote>\n Intel is the world's largest chipmaker. It designs and manufactures microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors. It was the prime proponent of Moore's Law for advances in semiconductor manufacturing, though the firm has recently faced manufacturing delays. While Intel's server processor business has benefited from the shift to the cloud, the firm has also been expanding into new adjacencies as the personal computer market has stagnated. These include areas such as the Internet of Things, artificial intelligence, and automotive. Intel has been active on the merger and acquisitions front, acquiring Altera, Mobileye, and Habana Labs in order to bolster these efforts in non-PC arenas.\n</blockquote>\n<p><i>Source: YCharts</i></p>\n<p><b>Valuation/Upside Potential</b></p>\n<p>Intel looks extremely attractive from a valuation standpoint and is currently trading at a decent discount to all of its long-term valuation metrics (hence the high Value Ranking of 10).</p>\n<p>Specifically, Intel is trading at a nice discount to its historical P/E multiple on a forward basis (10.6x 2021 earnings).<i>Note that the company actually just increased its guidance for fiscal 2021 earnings to $5.28 per share</i>.</p>\n<p>That said, as supply chain worries decrease over time, we definitely think there could be some room for margin expansion in the future.</p>\n<p>If you put just a 12x-14x multiple on consensus forward earnings of $5.28 per share for FYE 2021, that would equate to a $63.00- $73.00 stock price (representing 25%-45% upside from current levels).</p>\n<p>Although it probably won't get there in a straight line...</p>\n<p><b>\"Triple Play\" Trade Analysis</b></p>\n<p>A \"Triple Play\" trade involves simultaneously selling a cash-secured put and a covered call on a stock that you own.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7e3af23e0208929d569a6e62a12a9607\" tg-width=\"640\" tg-height=\"360\" referrerpolicy=\"no-referrer\"><span>Source: Option Income Advisor</span></p>\n<p>Note that if you don't currently own INTC stock, you will want to buy it before you write the covered call.</p>\n<p>This trade will allow you to take advantage of the upside potential in the stock while also protecting some of the near-term downside (if any).</p>\n<p><b>Step 1: Sell Cash-Secured Puts (50% of position size)</b></p>\n<p>The first step of the Triple Play trade is to sell a cash-secured put on the stock for 50% of your target position size. For example, if you wanted to own 400 shares of INTC... you would sell 2 cash-secured put contract, which represents 200 shares of stock.</p>\n<p>The three main data points we look at when analyzing a cash-secured put trade are:</p>\n<ul>\n <li>Premium Yield % (or Average Monthly Yield %): Measure of expected return on capital assuming that the option expires worthless (out-of-the-money).<i>Assumes that the option is fully cash secured.</i></li>\n <li>Margin-of-Safety %: Measure of downside protection or the percentage that the underlying stock could decline and would still allow you to break even on the option trade.</li>\n <li>Delta: A good proxy for the probability that the put option will finish in-the-money.</li>\n</ul>\n<p><i>Note that there's always a negative correlation between Premium Yield and Margin of Safety: The higher the Premium Yield for a given strike month, the lower the Margin of Safety.</i></p>\n<p><i>Investors always should be honest with themselves about their risk tolerance. Selling CSPs can be adapted to suit your needs.</i></p>\n<p>As discussed in the video, we like the $45.00-$50.00 range for INTC in the near term. So we like the following cash-secured put:</p>\n<p><i><b>INTC Nov 19th $47.50.00 Put (28 days until expiration)</b></i></p>\n<ul>\n <li>Option Premium: ~$0.58 premium</li>\n <li>Average Monthly Yield %: 1.3% (15.6% annualized)</li>\n <li>Margin-of-Safety %: 4.2%</li>\n <li>Delta: 28</li>\n</ul>\n<p><b>Step 2: Buy the Stock (50% of position size)</b></p>\n<p><i>Note: At the time of publication, INTC was trading at $49.60. If you already own the stock, you can skip to Step 3.</i></p>\n<p>The second step of the Triple Play is to buy the stock (50% of your target position size). For example, if you wanted to own 400 shares of INTC... you would buy 200 shares of stock.</p>\n<p><b>Step 3: Sell Covered Calls On Your Stock Position (*optional*)</b></p>\n<p>A covered call strategy will help generate some short-term income, maintain some upside exposure, and mitigate some downside risk.</p>\n<p>With a covered call, you are agreeing to sell your stock at a higher price (your call option strike price) but you get to keep your call option premium either way.</p>\n<p>As discussed in the video, since we like the upside potential in the near term with INTC, you will want to give yourself some room for the stock to run.<b>So we would actually recommend waiting for the stock to trade a little higher before selling covered calls.</b></p>\n<p>That said, if you wanted to execute the covered calls today, I would certainly consider taking less premium income to preserve more potential upside profit. For example, the $53.00 call would give you an extra 0.5% of income per month (6.0% annualized)...which would essentially triple your dividend yield on the stock!</p>\n<p><i><b>INTC Nov 19th $53.00 Call (28 days until expiration)</b></i></p>\n<ul>\n <li>Option Premium: ~$0.25 premium</li>\n <li>Average Monthly Yield %: 0.5% (6.0% annualized)</li>\n <li>Upside Profit %: 7.4%</li>\n <li>Delta: 15</li>\n</ul>\n<p><b>Conclusion</b></p>\n<p>This Triple Play trade will allow you to take advantage of the upside potential in INTC stock while also giving you some downside cushion if shares trade lower in the near term. As the covered calls and cash-secured puts expire, you can rinse and repeat the Triple Play trade!</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Intel: Good Value Or Value Trap?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntel: Good Value Or Value Trap?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-24 09:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4461530-intel-intc-stock-good-value-or-value-trap><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nIntel had a mixed earnings report that sent some investors running for the hills.\nThe company beat earnings and actually raised guidance for 2021, but they signaled that supply chain issues ...</p>\n\n<a href=\"https://seekingalpha.com/article/4461530-intel-intc-stock-good-value-or-value-trap\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INTC":"英特尔"},"source_url":"https://seekingalpha.com/article/4461530-intel-intc-stock-good-value-or-value-trap","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100055241","content_text":"Summary\n\nIntel had a mixed earnings report that sent some investors running for the hills.\nThe company beat earnings and actually raised guidance for 2021, but they signaled that supply chain issues remain and profitability in 2022 will be lower.\nAfter the sell-off, is Intel a good value or a value trap?\n\n4kodiak/iStock Unreleased via Getty Images\nThe waters have been pretty rough for Intel Corp. (INTC) investors over the past few years.\nIt seems like every time the sun comes out...there is another storm right around the corner.\nAs highlighted on the earnings call last night, the next \"storm\" brewing for Intel is continued supply chain issues (component shortages in the PC business) and reduced near-term profitability from rising capital expenditure needs, which has sent the stock plummeting 11% this morning into the abyss.\n\nHowever, buying the dips has actually been pretty lucrative in the recent past...if, of course, you were lucky enough to fade the rallies.\nTo be fair, Intel has had its fair share of challenges this year, despite general tailwinds in the industry (i.e., chip demand far outpacing supply).\nSpecifically, Intel has had some well-documented manufacturing blunders that have caused major delays and loss of some market share...mainly to Advanced Micro Devices (AMD).\nThis has triggered concern amongst investors that the stock may be a potential \"value trap\" now.\nAll that said, Intel is dedicated to spending $25 billion to $28 billion in 2022 and just broke ground on some new fabs.\nPersonally, I don't think we are anywhere near peak demand for chips and I believe that Intel's fabrication capabilities are (and will continue to be) a huge advantage for the company for years to come.\nSo how can we structure a trade to take advantage of the upside potential in the stock (after this pullback) while also protecting ourselves from more near-term downside (if any)?\nIt's a perfect situation for a \"Triple Play\" trade!\nIntel Corp.\nSector/Industry:Technology/Semiconductors\n\n Intel is the world's largest chipmaker. It designs and manufactures microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors. It was the prime proponent of Moore's Law for advances in semiconductor manufacturing, though the firm has recently faced manufacturing delays. While Intel's server processor business has benefited from the shift to the cloud, the firm has also been expanding into new adjacencies as the personal computer market has stagnated. These include areas such as the Internet of Things, artificial intelligence, and automotive. Intel has been active on the merger and acquisitions front, acquiring Altera, Mobileye, and Habana Labs in order to bolster these efforts in non-PC arenas.\n\nSource: YCharts\nValuation/Upside Potential\nIntel looks extremely attractive from a valuation standpoint and is currently trading at a decent discount to all of its long-term valuation metrics (hence the high Value Ranking of 10).\nSpecifically, Intel is trading at a nice discount to its historical P/E multiple on a forward basis (10.6x 2021 earnings).Note that the company actually just increased its guidance for fiscal 2021 earnings to $5.28 per share.\nThat said, as supply chain worries decrease over time, we definitely think there could be some room for margin expansion in the future.\nIf you put just a 12x-14x multiple on consensus forward earnings of $5.28 per share for FYE 2021, that would equate to a $63.00- $73.00 stock price (representing 25%-45% upside from current levels).\nAlthough it probably won't get there in a straight line...\n\"Triple Play\" Trade Analysis\nA \"Triple Play\" trade involves simultaneously selling a cash-secured put and a covered call on a stock that you own.\nSource: Option Income Advisor\nNote that if you don't currently own INTC stock, you will want to buy it before you write the covered call.\nThis trade will allow you to take advantage of the upside potential in the stock while also protecting some of the near-term downside (if any).\nStep 1: Sell Cash-Secured Puts (50% of position size)\nThe first step of the Triple Play trade is to sell a cash-secured put on the stock for 50% of your target position size. For example, if you wanted to own 400 shares of INTC... you would sell 2 cash-secured put contract, which represents 200 shares of stock.\nThe three main data points we look at when analyzing a cash-secured put trade are:\n\nPremium Yield % (or Average Monthly Yield %): Measure of expected return on capital assuming that the option expires worthless (out-of-the-money).Assumes that the option is fully cash secured.\nMargin-of-Safety %: Measure of downside protection or the percentage that the underlying stock could decline and would still allow you to break even on the option trade.\nDelta: A good proxy for the probability that the put option will finish in-the-money.\n\nNote that there's always a negative correlation between Premium Yield and Margin of Safety: The higher the Premium Yield for a given strike month, the lower the Margin of Safety.\nInvestors always should be honest with themselves about their risk tolerance. Selling CSPs can be adapted to suit your needs.\nAs discussed in the video, we like the $45.00-$50.00 range for INTC in the near term. So we like the following cash-secured put:\nINTC Nov 19th $47.50.00 Put (28 days until expiration)\n\nOption Premium: ~$0.58 premium\nAverage Monthly Yield %: 1.3% (15.6% annualized)\nMargin-of-Safety %: 4.2%\nDelta: 28\n\nStep 2: Buy the Stock (50% of position size)\nNote: At the time of publication, INTC was trading at $49.60. If you already own the stock, you can skip to Step 3.\nThe second step of the Triple Play is to buy the stock (50% of your target position size). For example, if you wanted to own 400 shares of INTC... you would buy 200 shares of stock.\nStep 3: Sell Covered Calls On Your Stock Position (*optional*)\nA covered call strategy will help generate some short-term income, maintain some upside exposure, and mitigate some downside risk.\nWith a covered call, you are agreeing to sell your stock at a higher price (your call option strike price) but you get to keep your call option premium either way.\nAs discussed in the video, since we like the upside potential in the near term with INTC, you will want to give yourself some room for the stock to run.So we would actually recommend waiting for the stock to trade a little higher before selling covered calls.\nThat said, if you wanted to execute the covered calls today, I would certainly consider taking less premium income to preserve more potential upside profit. For example, the $53.00 call would give you an extra 0.5% of income per month (6.0% annualized)...which would essentially triple your dividend yield on the stock!\nINTC Nov 19th $53.00 Call (28 days until expiration)\n\nOption Premium: ~$0.25 premium\nAverage Monthly Yield %: 0.5% (6.0% annualized)\nUpside Profit %: 7.4%\nDelta: 15\n\nConclusion\nThis Triple Play trade will allow you to take advantage of the upside potential in INTC stock while also giving you some downside cushion if shares trade lower in the near term. As the covered calls and cash-secured puts expire, you can rinse and repeat the Triple Play trade!","news_type":1},"isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":888007074,"gmtCreate":1631411396998,"gmtModify":1631889928976,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888007074","repostId":"1145075862","repostType":4,"repost":{"id":"1145075862","kind":"news","pubTimestamp":1631411128,"share":"https://www.laohu8.com/m/news/1145075862?lang=&edition=full","pubTime":"2021-09-12 09:45","market":"us","language":"en","title":"Pinterest Stock: 2 Reasons To Be Excited and 3 Reasons To Worry","url":"https://stock-news.laohu8.com/highlight/detail?id=1145075862","media":"InvestorPlace","summary":"Pinterest is more than a pure social media stock, but it currently has too many fundamental issues","content":"<p>Compared to other social media stocks,<b>Pinterest</b>&nbsp;(NYSE:<b><u>PINS</u></b>) stock is a bit of an oddball. I personally don’t have much use for the platform, but I can see the appeal … somewhat. After all, we could all use a daily dose of inspiration for shopping, relaxing, business and marketing purposes. Still, I’m not the only one who doesn’t quite “get it.”</p>\n<p>But if you’re someone who is interested in investing in PINS stock, here’s a deeper look at what you need to know about the company — and stock — moving forward.</p>\n<p><b>PINS Stock: A Very Strong Balance Sheet</b></p>\n<p>A close look at the balance sheet for Pinterest shows that it has strong financial strength. In fact, according to<i>GuruFocus</i>the current cash-to-debt, debt-to-equity ratios are 17.62 and 0.05, respectively.</p>\n<p>A strong balance sheet is a positive factor when considering whether a stock is investment-worthy. However, it is not the only thing to consider. When looking at the balance sheet, the phrase “cash is king” should ring in your ears. After all, plenty of cash is necessary to run a successful business. Thankfully for PINS, the company has performed well in this regard.</p>\n<p>In 2019, it reported cash and short-term investments of $1.72 billion. That was an increase of 173.34% compared to 2018. In 2020, Pinterest experienced another moderate increase of 2.61% with a figure of $1.76 billion reported.</p>\n<p>In general, the cash and cash equivalents growth for the period 2017-2020 is too high.</p>\n<p><b>Revenue Growth: Consistent and Strong</b></p>\n<p>Revenue is the start of everything in business, bringing cash and using cash, to make a profit. Pinterest excels in its revenue growth for 2017-2020. According to<i>MarketWatch</i>, in 2017, it reported revenue of $472.85 million. Then in 2018, 2019 and 2020, its revenue grew 59.87%, 51.17% and 48.12%, respectively. Pinterest reported 2020 revenue of $1.69 billion. This is a strong revenue trend that I admire.</p>\n<p>But, while a strong balance sheet and strong revenue growth are the two factors to like about Pinterest, it isn’t without its blemishes. Here are the three main things that make PINS stock less appealing.</p>\n<p><b>Lackluster User Growth</b></p>\n<p>Pinterest benefited greatly from the coronavirus pandemic in 2020. The stock reached a 52-week high of $89.90 on strong momentum that started in late 2020. But the stock has since tumbled about 40% to its current price near $55.</p>\n<p>The main issue? Repeated&nbsp;misses on its user growth targets. The news on lower-than-expected monthly users led to a downgrade by JPMorgan&nbsp;on Pinterest stock.</p>\n<p>If lackluster or, worse,<i>declining</i>&nbsp;user growth continues in the next quarters this could put a significant dent in the long-term case for PINS stock. After all, it would lead to a decline in advertising revenue for Pinterest. Not so good.</p>\n<p>Pinterest’s management must find a solution to this decline in users as more people start to enter the “new normal.” Otherwise, its success in 2020 will be short lived.</p>\n<p><b>Profitability: Not Present Yet</b></p>\n<p>Another risk factor to consider with Pinterest is that despite its strong revenue growth, the company is still losing money. We can see this trend in its net losses of $130.04 million, $62.97 million, $1.36 billion and $128.32 million for 2017, 2018, 2019 and 2020, respectively.</p>\n<p>This ultimately points to an inefficient business model, as the company is struggling to deliver profits.</p>\n<p><b>Valuation: Too Pricey</b></p>\n<p>The final issue with PINS stock that I’d like to bring to your attention is it’s overprice valuation. If we use<i>MSN Money</i>to<i>c</i>ompare key financial metrics, such as price-to-sales ratio, price-to-book value and price-to-cash flow ratio, to same ratios of the Software &amp; IT Services space more broadly, we find that Pinterest is relatively overvalued.</p>\n<p>Specifically, PINS stock has a price-to-sales ratio of 21.23x, a price-to-book value ratio of 15.57x and a price-to-cash flow ratio of 3,145x. Meanwhile, the industry’s equivalent ratios are as follows: 7.35x, 7.76x and 29.68x, respectively.</p>\n<p>Ultimately, PINS stock has some severe fundamental issues to solve before it’s truly buy-worthy in my book. Until revenue generates profit and its valuation is attractive, I suggest avoiding the stock.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pinterest Stock: 2 Reasons To Be Excited and 3 Reasons To Worry</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPinterest Stock: 2 Reasons To Be Excited and 3 Reasons To Worry\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 09:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/pinterest-stock-2-reasons-to-be-excited-and-3-reasons-to-worry/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Compared to other social media stocks,Pinterest (NYSE:PINS) stock is a bit of an oddball. I personally don’t have much use for the platform, but I can see the appeal … somewhat. After all, we could ...</p>\n\n<a href=\"https://investorplace.com/2021/09/pinterest-stock-2-reasons-to-be-excited-and-3-reasons-to-worry/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PINS":"Pinterest, Inc."},"source_url":"https://investorplace.com/2021/09/pinterest-stock-2-reasons-to-be-excited-and-3-reasons-to-worry/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145075862","content_text":"Compared to other social media stocks,Pinterest (NYSE:PINS) stock is a bit of an oddball. I personally don’t have much use for the platform, but I can see the appeal … somewhat. After all, we could all use a daily dose of inspiration for shopping, relaxing, business and marketing purposes. Still, I’m not the only one who doesn’t quite “get it.”\nBut if you’re someone who is interested in investing in PINS stock, here’s a deeper look at what you need to know about the company — and stock — moving forward.\nPINS Stock: A Very Strong Balance Sheet\nA close look at the balance sheet for Pinterest shows that it has strong financial strength. In fact, according toGuruFocusthe current cash-to-debt, debt-to-equity ratios are 17.62 and 0.05, respectively.\nA strong balance sheet is a positive factor when considering whether a stock is investment-worthy. However, it is not the only thing to consider. When looking at the balance sheet, the phrase “cash is king” should ring in your ears. After all, plenty of cash is necessary to run a successful business. Thankfully for PINS, the company has performed well in this regard.\nIn 2019, it reported cash and short-term investments of $1.72 billion. That was an increase of 173.34% compared to 2018. In 2020, Pinterest experienced another moderate increase of 2.61% with a figure of $1.76 billion reported.\nIn general, the cash and cash equivalents growth for the period 2017-2020 is too high.\nRevenue Growth: Consistent and Strong\nRevenue is the start of everything in business, bringing cash and using cash, to make a profit. Pinterest excels in its revenue growth for 2017-2020. According toMarketWatch, in 2017, it reported revenue of $472.85 million. Then in 2018, 2019 and 2020, its revenue grew 59.87%, 51.17% and 48.12%, respectively. Pinterest reported 2020 revenue of $1.69 billion. This is a strong revenue trend that I admire.\nBut, while a strong balance sheet and strong revenue growth are the two factors to like about Pinterest, it isn’t without its blemishes. Here are the three main things that make PINS stock less appealing.\nLackluster User Growth\nPinterest benefited greatly from the coronavirus pandemic in 2020. The stock reached a 52-week high of $89.90 on strong momentum that started in late 2020. But the stock has since tumbled about 40% to its current price near $55.\nThe main issue? Repeated misses on its user growth targets. The news on lower-than-expected monthly users led to a downgrade by JPMorgan on Pinterest stock.\nIf lackluster or, worse,declining user growth continues in the next quarters this could put a significant dent in the long-term case for PINS stock. After all, it would lead to a decline in advertising revenue for Pinterest. Not so good.\nPinterest’s management must find a solution to this decline in users as more people start to enter the “new normal.” Otherwise, its success in 2020 will be short lived.\nProfitability: Not Present Yet\nAnother risk factor to consider with Pinterest is that despite its strong revenue growth, the company is still losing money. We can see this trend in its net losses of $130.04 million, $62.97 million, $1.36 billion and $128.32 million for 2017, 2018, 2019 and 2020, respectively.\nThis ultimately points to an inefficient business model, as the company is struggling to deliver profits.\nValuation: Too Pricey\nThe final issue with PINS stock that I’d like to bring to your attention is it’s overprice valuation. If we useMSN Moneytocompare key financial metrics, such as price-to-sales ratio, price-to-book value and price-to-cash flow ratio, to same ratios of the Software & IT Services space more broadly, we find that Pinterest is relatively overvalued.\nSpecifically, PINS stock has a price-to-sales ratio of 21.23x, a price-to-book value ratio of 15.57x and a price-to-cash flow ratio of 3,145x. Meanwhile, the industry’s equivalent ratios are as follows: 7.35x, 7.76x and 29.68x, respectively.\nUltimately, PINS stock has some severe fundamental issues to solve before it’s truly buy-worthy in my book. Until revenue generates profit and its valuation is attractive, I suggest avoiding the stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881680595,"gmtCreate":1631330767917,"gmtModify":1631889928976,"author":{"id":"3582719067968878","authorId":"3582719067968878","name":"Nyannie","avatar":"https://static.tigerbbs.com/e49d49ced16baf68b59df813f08820a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582719067968878","authorIdStr":"3582719067968878"},"themes":[],"htmlText":"Gkkd","listText":"Gkkd","text":"Gkkd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/881680595","repostId":"1105074635","repostType":4,"repost":{"id":"1105074635","kind":"news","pubTimestamp":1631321029,"share":"https://www.laohu8.com/m/news/1105074635?lang=&edition=full","pubTime":"2021-09-11 08:43","market":"us","language":"en","title":"The S&P 500 Has Had a Good Run. Why Wall Street Thinks a Pullback Is Coming.","url":"https://stock-news.laohu8.com/highlight/detail?id=1105074635","media":"Barrons","summary":"S&P 500 index funds will tumble by Christmas, one Wall Street strategist predicts. Not necessarily, ","content":"<p>S&amp;P 500 index funds will tumble by Christmas, one Wall Street strategist predicts. Not necessarily, says another—but they’ll lose money over the next decade. I can’t decide whether to panic or just sulk.</p>\n<p>The index decides the fate of more than $5 trillion in linked investor assets. My only exposure is in my retirement, joint, college, healthcare, and, come to think of it, all other investment accounts. I don’t think my Chipotle Rewards account is affected, but I haven’t read the small print.</p>\n<p>The concern, of course, is that S&amp;P 500 trackers have had it too good for too long. The index has returned 376% over the past decade, or close to 17% a year, compounded. Among active managers tasked with beating the index, four out of five failed during the 10 years through 2020.</p>\n<p>For Bogleheads, as devotees of the late Vanguard founder and indexing pioneer John Bogle call themselves, the explanation is simple: Stock-picking is futile. But if that’s so, the typical active manager should do no better or worse than indexes on underlying stock performance, and underperform only to the extent he or she charges extra fees. In fact, they have trailed over 10 years by an average of 2.5% a year. Stinking that badly is a skill of its own—one that theoretically shouldn’t exist.</p>\n<p>Another explanation is that the S&amp;P 500’s popularity has created its own tailwind. “Flows into index funds raise the prices of large stocks,” conclude researchers from Michigan State University, the London School of Economics, and the University of California, Irvine,in a working paper&nbsp;that has been circulating since late last year. By now, you’ve heard that five companies&nbsp;—&nbsp;Apple,Microsoft,Alphabet,Amazon.com,and&nbsp;Facebook—combined for one-quarter of the S&amp;P 500’s market value. But all are still growing nicely, so why worry now?</p>\n<p>This past Tuesday, Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, predicted a 10% to 15% slide for the S&amp;P 500 before year’s end, but she says that doesn’t make her bearish. She points out that most 12-month stretches contain a big pullback for the index, but that we haven’t had one since March 2020. Tech giants, she has noticed, have lately traded hand-in-hand with Treasuries, suggesting that investors have come to view them as havens.</p>\n<p>“Owning the index today in a global context is a relatively defensive position, and we believe that it’s time to play offense,” she says.</p>\n<p>In Shalett’s view, interest rates will rise as global economies rebound, putting pressure on stock valuations. She predicts upside earnings surprises and stock outperformance for cyclical sectors like financials, industrials, energy, and materials, and for some pockets of consumer services and healthcare. “We’re very excited about buying a lot of different stocks,” she says. “We’re just not super-psyched about owning the index.”</p>\n<p>On Wednesday, Bank of America Securities issued a similarly mixed signal. It raised its year-end S&amp;P 500 target from 3800 all the way to 4250, which sounds optimistic. But it referred to the change as a mark to market—something typically done obligingly by accountants, not enthusiastically by forecasters. Also, the new target implies a decline of 5% or so from recent levels. Indexers have already made an easy 20% this year, so why sweat a holiday haircut? Because the bank is also predicting a 10-year average loss in the index of 0.8% a year.</p>\n<p>It’s devilishly difficult to predict short-term stock market returns. I tend to follow such forecasts more for the rationales than the targets. But long-term returns might be more closely linked than short-term ones to starting valuations, making forecasting more feasible. BofA says one measure has predicted about 80% of 10-year returns for the S&amp;P 500 since 1987: the ratio of the index’s price to what the bank calls its normalized earnings for the past 12 months. A typical reading is 19. The latest is 29. That has nudged the model’s predicted 10-year return below zero for the first time since 1999.</p>\n<p>BofA’s prescription is to buy dividend-growers and inflation beneficiaries like energy, financials, and materials. It also likes small-cap stocks, which it says are more closely tied than large-caps to U.S. economic growth, and have valuations that point to positive 10-year returns.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The S&P 500 Has Had a Good Run. Why Wall Street Thinks a Pullback Is Coming.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe S&P 500 Has Had a Good Run. Why Wall Street Thinks a Pullback Is Coming.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-11 08:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/sp-500-index-is-looking-vulnerable-51631313125?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>S&P 500 index funds will tumble by Christmas, one Wall Street strategist predicts. Not necessarily, says another—but they’ll lose money over the next decade. I can’t decide whether to panic or just ...</p>\n\n<a href=\"https://www.barrons.com/articles/sp-500-index-is-looking-vulnerable-51631313125?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.barrons.com/articles/sp-500-index-is-looking-vulnerable-51631313125?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105074635","content_text":"S&P 500 index funds will tumble by Christmas, one Wall Street strategist predicts. Not necessarily, says another—but they’ll lose money over the next decade. I can’t decide whether to panic or just sulk.\nThe index decides the fate of more than $5 trillion in linked investor assets. My only exposure is in my retirement, joint, college, healthcare, and, come to think of it, all other investment accounts. I don’t think my Chipotle Rewards account is affected, but I haven’t read the small print.\nThe concern, of course, is that S&P 500 trackers have had it too good for too long. The index has returned 376% over the past decade, or close to 17% a year, compounded. Among active managers tasked with beating the index, four out of five failed during the 10 years through 2020.\nFor Bogleheads, as devotees of the late Vanguard founder and indexing pioneer John Bogle call themselves, the explanation is simple: Stock-picking is futile. But if that’s so, the typical active manager should do no better or worse than indexes on underlying stock performance, and underperform only to the extent he or she charges extra fees. In fact, they have trailed over 10 years by an average of 2.5% a year. Stinking that badly is a skill of its own—one that theoretically shouldn’t exist.\nAnother explanation is that the S&P 500’s popularity has created its own tailwind. “Flows into index funds raise the prices of large stocks,” conclude researchers from Michigan State University, the London School of Economics, and the University of California, Irvine,in a working paper that has been circulating since late last year. By now, you’ve heard that five companies — Apple,Microsoft,Alphabet,Amazon.com,and Facebook—combined for one-quarter of the S&P 500’s market value. But all are still growing nicely, so why worry now?\nThis past Tuesday, Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, predicted a 10% to 15% slide for the S&P 500 before year’s end, but she says that doesn’t make her bearish. She points out that most 12-month stretches contain a big pullback for the index, but that we haven’t had one since March 2020. Tech giants, she has noticed, have lately traded hand-in-hand with Treasuries, suggesting that investors have come to view them as havens.\n“Owning the index today in a global context is a relatively defensive position, and we believe that it’s time to play offense,” she says.\nIn Shalett’s view, interest rates will rise as global economies rebound, putting pressure on stock valuations. She predicts upside earnings surprises and stock outperformance for cyclical sectors like financials, industrials, energy, and materials, and for some pockets of consumer services and healthcare. “We’re very excited about buying a lot of different stocks,” she says. “We’re just not super-psyched about owning the index.”\nOn Wednesday, Bank of America Securities issued a similarly mixed signal. It raised its year-end S&P 500 target from 3800 all the way to 4250, which sounds optimistic. But it referred to the change as a mark to market—something typically done obligingly by accountants, not enthusiastically by forecasters. Also, the new target implies a decline of 5% or so from recent levels. Indexers have already made an easy 20% this year, so why sweat a holiday haircut? Because the bank is also predicting a 10-year average loss in the index of 0.8% a year.\nIt’s devilishly difficult to predict short-term stock market returns. I tend to follow such forecasts more for the rationales than the targets. But long-term returns might be more closely linked than short-term ones to starting valuations, making forecasting more feasible. BofA says one measure has predicted about 80% of 10-year returns for the S&P 500 since 1987: the ratio of the index’s price to what the bank calls its normalized earnings for the past 12 months. A typical reading is 19. The latest is 29. That has nudged the model’s predicted 10-year return below zero for the first time since 1999.\nBofA’s prescription is to buy dividend-growers and inflation beneficiaries like energy, financials, and materials. It also likes small-cap stocks, which it says are more closely tied than large-caps to U.S. economic growth, and have valuations that point to positive 10-year returns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}